
<html lang="en"     class="pb-page"  data-request-id="f2243660-48f5-4dd1-b46d-edf0cb6ea51b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm100387d"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents" /></meta><meta name="dc.Creator" content="Guoqiang  Dong" /></meta><meta name="dc.Creator" content="Chunquan  Sheng" /></meta><meta name="dc.Creator" content="Shengzheng  Wang" /></meta><meta name="dc.Creator" content="Zhenyuan  Miao" /></meta><meta name="dc.Creator" content="Jianzhong  Yao" /></meta><meta name="dc.Creator" content="Wannian  Zhang" /></meta><meta name="dc.Description" content="Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally di..." /></meta><meta name="Description" content="Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally di..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 13, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100387d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100387d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100387d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100387d" /></link>
        
    
    

<title>Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100387d" /></meta><meta property="og:title" content="Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0008.jpeg" /></meta><meta property="og:description" content="Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure−activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC50 values in the range 0.049−2.6 μM." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100387d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100387d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100387d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100387d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100387d&amp;href=/doi/10.1021/jm100387d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 7521-7531</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901885s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1001887" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guoqiang++Dong">Guoqiang Dong</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chunquan++Sheng">Chunquan Sheng</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shengzheng++Wang">Shengzheng Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhenyuan++Miao">Zhenyuan Miao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianzhong++Yao">Jianzhong Yao</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wannian++Zhang">Wannian Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People’s Republic of China</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For C.S.: phone/fax, 86-21-65516994; e-mail, <a href="/cdn-cgi/l/email-protection#bccfd4d9d2dbdfcdfcd4d3c8d1ddd5d092dfd3d1"><span class="__cf_email__" data-cfemail="4e3d262b20292d3f0e26213a232f2722602d2123">[email protected]</span></a>. For W.Z.: phone/fax, 86-21-81871243; e-mail, <a href="/cdn-cgi/l/email-protection#8ff5e7eee1e8f8e1e4cfe7e0fbe2eee6e3a1ece0e2"><span class="__cf_email__" data-cfemail="166c7e77787161787d567e79627b777f7a3875797b">[email protected]</span></a></div><div class="corresp-fn" id="fn1">†These two authors contributed equally to this work.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100387d&amp;href=/doi/10.1021%2Fjm100387d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 7521–7531</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 13, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 March 2010</li><li><span class="item_label"><b>Published</b> online</span>13 October 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 November 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100387d" title="DOI URL">https://doi.org/10.1021/jm100387d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7521%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuoqiang%2BDong%252C%2BChunquan%2BSheng%252C%2BShengzheng%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D21%26contentID%3Djm100387d%26title%3DSelection%2Bof%2BEvodiamine%2Bas%2Ba%2BNovel%2BTopoisomerase%2BI%2BInhibitor%2Bby%2BStructure-Based%2BVirtual%2BScreening%2Band%2BHit%2BOptimization%2Bof%2BEvodiamine%2BDerivatives%2Bas%2BAntitumor%2BAgents%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7531%26publicationDate%3DNovember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100387d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3472</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">76</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100387d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guoqiang&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Chunquan&quot;,&quot;last_name&quot;:&quot;Sheng&quot;},{&quot;first_name&quot;:&quot;Shengzheng&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhenyuan&quot;,&quot;last_name&quot;:&quot;Miao&quot;},{&quot;first_name&quot;:&quot;Jianzhong&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Wannian&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7521-7531&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100387d&quot;},&quot;abstract&quot;:&quot;Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure−activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC50 values in the range 0.049−2.6 μM.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100387d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100387d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100387d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100387d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100387d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100387d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100387d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100387d&amp;href=/doi/10.1021/jm100387d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100387d" /></input><a href="/doi/pdf/10.1021/jm100387d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100387d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100387d%26sid%3Dliteratum%253Aachs%26pmid%3D20942490%26genre%3Darticle%26aulast%3DDong%26date%3D2010%26atitle%3DSelection%2Bof%2BEvodiamine%2Bas%2Ba%2BNovel%2BTopoisomerase%2BI%2BInhibitor%2Bby%2BStructure-Based%2BVirtual%2BScreening%2Band%2BHit%2BOptimization%2Bof%2BEvodiamine%2BDerivatives%2Bas%2BAntitumor%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D21%26spage%3D7521%26epage%3D7531%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a>,</li><li><a href="/action/doSearch?ConceptID=291098" title="Antitumor activity">Antitumor activity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jmcmar.2010.53.issue-21/production/jmcmar.2010.53.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds <b>1</b>, <b>14</b>, <b>20</b>, <b>21</b>, and <b>23</b>) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit <b>20</b> (evodiamine) was chosen for preliminary structure−activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound <b>29u</b>, was the most active one with IC<sub>50</sub> values in the range 0.049−2.6 μM.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">DNA topoisomerase I (TopoI<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: TopoI, topoisomerase I; CPT, camptothecin; hCPT, homocamptothecin; SBVS, structure-based virtual screening; rmsd, root-mean-square deviation; SAR, structure−activity relationship; MD, molecular dynamics; GA, genetic algorithm; OD, absorbance.</p></div> is a ubiquitous and essential enzyme in mammals.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> TopoI produces a single strand break in DNA allowing relaxation of DNA supercoils. The catalytic mechanism involves a nucleophilic attack by the active site tyrosine OH group (Tyr723 in human TopoI) on the phosphate group at 3′-end of the cutting strand,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> which results in the broken of the DNA phosphodiester bond and the formation of a binary DNA−TopoI covalent complex (cleavable complex). After cleavage, the broken (scissile) DNA strand can rotate around the unbroken (nonscissile) strand and remove DNA supercoils.</div><div class="NLM_p">TopoI is a validated target for cancer chemotherapy<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> since its identification as the only target of camptothecin (CPT),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> which was first isolated from the Chinese tree <i>Camptotheca acuminata</i> by Wall and co-workers in 1966.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> CPT and its derivatives act by binding to a transient TopoI−DNA covalent complex, leading to an accumulation of DNA strand breaks upon replication, ultimately resulting in cell death during the S phase of the cell cycle.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> CPT shows potent antitumor activity and has been evaluated in the clinic. However, its therapeutic application is hindered because of poor aqueous solubility and high in vivo hepatoxicity. Subsequently, the structural modification of natural CPT has generated many new CPT derivatives with improved pharmacological or pharmacokinetic profile.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> For example, topotecan<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and irinotecan<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) have entered clinical use. Several drug candidates, such as rubitecan,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> lurtotecan,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and exatecan,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> are currently at different stages of the clinical trials.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of clinical relevant topoisomerase I inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although CPT analogues have achieved great success in clinical cancer chemotherapy, the intrinsic instability of the highly electrophilic α-hydroxylactone of the E ring undergoes rapid hydrolysis to the biologically inactive carboxylate form under physiological conditions.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In order to improve the stability of E-ring, two kinds of modifications have been performed. One approach is the insertion of a methylene spacer between the alcohol and carboxyl functions of CPT to obtain homocamptothecin (hCPT).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The modified A and/or B ring hCPT analogues<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a> have produced two candidates in clinical trial (i.e., diflomotecan<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and BN80927,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The second approach is the conversion of the E-ring to a five-membered ring (α-keto derivatives).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> They can completely block E-ring-opening and retain high TopoI inhibitory activity. The cyclobutane methylenedioxy derivative S39625 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) shows remarkable potency and is under consideration for clinical trials.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">Although CPT derivatives are the only clinically approved TopoI inhibitors, they have several major limitations:<a onclick="showRef(event, 'ref1 ref3 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref1 ref3 ref27 ref28">(1, 3, 27, 28)</a> (1) As discussed above, CPTs are chemically unstable and rapidly inactivated to carboxylate in blood;. (2) The CPT-trapped cleavage complexes reverse within minutes after drug removal,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> which means that they must be given as prolonged and/or repeated infusions to maintain persistent cleavage complexes. (3) Cells overexpressing the drug efflux membrane transporters are cross-resistant to CPTs.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> Moreover, several resistance mutations of TopoI (such as Asn722S and Arg364H) have been reported.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> (4) The side effects of camptothecins are dose-limiting and potentially severe (such as diarrhea and neutropenia), which limit the dose that can be safely administered.</div><div class="NLM_p">To overcome the drawbacks of CPTs, the discovery of non-CPT TopoI inhibitors has recently emerged as a promising field to find better antitumor agents. Among non-CPT compounds, the most promising are indolocarbazoles, indenoisoquinolines, and phenanthridines.<a onclick="showRef(event, 'ref3 ref35'); return false;" href="javascript:void(0);" class="ref ref3 ref35">(3, 35)</a> Two indolocarbazoles, edotecarin<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and BMS-250749,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> have entered clinical trial, and two indenoisoquinolines derivatives (NSC 725776 and 724998) are under review for clinical trials (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> They have shown favorable characteristics for the development of novel anticancer agents.</div><div class="NLM_p">Moreover, the discovery of novel TopoI inhibitors is facilitated by the improvement of a variety of biochemical and cellular assays and X-ray crystal structures. The X-ray crystal structures of human apo-TopoI<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and TopoI−DNA complex bound with camptothecin (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I">1T8I</a>),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> topotecan (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T">1K4T</a>),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> indolocarbazole (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SCU">1SCU</a>),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> indenoisoquinoline (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SC7">1SC7</a>),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and norindenoisoquinoline (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1TL8">1TL8</a>)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> have been reported. The understanding of TopoI’s molecular structure and mechanism of action provides insights into the physiological functions of TopoI and also provides a strong structural basis for the rational design of highly potent non-CPT TopoI inhibitors.</div><div class="NLM_p last">Structure-based virtual screening (SBVS) is becoming a powerful tool for hit identification.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41-43)</a> In this work, we describe the rapid and successful identification of novel TopoI inhibitors using SBVS. Five hits were identified to possess both TopoI inhibitory activity and in vitro antitumor activity. After preliminary optimization of hit <b>20</b>, both antitumor activity and antitumor spectrum were improved. To the best of our knowledge, this is the first example of the successful application of SBVS to identify novel TopoI inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Virtual Screening</h3><div class="NLM_p">The evaluation of the reliability of various docking methods for the docking of TopoI inhibitors was performed (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for detailed results). Gold with GoldScore fitness function was found to be the best method for TopoI−DNA−CPT complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I">1T8I</a>). A schematic summary of the overall virtual screening procedure in this study is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. A total of 287000 compounds in SPECS database (<a href="http://www.specs.com" class="extLink">www.specs.com</a>) were docked and ranked with GOLD. The fitness score of CPT in the active site of TopoI (fitness score of 90) was used as a cutoff value for the selection of the initial compounds. Thus, top-ranked 7622 complexes were first selected and submitted to docking validation and visual inspection. The selection of the candidate molecules was based on the following criteria: (1) Complementarity exists between the ligand and the active site of TopoI. (2) Reasonable chemical structure and pose are in the active site of TopoI. Some unusually highly scored molecules were found to have many rotatable bonds (such as long aliphatic structures), which were excluded for further evaluation. (3) There is formation of at least one hydrogen bond between the ligand and the important residues of TopoI (such as Arg364, Asp533, and Asn722, etc). As revealed by various TopoI−inhibitor complex structures,<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> these residues are critical for the inhibitor binding. (4) Protonation state and the tautomeric form of the ligand have to be acceptable. (5) The binding mode of the compounds can be reproduced by at least two docking methods. As a result, 163 candidate compounds can meet the above criteria. In order to achieve good chemical diversity, the resulting 163 candidates were subsequently filtered by similarity/substructure search. For the compounds with the same scaffold, only the one with the best fitness score was kept. Consequently, 48 potential TopoI inhibitors were designated for purchase. However, only 23 compounds turned out to be commercially available for in vitro assaying (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Flowchart of the virtual screening procedure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of the purchased compounds from virtual screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vitro TopoI Inhibition Assay</h3><div class="NLM_p">Generally, TopoI inhibitors act by stabilizing a covalent TopoI−DNA complex called the cleavable complex. Therefore, TopoI-mediated DNA cleavage assays with purified TopoI were used to investigate the inhibitory activity of the purchased compounds with their concentrations ranging from 1 to 500 μM. The ability of compounds to stabilize the cleavable complex was evaluated by incubating TopoI and supercoiled DNA pBR322 in the presence of drugs. Cleavable complexes were revealed by the appearance of short DNA fragments when the samples were analyzed by gel electrophoresis under denaturing conditions. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, 14 of 23 compounds were discovered to be active against TopoI-mediated relaxation of supercoiled DNA at high concentrations (500 μM). The TopoI inhibition activity of 14 hits was further tested at lower concentrations with five compounds (<b>1</b>, <b>6</b>, <b>14</b>, <b>19</b>, and <b>21</b>) active at 50 μM and two compounds (<b>1</b> and <b>6</b>) active against 10 μM (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Gel electrophoresis of TopoI-induced DNA cleavage assay for hits from virtual screening. (A) Inhibition of TopoI relaxation activity at 500 μM: lane 1, DNA + TopoI; lane 2, supercoiled plasmid DNA; lane 3, DNA + TopoI + CPT; lanes 4−17, DNA + TopoI + hit (<b>1</b>, <b>3</b>, <b>5</b>, <b>6</b>, <b>8</b>, <b>11</b>, <b>12</b>, <b>13</b>, <b>14</b>, <b>16</b>, <b>19</b>, <b>20</b>, <b>21</b>, and <b>23</b>, respectively). (B) Inhibition of TopoI relaxation activity ranging from 50 to 500 μM: lane 1, supercoiled plasmid DNA; lane 2, DNA + TopoI; lanes 3−5, DNA + TopoI + compound <b>20</b> (500, 100, and 50 μM); lanes 6−8, DNA + TopoI + 1 (500, 100, and 50 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> In Vitro Antitumor Activity</h3><div class="NLM_p last">The solid tumor cell lines A-549 (for non-small-cell lung cancer), LOVO (for colon cancer), HCT116 (for colon cancer), and MDA-MB-435 (for breast cancer) were chosen for testing the in vitro antitumor activities of the compounds. CPT and irinotecan were used as the reference compounds. In order to investigate the correlation between the TopoI inhibitory activity and antitumor activity, all the purchased compounds were tested for their cytotoxicity. The results revealed that most of the compounds without TopoI inhibitory activity did not show in vitro antitumor activity. Some weak TopoI inhibitors (such as <b>3</b>, <b>5</b>, <b>8</b>, <b>12</b>, and <b>16</b>) were also inactive against the tested tumor cell lines. Among the TopoI inhibitors, five compounds (<b>1</b>, <b>14</b>, <b>20</b>, <b>21</b>, and <b>23</b>) showed moderate to good cytotoxicity. However, no in vitro antitumor activity was observed for compound <b>6</b>, the most potent TopoI inhibitor. It is well accepted that the penetration ability of cell membrane is an important factor for the cytotoxicity. Compound <b>6</b> has a carboxyl group and has difficulty crossing the cell membrane. Compounds <b>1</b> and <b>21</b>, another two potent TopoI inhibitors, also showed good in vitro antitumor activity with broad spectrum. They are active against all the three human tumor cell lines with their IC<sub>50</sub> values in the range 0.50−43 μM. The potent antitumor activity of the compounds can be well related to their capacity to inhibit TopoI. Although the cytotoxicity of compounds identified from virtual screening is lower than that of CPT and irinotecan, they provide novel chemotypes for the discovery of novel antitumor agents.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Binding Mode of the New TopoI Inhibitors</h3><div class="NLM_p">In order to obtain accurate binding mode of the hits, molecular dynamics (MD) simulations were performed on the docking model of compounds <b>1</b>, <b>6</b>, <b>20</b>, and <b>21</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for detailed computational protocols and results). We used the Desmond method (Desmond_Maestro_academic-2009-02,<a href="http://www.deshawresearch.com" class="extLink">http://www.deshawresearch.com</a>) to carry out all the simulations. After 2 ns of MD calculations, stable TopoI−DNA−inhibitor ternary complexes were obtained. The MD results indicated that the conformation of hits in the active site of TopoI was very similar to that in the docking model (rmsd of <2 Å) and important stacking and hydrogen-bonding interactions were preserved. Although the hits represent several unique chemotypes, they were predicted to bind with the TopoI active site in a manner similar to that of the known TopoI inhibitors except compound <b>20</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Most of the compounds have planar structure, which intercalates at the site of DNA cleavage and forms base-stacking interactions with both the −1 (upstream) and +1 (downstream) base pairs. Moreover, they can form hydrogen-bonding interaction with the surrounding residues, such as Arg364 and Asn352. For example, compound <b>6</b> can intercalate into DNA base pairs with the thiazolotriazol ring mimicking the BC ring of CPT and with the phenyl group mimicking the E ring of CPT (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). The thiazolone carbonyl oxygen and triazole nitrogen can form two hydrogen bonds with Arg364. Its indol-2-one-<i>N</i>-acetic acid part is faced into the major groove, and the terminal carboxyl group forms no direct interaction with TopoI, suggesting that the carboxyl group can be replaced by a more hydrophobic group to improve its cytotoxicity. Unlike other hits, compound <b>20</b> shares “L type” conformation in the active site of TopoI (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). Only the DE ring of <b>20</b> intercalates at the DNA cleavage site and stacks with the base pairs. Hydrogen bonding interaction is observed between its indole NH and Arg364 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Schematic representation of the proposed binding mode for compounds <b>1</b> (A), <b>6</b> (B), <b>20</b> (C), and <b>21</b> (D) in the TopoI−DNA complex. The figure was generated using PyMol (<a href="http://pymol.sourceforge.net/" class="extLink">http://pymol.sourceforge.net/</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Among the identified hits, compounds <b>1</b> and <b>21</b> showed potent activity in both TopoI inhibition assay and antitumor activity assay. The binding mode of compound <b>1</b> in the active site of TopoI is similar to that of CPT. Its orientation in the active site cavity is perpendicular to the main axis of the DNA and parallel to the bases. The planar nature of the anthrathiadiazole ring system allows it to stack with the base pairs. Hydrogen-bonding interaction was observed between the nitrogen atom of thiadiazole ring and Arg364 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). The 4-tosyl group was faced into the major groove and formed hydrophobic interaction with the surrounding hydrophobic residues such as Ala351 and Met428. Compound <b>21</b> is the only charged inhibitor depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. Like CPT, the six-member planar ring of <b>21</b> intercalates at the site of DNA cleavage, between the +1 and −1 base pairs (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D). Its C ring is on the minor groove side of the intercalation binding pocket, and its nitrogen atom forms a hydrogen bond with Arg364 at a distance of 2.36 Å. The amide side chain of the B-ring nitrogen projects in the major groove with its amide NH forming hydrogen bonding interaction with Asn352. In summary, compounds <b>1</b>, <b>6</b>, and <b>21</b> have three common structural features: (1) a planar aromatic ring that intercalates at DNA cleavage site; (2) a heterocyclic nitrogen atom as a hydrogen bond acceptor that forms a hydrogen bond with Arg364; (3) a hydrophobic side chain that faces into the major groove. These structural features are well consistent with the known TopoI inhibitors, such as CPTs, indolocarbazoles, and indenoisoquinolines.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Preliminary Optimization of Hit 20 and Structure−Activity Relationships</h3><div class="NLM_p">Compounds <b>1</b>, <b>14</b>, <b>20</b>, <b>21</b>, and <b>23</b> showed both TopoI inhibitory activities and potent in vitro antitumor activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). They provided good starting points for further optimization. In the present study, compound <b>20</b> (evodiamine), a quinolone alkaloid isolated from the fruit of <i>Evodia rutaecarpa</i>,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> was first chosen for preliminary structure−activity relationship studies. Evodiamine has shown various biological activities, including catecholamine secretion,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> testosterone secretion,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> antiobesity,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> anti-inflammatory,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> antiapoptosis,<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> antinociceptive,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> vasodilatory,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and thermoregulatory<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> effects. However, the SAR study of evodiamine has not been reported. We chose evodiamine for hit optimization because it possesses several advantages for structural modification. (1) It is the only compound with a free N−H function from which derivatives can be readily obtained. (2) It has relatively low molecular weight (MW = 303) and is suitable for further optimization. (3) It shows the best cytotoxicity against the breast cancer cell line MDA-MB-435 (IC<sub>50</sub> = 29 μM). (3) Unlike other planar hits, it binds to TopoI with “L type” conformation, which is uncommon for TopoI inhibitors.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Antitumor Activity of the Compounds Obtained from Virtual Screening (IC<sub>50</sub>, μM)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center">IC<sub>50</sub>, μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A549</th><th class="colsep0 rowsep0" align="center">LOVO</th><th class="colsep0 rowsep0" align="center">MDA-MB-435</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.50 ± 0.021</td><td class="colsep0 rowsep0" align="left">43 ± 1.1</td><td class="colsep0 rowsep0" align="left">25 ± 0.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">120 ± 2.3</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">75 ± 1.8</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">240 ± 29</td><td class="colsep0 rowsep0" align="left">170 ± 15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">190 ± 8.2</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">29 ± 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">37 ± 1.6</td><td class="colsep0 rowsep0" align="left">26 ± 2.0</td><td class="colsep0 rowsep0" align="left">77 ± 7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">45 ± 3.5</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">180 ± 7.2</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPT</td><td class="colsep0 rowsep0" align="left">0.057 ± 0.0018</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.71</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.014</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IRT</td><td class="colsep0 rowsep0" align="left">6.4 ± 0.35</td><td class="colsep0 rowsep0" align="left">8.8 ± 0.31</td><td class="colsep0 rowsep0" align="left">17 ± 0.80</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">na = not active.</p></div></div></div><div class="NLM_p">From the chemical point of view, the indole NH of evodiamine is a good functional group for the synthesis of various derivatives. The docking model also revealed that evodiamine only partly intercalated into the DNA base pairs (DE ring) and the attachment of an aromatic group to the indole NH could improve the base-stacking interactions with TopoI. In order to keep the hydrogen bonding interaction with Arg364, a proper linker between the aromatic group and the indole NH is needed to interact with Arg364. As a result, <i>N</i>-benzoylevodiamine derivatives were selected from molecular docking studies. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> illustrated the binding mode of compound <b>29u</b>. The position of 4-chlorine benzoyl group of compound <b>29u</b> in the active site of TopoI was similar to the position of the BC ring of CPT and formed additional base-stacking interactions with both the −1 (upstream) and +1 (downstream) base pairs (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). Especially, its carbonyl oxygen atom could also form hydrogen bonding interaction with Arg364. Therefore, a series of <i>N</i>-benzoylevodiamine analogues were designed and synthesized. In order to investigate the structure−activity relationship (SAR), <i>N</i>-alkyl, benzyl, cyano, and ester evodiamine derivatives were also prepared.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Superimposition of the docked conformations of <b>20</b> with CPT. (B) Superimposition of the docked conformations of <b>29u</b> with CPT. (C) Binding mode of compounds <b>29u</b> in the active site of TopoI−DNA complex. The figure was generated using PyMol (<a href="http://pymol.sourceforge.net/" class="extLink">http://pymol.sourceforge.net/</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthetic route of compounds <b>29a</b>−<b>x</b> is depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Evodiamine was synthesized by the reported procedure (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref44 ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46 ref47 ref48">(44-48)</a> Starting from <b>24</b>, it was converted to amide <b>25</b> by reacting with ethyl formate. In the presence of POCl<sub>3</sub>, the key intermediate ABC ring <b>26</b> was obtained by ring closure reaction of amide <b>25</b>. On the other hand, reacting 2-(methylamino)benzoic acid <b>27</b> with ClCOOEt afforded isatoic anhydride <b>28</b>. Evodiamine was obtained by ring closure reaction between <b>28</b> and carboline <b>26</b>. In the presence of NaH and DMF, evodiamine was treated with various RX reagents (such as substituted benzolyl chloride, substituted benzyl chloride, alkyl chloride, etc.) to afford the compounds <b>29a</b>−<b>x</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCOOEt, reflux, 12 h, yield 84%; (b) POCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 2 h, room temp 2 h, yield 55%; (c) ClCOOEt, reflux, 12 h, yield 60%; (d) <b>26</b>, CH<sub>2</sub>Cl<sub>2</sub>, 30−60 °C, 6 h, yield 70%; (e) RX, NaH, DMF, 80 °C, 24 h, yield 11−79%.</p></p></figure><div class="NLM_p">In vitro TopoI inhibition assay indicated that the <i>N</i>-benzoyl analogue <b>29u</b> showed higher activity than evodiamine. Compound <b>29u</b> was active against TopoI-mediated relaxation of supercoiled DNA at 100 μM, which is consistent with the docking model of evodiamine and <b>29u</b>. Moreover, improved in vitro antitumor activities and spectrum of evodiamine derivatives were also observed (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Evodiamine is only active against the breast cancer cell line. After the introduction of an ethyl carboxylate group on the indole NH (compound <b>29c</b>), both cytotoxicity and antitumor spectrum were improved. The IC<sub>50</sub> values of compound <b>29c</b> are in the range 9.4−130 μM. The insertion of a methylene group between indole NH and carboxylate group of compound <b>29c</b> resulted in a decrease of the activity. Compound <b>29d</b> lost activity against lung cancer and colon cancer cell lines again. When compound <b>29d</b> was hydrolyzed to compound <b>29a</b>, the cytotoxicity and spectrum were improved again. Compound <b>29e</b>, bearing a benzoyl substituent, showed good inhibitory effects against all the three cancer cell lines with IC<sub>50</sub> values in the range 0.047−15 μM. Remarkably, compound <b>29e</b> was particularly effective against breast cancer cell line, which was more potent than the reference drugs CPT and irinotecan. The replacement of the benzoyl group of compound <b>29e</b> by a benzyl group (compound <b>29j</b>) resulted in a decrease of the cytotoxicity to a large extent. For compound <b>29j</b>, the addition of a chlorine at position 2 of the benzyl group (compound <b>29g</b>) led to a slight increase of the cytotoxicity. On the other hand, a loss of the cytotoxicity was observed for 3-Cl (compound <b>29f</b>), 2,4-dichloro (compound <b>29i</b>), and 4-methoxyl (compound <b>29m</b>) derivatives. Furthermore, most of the alkyl derivatives (e.g., <b>29k</b>, <b>29l</b>, and <b>29n</b>) proved to be totally inactive. Only compound <b>29h</b> showed moderate activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Antitumor Activity of the N-Substituted Evodiamine Analogues (IC<sub>50</sub>, μM)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center">IC<sub>50</sub>, μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A549</th><th class="colsep0 rowsep0" align="center">LOVO</th><th class="colsep0 rowsep0" align="center">MDA-MB-435</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29a</b></td><td class="colsep0 rowsep0" align="left">72 ± 2.3</td><td class="colsep0 rowsep0" align="left">130 ± 10</td><td class="colsep0 rowsep0" align="left">13 ± 0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29b</b></td><td class="colsep0 rowsep0" align="left">220 ± 7.9</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">200 ± 4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29c</b></td><td class="colsep0 rowsep0" align="left">130 ± 3.7</td><td class="colsep0 rowsep0" align="left">95 ± 7.3</td><td class="colsep0 rowsep0" align="left">9.4 ± 0.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29d</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">150 ± 7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29e</b></td><td class="colsep0 rowsep0" align="left">10 ± 0.60</td><td class="colsep0 rowsep0" align="left">15 ± 0.39</td><td class="colsep0 rowsep0" align="left">0.047 ± 0.0015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29f</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29g</b></td><td class="colsep0 rowsep0" align="left">29 ± 1.3</td><td class="colsep0 rowsep0" align="left">74 ± 1.6</td><td class="colsep0 rowsep0" align="left">42 ± 0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29h</b></td><td class="colsep0 rowsep0" align="left">120 ± 4.2</td><td class="colsep0 rowsep0" align="left">59 ± 6.9</td><td class="colsep0 rowsep0" align="left">110 ± 5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29i</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29j</b></td><td class="colsep0 rowsep0" align="left">55 ± 2.4</td><td class="colsep0 rowsep0" align="left">67 ± 3.3</td><td class="colsep0 rowsep0" align="left">110 ± 3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29k</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29l</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29m</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29n</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPT</td><td class="colsep0 rowsep0" align="left">0.057 ± 0.0030</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.067</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.031</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IRT</td><td class="colsep0 rowsep0" align="left">6.4 ± 0.27</td><td class="colsep0 rowsep0" align="left">8.8 ± 0.10</td><td class="colsep0 rowsep0" align="left">17 ± 0.95</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">na = not active.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Antitumor Activity of the N-Substituted Benzoxyl Evodiamine Analogues (IC<sub>50</sub>, μM)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center">IC<sub>50</sub>, μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A549</th><th class="colsep0 rowsep0" align="center">MDA-MB-435</th><th class="colsep0 rowsep0" align="center">HCT116</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29o</b></td><td class="colsep0 rowsep0" align="left">4.3 ± 0.21</td><td class="colsep0 rowsep0" align="left">0.13 ± 0.011</td><td class="colsep0 rowsep0" align="left">5.1 ± 0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29p</b></td><td class="colsep0 rowsep0" align="left">14 ± 3.1</td><td class="colsep0 rowsep0" align="left">0.18 ± 0.014</td><td class="colsep0 rowsep0" align="left">4.7 ± 0.066</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29q</b></td><td class="colsep0 rowsep0" align="left">2.9 ± 0.082</td><td class="colsep0 rowsep0" align="left">0.051 ± 0.0029</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29r</b></td><td class="colsep0 rowsep0" align="left">4.2 ± 0.33</td><td class="colsep0 rowsep0" align="left">0.15 ± 0.0063</td><td class="colsep0 rowsep0" align="left">3.9 ± 0.041</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29s</b></td><td class="colsep0 rowsep0" align="left">3.0 ± 0.17</td><td class="colsep0 rowsep0" align="left">0.038 ± 0.0032</td><td class="colsep0 rowsep0" align="left">4.3 ± 0.022</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29t</b></td><td class="colsep0 rowsep0" align="left">2.8 ± 0.031</td><td class="colsep0 rowsep0" align="left">0.55 ± 0.026</td><td class="colsep0 rowsep0" align="left">4.1 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29u</b></td><td class="colsep0 rowsep0" align="left">0.86 ± 0.044</td><td class="colsep0 rowsep0" align="left">0.049 ± 0.0030</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.083</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29v</b></td><td class="colsep0 rowsep0" align="left">5.3 ± 0.38</td><td class="colsep0 rowsep0" align="left">0.39 ± 0.034</td><td class="colsep0 rowsep0" align="left">3.8 ± 0.066</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29w</b></td><td class="colsep0 rowsep0" align="left">35 ± 0.46</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">89 ± 0.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29x</b></td><td class="colsep0 rowsep0" align="left">74 ± 9.1</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">45 ± 4.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">na = not active.</p></div></div></div><div class="NLM_p last">Because <i>N</i>-benzoyl derivative (compound <b>29e</b>) revealed good cytotoxicity with broad spectrum, we further introduced various substituents on the benzoyl group (compounds <b>29o</b>−<b>x</b>). It can be seen that the cytotoxic potency of the compounds varies considerably depending on the type and position of the substituents. Compared with compound <b>29e</b>, several compounds (e.g., <b>29s</b> and <b>29u</b>) showed improved activity. In general, 4-substituted derivatives were more potent than 2-substituted and 3-substituted derivatives. For example, compound <b>29u</b> showed higher cytotoxicity than compounds <b>29p</b> and <b>29q</b>. For the 4-substituted derivatives, halogens (i.e., chlorine and fluorine) and methyl group are favorable for the cytotoxicity. In comparison with the monochlorine substituted compounds (compounds <b>29p</b> and <b>29u</b>), the disubstituted derivative (compound <b>29v</b>) led to a decrease of the cytotoxicity. Remarkably, the IC<sub>50</sub> values of compound <b>29u</b> against A549, MDA-MB435, and HCT116 cell lines are 0.86, 0.049, and 2.6 μM, respectively, suggesting that it is a promising lead for the discovery of novel anticancer agents.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From the above results, we can find that molecular weight and synthetic possibility should be considered as two important factors for the selection of hits for structural optimization. In most cases, the molecular weight and hydrophobicity will be increased during the process of hit-to-lead and lead-to-candidate. A starting structure with relatively low molecular weight is more likely to be optimized to druglike candidates. On the other hand, the synthetic possibility is also a major problem for natural product-like hits from virtual screening. Evodiamine has a free amine group with moderate molecular weight, which can be easily transformed to active derivatives with druglike properties. This example might give us some useful information about hit selection after SBVS studies. Such structural requirement, a scaffold with a free N−H group and molecular weight of about 350, could be included in the next SBVS study.</div><div class="NLM_p last">Evodiamine shares an interesting “L type” conformation in the active site of topo1−DNA cleavable complex. Its free indole N−H function is a good site for chemical derivatization. However, the hydrogen bond with Arg364 would be broken if the indole amine was substituted. In order to address the contradiction, proper functional group transformation to keep the hydrogen bonding interaction is an efficient method to retain the binding affinity. In the present study, the indole amine was transferred to the amide and its carbonyl group can also form a hydrogen bond with Arg364. By means of this method, we think a key N−H group participating in a special binding mode is amenable to further chemistry and can be transformed to generate active derivatives.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30563" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30563" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry. General Methods</h3><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance 300 spectrometer (Bruker Company, Germany), using TMS as an internal standard and CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvent. Chemical shifts are given in ppm (δ). Elemental analyses were performed with a MOD-1106 instrument and were consistent with theoretical values within 0.4%. The mass spectra were recorded on an Esquire 3000 LC−MS mass spectrometer. Silica gel thin-layer chromatography was performed on precoated plates GF-254 (Qingdao Haiyang Chemical, China). The purity of final compounds was assessed on the basis of analytical HPLC, and the results were greater than 95%. All solvents and reagents were analytically pure, and no further purification was needed. All starting materials were commercially available.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedure for the Synthesis of Compounds <b>29a</b>−<b>x</b></h3><div class="NLM_p last">NaH (60% oil, 6.6 mmol) was suspended in a solution of evodiamine<a onclick="showRef(event, 'ref44 ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46 ref47 ref48">(44-48)</a> (0.20 g, 0.66 mmol) in DMF (20 mL). The reacting mixture was heated to 80 °C and stirred for 24 h. The mixture was diluted with H<sub>2</sub>O (50 mL) and then extracted with EtOAc (50 mL × 3). The extract was washed with saturated NaCl solution (50 mL × 3), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc/hexane = 1:4) to give compounds <b>20a</b>−<b>x</b> with moderate to good yields.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>N</i>-Acetic Acid Evodiamine (<b>29a</b>)</h3><div class="NLM_p last">Yield 60%, yellow oil. <sup>1</sup>H NMR (DMSO, 500 MHz) δ 2.41 (s, 3H), 2.85 (m, 1H), 3.05 (m, 1H), 3.17 (m, 1H), 4.80 (m, 1H), 5.07 (dd, 2H, <i>J</i><sub>1</sub> = 18.1 Hz, <i>J</i><sub>2</sub> = 18.1 Hz), 6.02 (s, 1H), 7.02−8.01 (m, 8H). ESI-MS (<i>m</i>/<i>z</i>): 362.2 [M + 1]. Anal. (C<sub>21</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-Acetonitrile Evodiamine (<b>29b</b>)</h3><div class="NLM_p last">Yield 44%, white solid. <sup>1</sup>H NMR (DMSO, 500 MHz) δ 2.39 (s, 3H), 2.82 (m, 1H), 2.98 (m, 1H), 3.14 (m, 1H), 4.66 (m, 1H), 5.57 (s, 2H), 6.21 (s, 1H), 7.21−7.95 (m, 8H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 500 MHz) δ 20.08, 31.73, 36.97, 39.00, 67.89, 109.02, 114.44, 115.51, 119.54, 121.22, 123.61, 124.00, 124.24, 125.04, 126.32, 127.60, 129.00, 133.14, 136.92, 150.47, 164.34. ESI-MS (<i>m</i>/<i>z</i>): 343.74 [M + 1]. Anal. (C<sub>21</sub>H<sub>18</sub>N<sub>4</sub>O) C, H, N.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>N</i>-Ethyl Formate Evodiamine (<b>29c</b>)</h3><div class="NLM_p last">Yield 11%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.29 (t, 3H, <i>J</i> = 6.7 Hz), 2.45 (s, 3H), 2.86 (m, 1H), 2.99 (m, 1H), 3.20 (m, 1H), 4.45 (m, 2H), 4.91 (m, 1H), 6.29 (s, 1H), 7.04−8.27 (m, 8H). ESI-MS (<i>m</i>/<i>z</i>): 376.45 [M + 1]. Anal. (C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-Ethyl Acetate Evodiamine (<b>29d</b>)</h3><div class="NLM_p last">Yield 44%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.25 (t, 3H), 2.40 (s, 3H), 2.84 (m, 1H), 3.03 (m, 1H), 3.24 (m, 1H), 4.20 (m, 2H), 4.92 (m, 1H), 4.93 (d, 1H), 5.15 (d, 1H), 5.93 (s, 1H), 7.15−8.23 (m, 8H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 500 MHz) δ 14.13, 20.16, 36.66, 39.20, 45.21, 60.47, 68.00, 109.09, 113.89, 119.08, 120.17, 123.10, 123.33, 124.28, 124.52, 125.92, 128.40, 128.93, 132.84, 137.77, 150.83, 164.42, 168.54. ESI-MS (<i>m</i>/<i>z</i>): 390.35 [M + 1]. Anal. (C<sub>23</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-Benzoylevodiamine (<b>29e</b>)</h3><div class="NLM_p last">Yield 37%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.43 (s, 3H), 2.92 (m, 1H), 3.05 (m, 1H), 3.18 (m, 1H), 4.90 (m, 1H), 5.94 (s, 1H), 7.15−8.15 (m, 13H). ESI-MS (<i>m</i>/<i>z</i>): 408.84 [M + 1]. Anal. (C<sub>26</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-(3-Chlorobenzyl)evodiamine (<b>29f</b>)</h3><div class="NLM_p last">Yield 67%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.35 (s, 3H), 2.95 (m, 1H), 3.06 (m, 1H), 3.21 (m, 1H), 4.90 (m, 1H), 5.38 (d, 1H, <i>J</i> = 16.8 Hz), 5.65 (d, 1H, <i>J</i> = 16.8 Hz), 5.81 (s, 1H), 6.88−8.11 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 428.61 [M + 1]. Anal. (C<sub>26</sub>H<sub>22</sub>ClN<sub>3</sub>O) C, H, N.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-(2-Chlorobenzyl)evodiamine (<b>29g</b>)</h3><div class="NLM_p last">Yield 75%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.40 (s, 3H), 2.96 (m, 1H), 3.07 (m, 1H), 3.21 (m, 1H), 4.91 (m, 1H), 5.54 (d, 1H, <i>J</i> = 17.7 Hz), 5.78 (d, 1H, <i>J</i> = 17.8 Hz), 6.36 (s, 1H), 6.99−8.08 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 428.90 [M + 1]. Anal. (C<sub>26</sub>H<sub>22</sub>ClN<sub>3</sub>O) C, H, N.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-Hexylevodiamine (<b>29h</b>)</h3><div class="NLM_p last">Yield 27%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 0.84 (t, 3H), 1.25−1.83 (m, 8H), 2.40 (s, 3H), 2.93 (m, 1H), 3.02 (m, 1H), 3.19 (m, 1H), 4.17 (t, 2H, <i>J</i> = 7.5 Hz), 4.90 (m, 1H), 5.96 (s, 1H), 7.15−8.15 (m, 8H). ESI-MS (<i>m</i>/<i>z</i>): 488.93 [M + 1]. Anal. (C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-(2,4-Dichlorobenzyl)evodiamine (<b>29i</b>)</h3><div class="NLM_p last">Yield 36%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.39 (s, 3H), 2.95 (m, 1H), 3.07 (m, 1H), 3.21 (m, 1H), 4.92 (m, 1H), 5.46 (d, 1H, <i>J</i> = 16.7 Hz), 5.76 (d, 1H, <i>J</i> = 16.7 Hz), 6.31 (s, 1H), 6.97−8.09 (m, 11H). ESI-MS (<i>m</i>/<i>z</i>): 462.68 [M]. Anal. (C<sub>26</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-Benzylevodiamine (<b>29j</b>)</h3><div class="NLM_p last">Yield 58%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.38 (s, 3H), 2.93 (m, 1H), 3.06 (m, 1H), 3.19 (m, 1H), 4.91 (m, 1H), 5.44 (d, 1H, <i>J</i> = 16.7 Hz), 5.68 (d, 1H, <i>J</i> = 16.7 Hz), 5.81 (s, 1H), 7.00−8.10 (m, 13H). ESI-MS (<i>m</i>/<i>z</i>): 394.72 [M + 1]. Anal. (C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-Propylevodiamine (<b>29k</b>)</h3><div class="NLM_p last">Yield 79%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 0.95 (t, 3H, <i>J</i> = 7.4 Hz), 1.86 (m, 2H), 2.40 (s, 3H), 2.89 (m, 1H), 3.02 (m, 1H), 3.19 (m, 1H), 4.17 (m, 1H), 4.31 (m, 1H), 4.92 (m, 1H), 5.97 (s, 1H), 7.17−8.15 (m, 8H). ESI-MS (<i>m</i>/<i>z</i>): 346.68 [M + 1]. Anal. (C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-Ethylevodiamine (<b>29l</b>)</h3><div class="NLM_p last">Yield 64%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.42 (t, 3H, <i>J</i> = 7.2 Hz), 2.42 (s, 3H), 2.89 (m, 1H), 3.02 (m, 1H), 3.19 (m, 1H), 4.24 (m, 1H), 4.43 (m, 1H), 4.92 (m, 1H), 5.97 (s, 1H), 7.17−8.15 (m, 8H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 500 MHz) δ 15.16, 20.21, 29.52, 36.25, 39.16, 67.78, 109.44, 109.45, 112.76, 118.85, 119.35, 122.40, 122.93, 123.97, 125.63, 127.92, 128.77, 132.67, 136.63, 150.77, 164.36. ESI-MS (<i>m</i>/<i>z</i>): 332.83 [M + 1]. Anal. (C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(4-Methoxylbenzyl)evodiamine (<b>29m</b>)</h3><div class="NLM_p last">Yield 36%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.39 (s, 3H), 2.92 (m, 1H), 3.03 (m, 1H), 3.14 (m, 1H), 3.73 (s, 3H), 4.88 (m, 1H), 5.38 (d, 1H, <i>J</i> = 16.7 Hz), 5.68 (d, 1H, <i>J</i> = 16.7 Hz), 5.81 (s, 1H), 6.74−7.62 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 424.65 [M + 1]. Anal. (C<sub>27</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-Isopropylevodiamine (<b>29n</b>)</h3><div class="NLM_p last">Yield 66%, yellow solid. <sup>1</sup>H NMR (DMSO, 300 MHz) δ 1.49 (d, 3H, <i>J</i> = 6.9 Hz), 1.70 (d, 3H, <i>J</i> = 6.9 Hz), 2.37 (s, 3H), 2.95 (m, 1H), 3.03 (m, 1H), 3.17 (m, 1H), 4.66 (m, 1H), 4.82 (m, 1H), 6.13 (s, 1H), 7.04−7.94 (m, 8H). ESI-MS (<i>m</i>/<i>z</i>): 346.37 [M + 1]. Anal. (C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(4-Fluorobenzoyl)evodiamine (<b>29o</b>)</h3><div class="NLM_p last">Yield 32%, yellow solid. <sup>1</sup>H NMR (DMSO, 300 MHz) δ 2.45 (s, 3H), 2.86 (m, 1H), 3.02 (m, 1H), 3.22 (m, 1H), 4.67 (m, 1H), 5.89 (s, 1H), 7.01−8.02 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 448.31 [M + Na]. Anal. (C<sub>26</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(2-Chlorobenzoyl)evodiamine (<b>29p</b>)</h3><div class="NLM_p last">Yield 52%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.41 (s, 3H), 2.90 (m, 1H), 3.04 (m, 1H), 3.21 (m, 1H), 4.78 (m, 1H), 5.74 (s, 1H), 6.98−8.01 (m, 12H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 500 MHz) δ 20.44, 36.00, 37.64, 67.84, 115.37, 118.92, 121.92, 122.86, 123.31, 123.60, 123.93, 126.19, 126.41, 127.61, 127.97, 128.55, 129.82, 130.91, 131.73, 131.88, 132.51, 132.84, 133.81, 134.60, 150.14, 164.41. ESI-MS (<i>m</i>/<i>z</i>): 464.83 [M + Na]. Anal. (C<sub>26</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(3-Chlorobenzoyl)evodiamine (<b>29q</b>)</h3><div class="NLM_p last">Yield 58%, yellow solid. <sup>1</sup>H NMR (DMSO, 300 MHz) δ 2.40 (s, 3H), 2.88 (m, 1H), 3.03 (m, 1H), 3.20 (m, 1H), 4.65 (m, 1H), 5.76 (s, 1H), 7.01−8.02 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 465.03 [M + Na]. Anal. (C<sub>26</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(2-Methylbenzoyl)evodiamine (<b>29r</b>)</h3><div class="NLM_p last">Yield 58%, yellow solid. <sup>1</sup>H NMR (DMSO, 300 MHz) δ 2.26 (s, 3H), 2.40 (s, 3H), 2.91 (m, 1H), 3.05 (m, 1H), 3.14 (m, 1H), 4.64 (m, 1H), 5.75 (s, 1H), 7.01−8.02 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 445.36 [M + Na]. Anal. (C<sub>27</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(4-Methylbenzoyl)evodiamine (<b>29s</b>)</h3><div class="NLM_p last">Yield 54%, white solid. H NMR (DMSO, 300 MHz) δ 2.30 (s, 3H), 2.36 (s, 3H), 2.87 (m, 1H), 3.03 (m, 1H), 3.17 (m, 1H), 4.65 (m, 1H), 5.75 (s, 1H), 6.99−7.82 (m, 12H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 500 MHz) δ 20.55, 21.62, 36.48, 38.01, 68.08, 114.41, 119.03, 121.14, 122.79, 123.45, 123.82, 124.97, 127.33, 128.57, 128.91, 128.98, 129.30, 129.53, 129.76, 130.02, 132.06, 132.82, 137.70, 143.93, 150.61, 164.53, 168.69. ESI-MS (<i>m</i>/<i>z</i>): 445.09 [M + Na]. Anal. (C<sub>27</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(4-Nitrobenzoyl)evodiamine (<b>29t</b>)</h3><div class="NLM_p last">Yield 44%, yellow solid. <sup>1</sup>H NMR (DMSO, 300 MHz) δ 2.21 (s, 3H), 2.89 (m, 1H), 3.00 (m, 1H), 3.15 (m, 1H), 4.64 (m, 1H), 5.74 (s, 1H), 6.95−7.97 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 453.63 [M + 1]. Anal. (C<sub>26</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(4-Chlorobenzoyl)evodiamine (<b>29u</b>)</h3><div class="NLM_p last">Yield 57%, yellow solid. <sup>1</sup>H NMR (DMSO, 300 MHz) δ 2.32 (s, 3H), 2.89 (m, 1H), 3.02 (m, 1H), 3.21 (m, 1H), 4.64 (m, 1H), 5.75 (s, 1H), 6.92−8.03 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 465.19 [M + Na]. Anal. (C<sub>26</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(2,4-Dichlorobenzoyl)evodiamine (<b>29v</b>)</h3><div class="NLM_p last">Yield 61%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 2.33 (s, 3H), 2.89 (m, 1H), 3.03 (m, 1H), 3.15 (m, 1H), 4.92 (m, 1H), 5.83 (s, 1H), 7.03−8.03 (m, 11H). ESI-MS (<i>m</i>/<i>z</i>): 477.02 [M + 1]. Anal. (C<sub>26</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(2-Fluorobenzoyl)evodiamine (<b>29w</b>)</h3><div class="NLM_p last">Yield 54%, yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 2.32 (s, 3H), 2.95 (m, 1H), 3.02 (m, 1H), 3.16 (m, 1H), 4.90 (m, 1H), 5.35 (s, 1H), 7.06−8.04 (m, 12H). ESI-MS (<i>m</i>/<i>z</i>): 424.98 [M]. Anal. (C<sub>26</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(4-Methoxybenzoyl)evodiamine (<b>29x</b>)</h3><div class="NLM_p last">Yield 59%, yellow solid. <sup>1</sup>H NMR (DMSO, 300 MHz) δ 2.32 (s, 3H), 2.86 (m, 1H), 3.02 (m, 1H), 3.17 (m, 1H), 3.82 (s, 3H), 4.66 (m, 1H), 5.86 (s, 1H), 6.98−7.75 (m, 12H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 500 MHz) δ 20.45, 36.49, 37.98, 55.37, 68.00, 113.89, 113.91, 114.13, 118.96, 120.69, 122.39, 122.51, 123.40, 123.68, 124.71, 126.79, 127.19, 128.47, 129.61, 132.00, 132.70, 137.64, 150.57, 163.51, 164.37, 167.93. ESI-MS (<i>m</i>/<i>z</i>): 448.93 [M + 1]. Anal. (C<sub>27</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Computational Protocols</h3><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Protein Preparation</h4><div class="NLM_p last">The crystallographic coordinates of the ternary complex of CPT−DNA−TopoI (3.0 Å resolution, <i>R</i><sub>cryst</sub> = 0.244) were obtained from the Brookhaven Protein Databank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I">1T8I</a>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> All crystallographic water molecules were removed from the coordinate set. The binding region was defined as all the atoms that are 15 Å around the centroid of CPT in the crystal structure.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Validation of the Docking Methods</h4><div class="NLM_p last">The ligands were extracted from the X-ray complexes, which were subsequently docked into their corresponding proteins by means of Gold 3.0.1,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> MolDock(MVD),<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Autodock 3.0,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and Autodock 4.0<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> software. The docking results were evaluated through a comparison between the resulting docked positions of the ligand and the experimental ones. As a measure of docking reliability, the rmsd value between the positions of heavy atoms of the ligand in the calculated and experimental structures was taken into account.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Gold 3.0.1</h4><div class="NLM_p last">Docking runs were performed using the program GOLD 3.0.1, and the standard default settings were used in all calculations. For each of the 10 independent genetic algorithm runs, a default maximum of 10 000 genetic operations was performed, using the default operator weights and a population size of 100 chromosomes. Two docking analyses were carried out. In the first case, GoldScore was used. Default cutoff values of 2.5 Å for hydrogen bonds and 4.0 Å for van der Waals interactions were employed. In the second one, ChemScore was used with the default setting. Early termination was allowed if the top three solutions were within rmsd value of 1.5 Å. The docking pose analysis was carried out for the pose that got the highest score.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> MolDock (MVD)</h4><div class="NLM_p last">MVD recognized DNA as ligand of TopoI. So we converted it to cofactor before docking. The cavity reference ligand was used for docking calculations using MolDock SE as searcher algorithm. During docking the binding site radius was set to 10 Å. Other parameters were default. In addition to MolDock Score, MolDock Score [grid] was also calculated for each compound. All of the two fitness functions used the default setting. The best docking conformations were selected on the basis of docking energies.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Autodock 3.0 and 4.0</h4><div class="NLM_p last">Autodock Tools was used to check and prepare the ligands and receptors files. A grid of 44, 44, and 42 points in the <i>x</i>, <i>y</i>, and <i>z</i> directions was constructed centered on the center of the mass of the inhibitors. We used a grid spacing of 0.375 Å and a distance-dependent function of the dielectric constant for the energetic map calculations. Lamarckian genetic algorithm was used. The docked compounds were subjected to 50 runs of the Autodock search, using 500 000 steps of energy evaluation and the default values of the other parameters. Cluster analysis was performed on the results using an rms tolerance of 1.0 Å. The docking pose analysis was carried out for the first pose of the first cluster and the first pose of the most populated cluster.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Virtual Screening</h4><div class="NLM_p last">The GOLD program (version 3.0.1) was applied to screen the SPECS database consisting of approximately 287000 compounds. The crystal structure of TopoI in complex with CPT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I">1T8I</a>) was used as the template for docking. Twenty genetic algorithm (GA) runs were performed for each molecule. For each GA run, 100 000 operations were applied on a set of five islands with a population size of 100. The weights for three types of operations (crossover, mutation, and migration) were chosen as 95%, 95%, and 10%, respectively. The selection pressure, which is the ratio of the probability of the most fit member selected as a parent to the probability of an average member selected as a parent, was set to 1:1. The annealing parameters of van der Waals and hydrogen bonding were set to 4.0 and 2.5 Å to allow a few bad bumps and poor hydrogen bonds at the beginning of a GA run. The “early termination” option was turned off to allow the continued docking even though the first three docking solutions were very similar, with rmsd values less than 1.5 Å. Moreover, analysis of various TopoI−inhibitor complex structures revealed important hydrogen bonding interactions with Arg364. Therefore, hydrogen bond constraints with a constraint weight of 10 were applied to specify that Arg364 should form the H-bond with the docked compounds. Absence of the hydrogen bonding interactions with Arg364 was penalized by the value of 10 in the GoldScore function. GoldScore implemented in GOLD was applied to rank the docked compounds.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Enzyme Inhibition Assay</h4><div class="NLM_p last">The enzyme activity was measured by assessing relaxation of supercoiled pBR322 plasmid DNA. Test compounds were dissolved in DMSO and were tested at final concentrations of 500, 100, 50, 10, and 1 μM. The reaction mixture contained 10× DNA TopoI buffer (2 μL), 0.1% BSA (2 μL), TopoI (0.5 U), the test compounds (various concentrations), pBR322 plasmid DNA (0.25 μg), and distilled water (varied as needed to bring the final volume to 20 μL) in a final volume of 20 μL. Reactions were carried out for 15 min at 37 °C and then stopped by adding SDS (0.5% final concentration). After that, 3.5 μL of 6× loading buffer (0.1 mM EDTA, 7% glycerol, 0.01% xylene cyanol FF, bromopenol blue 0.01%) was added. Reaction products were electrophoresed on a 0.8% agarose gel in TAE (Tris−acetate−EDTA) running buffer at 120 V for 40 min. To visualize the reaction products, the gel was stained with 0.5 μg/mL ethidium bromide for 10 min. DNA bands were visualized using a UV transilluminator.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> In Vitro Cytotoxicity Assay</h4><div class="NLM_p last">One-thousand-two-hundred cells per well were plated in 96-well plates. After culturing for 24 h, test compounds were added onto triplicate wells with different concentrations and 0.1% DMSO for control. After 3 days of incubation, 20 μL of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) solution (5 mg/mL) was added to each well, and after the samples were shaken for 1 min the plate was incubated further for 4 h. Formazan crystals were dissolved with 100 μL of DMSO. The absorbance (OD) was quantitated with microplate spectrophotometer at 570 nm. Wells containing no drugs were used as blanks for the spectrophotometer. The survival of the cells was expressed as percentage of untreated control wells.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49"><a href="/doi/suppl/10.1021/jm100387d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Computational details and results of docking methods validation and molecular dynamic simulations; Tanimoto similarity indices between purchased compounds and camptothecin; results of TopoI inhibitory activity for hits at lower concentrations. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100387d/suppl_file/jm100387d_si_001.pdf">jm100387d_si_001.pdf (231.07 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100387d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunquan Sheng</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People’s Republic of China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#84f7ece1eae3e7f5c4ecebf0e9e5ede8aae7ebe9a4feece5eae3f3eaefc4ecebf0e9e5ede8aae7ebe9"><span class="__cf_email__" data-cfemail="b2c1dad7dcd5d1c3f2daddc6dfd3dbde9cd1dddf">[email protected]</span> <span class="__cf_email__" data-cfemail="512b39303f36263f3a11393e253c30383d7f323e3c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wannian Zhang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People’s Republic of China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f7849f9299909486b79f98839a969e9bd994989ad78d9f96999080999cb79f98839a969e9bd994989a"><span class="__cf_email__" data-cfemail="a3d0cbc6cdc4c0d2e3cbccd7cec2cacf8dc0ccce">[email protected]</span> <span class="__cf_email__" data-cfemail="39435158575e4e57527951564d54585055175a5654">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guoqiang Dong</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shengzheng Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenyuan Miao</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianzhong Yao</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People’s Republic of China</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87086" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87086" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Natural Science Foundation of China (Grant No. 30930107), Shanghai Rising-Star Program (Grant No. 09QA1407000), and Shanghai Leading Academic Discipline Project (Project No. B906).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Topoisomerase I inhibitors: camptothecins and beyond</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1038%2Fnrc1977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16990856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=789-802&author=Y.+Pommier&title=Topoisomerase+I+inhibitors%3A+camptothecins+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase I inhibitors: camptothecins and beyond</span></div><div class="casAuthors">Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">789-802</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear DNA topoisomerase I (TOP1) is an essential human enzyme.  It is the only known target of the alkaloid camptothecin, from which the potent anticancer agents irinotecan and topotecan are derived.  As camptothecins bind at the interface of the TOP1-DNA complex, they represent a paradigm for interfacial inhibitors that reversibly trap macromol. complexes.  Several camptothecin and noncamptothecin derivs. are being developed to further increase antitumor activity and reduce side effects.  The mechanisms and mol. determinants of tumor response to TOP1 inhibitors are reviewed, and rational combinations of TOP1 inhibitors with other drugs are considered based on current knowledge of repair and checkpoint pathways that are assocd. with TOP1-mediated DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5lxd3qfkwbVg90H21EOLACvtfcHk0ljsYq3FpRBX7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D&md5=a437970077c0edbbab602b296fcd092a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1977%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTopoisomerase%2520I%2520inhibitors%253A%2520camptothecins%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D789%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tse, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkegaard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. C.</span><span> </span><span class="NLM_article-title">Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=5560-5565&author=Y.+C.+Tseauthor=K.+Kirkegaardauthor=J.+C.+Wang&title=Covalent+bonds+between+protein+and+DNA.+Formation+of+phosphotyrosine+linkage+between+certain+DNA+topoisomerases+and+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DY.%2BC.%26aulast%3DKirkegaard%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26atitle%3DCovalent%2520bonds%2520between%2520protein%2520and%2520DNA.%2520Formation%2520of%2520phosphotyrosine%2520linkage%2520between%2520certain%2520DNA%2520topoisomerases%2520and%2520DNA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D5560%26epage%3D5565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2894</span><span class="NLM_x">–</span> <span class="NLM_lpage">2902</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr900097c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2894-2902&author=Y.+Pommier&title=DNA+topoisomerase+I+inhibitors%3A+chemistry%2C+biology%2C+and+interfacial+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr900097c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900097c%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DDNA%2520topoisomerase%2520I%2520inhibitors%253A%2520chemistry%252C%2520biology%252C%2520and%2520interfacial%2520inhibition%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2894%26epage%3D2902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hsiang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">14873</span><span class="NLM_x">–</span> <span class="NLM_lpage">14878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=2997227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=14873-14878&author=Y.+H.+Hsiangauthor=R.+Hertzbergauthor=S.+Hechtauthor=L.+F.+Liu&title=Camptothecin+induces+protein-linked+DNA+breaks+via+mammalian+DNA+topoisomerase+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span></div><div class="casAuthors">Hsiang, Yaw Huei; Hertzberg, Robert; Hecht, Sidney; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14873-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Camptothecin (I)  [7689-03-4], a cytotoxic drug, is a strong inhibitor of nucleic acid synthesis in mammalian cells and a potent inducer of strand breaks in chromosomal DNA.  Neither equil. dialysis nor unwinding measurement indicated any interaction between camptothecin and purified DNA.  However, I induces extensive single-strand DNA breaks in systems contg. purified mammalian DNA topoisomerase  [80449-01-0] I.  DNA breakage in vitro is immediate and reversible.  Analyses of camptothecin-induced DNA breaks show that topoisomerase I is covalently linked to the 3' end of the broken DNA.  In addn., I inhibits the catalytic activity of mammalian DNA topoisomerase I.  Apparently, I blocks the rejoining step of the breakage-reunion reaction of mammalian DNA topoisomerase I; this blockade results in the accumulation of a cleavable complex which resembles the transient intermediate proposed for eukaryotic DNA topoisomerase I.  The inhibition of nucleic acid synthesis and the induction of DNA strand breaks obsd. in vivo may be related to the formation of this drug-induced cleavable complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4OWZ16tDJsbVg90H21EOLACvtfcHk0ljsYq3FpRBX7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D&md5=d5811c51314199e69d2fad324720b1aa</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiang%26aufirst%3DY.%2BH.%26aulast%3DHertzberg%26aufirst%3DR.%26aulast%3DHecht%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DCamptothecin%2520induces%2520protein-linked%2520DNA%2520breaks%2520via%2520mammalian%2520DNA%2520topoisomerase%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D14873%26epage%3D14878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wall, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wani, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, G. A.</span><span> </span><span class="NLM_article-title">The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from <i>Camptotheca acuminata</i></span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">3888</span><span class="NLM_x">–</span> <span class="NLM_lpage">3890</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00968a057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1966&pages=3888-3890&author=M.+E.+Wallauthor=M.+C.+Waniauthor=C.+E.+Cookauthor=K.+H.+Palmerauthor=A.+T.+McPhailauthor=G.+A.+Sim&title=The+isolation+and+structure+of+camptothecin%2C+a+novel+alkaloidal+leukemia+and+tumor+inhibitor+from+Camptotheca+acuminata"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fja00968a057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00968a057%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DM.%2BE.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DCook%26aufirst%3DC.%2BE.%26aulast%3DPalmer%26aufirst%3DK.%2BH.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26aulast%3DSim%26aufirst%3DG.%2BA.%26atitle%3DThe%2520isolation%2520and%2520structure%2520of%2520camptothecin%252C%2520a%2520novel%2520alkaloidal%2520leukemia%2520and%2520tumor%2520inhibitor%2520from%2520Camptotheca%2520acuminata%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1966%26volume%3D88%26spage%3D3888%26epage%3D3890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">D’Arpa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardmore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6919</span><span class="NLM_x">–</span> <span class="NLM_lpage">6924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=1698546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK3MXivFQ%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=6919-6924&author=P.+D%E2%80%99Arpaauthor=C.+Beardmoreauthor=L.+F.+Liu&title=Involvement+of+nucleic+acid+synthesis+in+cell+killing+mechanisms+of+topoisomerase+poisons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons</span></div><div class="casAuthors">D'Arpa, Peter; Beardmore, Christopher; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6919-24</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The primary cytotoxic mechanism of camptothecin has been proposed to involve an interaction between the replication machinery and the camptothecin-mediated topoisomerase I-DNA cleavable complex.  The present study show that killing of V79 cells by the topoisomerase II poisons 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide may involve ongoing RNA synthesis in addn. to ongoing DNA synthesis.  V79 cells synchronized by mitotic shake-off were treated with topoisomerase poisons in the presence of inhibitors of nucleic acid synthesis.  S-Phase V79 cells were more sensitive to the topoisomerase I poison camptothecin and the topoisomerase II poison m-AMSA than G1-phase cells.  The greater sensitivity of S-phase cells to killing by m-AMSA and camptothecin was abolished during cotreatment, but not posttreatment, with aphidicolin, suggesting that ongoing DNA synthesis is involved in cell killing by both topoisomerase I and II poisons.  Cotreatment with transcription inhibitors, such as 5,6-dichloro-1-β-D-ribofuranosyl benzimidazole or cordycepin, partially protected cells from the cytotoxic effects of m-AMSA but had no effect on camptothecin-mediated cytotoxicity.  These results suggest that ongoing RNA transcription may be involved in cell killing by topoisomerase II poisons but not topoisomerase I poisons.  Cotreatment with camptothecin reduced m-AMSA-mediated cytotoxicity in G1-phase V79 cells, suggesting a possible antagonism between topoisomerase I and II poisons.  This antagonistic effect between topoisomerase I and II poisons could be explained by the strong inhibitory effect of camptothecin on RNA transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKbW8PDr36bVg90H21EOLACvtfcHk0liBUQYbJmmjMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXivFQ%253D&md5=cdf75c946eb70fb695a5e6278178aaeb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arpa%26aufirst%3DP.%26aulast%3DBeardmore%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DInvolvement%2520of%2520nucleic%2520acid%2520synthesis%2520in%2520cell%2520killing%2520mechanisms%2520of%2520topoisomerase%2520poisons%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D6919%26epage%3D6924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Liu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, S. P.</span><span> </span><span class="NLM_article-title">Mechanism of action of camptothecin</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">922</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=922&publication_year=2000&pages=1-10&author=L.+F.+Liuauthor=S.+D.+Desaiauthor=T.+K.+Liauthor=Y.+Maoauthor=M.+Sunauthor=S.+P.+Sim&title=Mechanism+of+action+of+camptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DDesai%26aufirst%3DS.%2BD.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DSim%26aufirst%3DS.%2BP.%26atitle%3DMechanism%2520of%2520action%2520of%2520camptothecin%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D922%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tsao, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arpa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1829</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=1312900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK38XitV2nu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=1823-1829&author=Y.+P.+Tsaoauthor=P.+D%E2%80%99Arpaauthor=L.+F.+Liu&title=The+involvement+of+active+DNA+synthesis+in+camptothecin-induced+G2+arrest%3A+altered+regulation+of+p34cdc2%2Fcyclin+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The involvement of active DNA synthesis in camptothecin-induced G2 arrest:  altered regulation of p34cdc2/cyclin B</span></div><div class="casAuthors">Tsao, Yeou Ping; D'Arpa, Peter; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1823-9</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Cell cycle arrest in G2 phase is a common response to a variety of DNA-damaging agents.  The coupling between DNA damage and G2 arrest was studied in synchronized HeLa cells using camptothecin, a highly specific inhibitor of topoisomerase I that damages DNA through the formation of reversible topoisomerase I-DNA cleavable complexes.  Brief camptothecin treatment of early S-phase HeLa cells caused arrest at G2 phase and abolished the activation of p34cdc2 protein kinase.  Both tyrosine dephosphorylation of p34cdc2 and cyclin B accumulation were altered.  These cell cycle-dependent changes were not obsd. when DNA replication was inhibited by aphidicolin during the brief camptothecin treatment.  The results suggest that to produce G2 arrest, active DNA synthesis is required at the time of camptothecin treatment, as was previously shown for camptothecin-induced cytotoxicity.  Furthermore, the results suggest that the interaction of the replication fork with DNA damage may ultimately trigger altered regulation of p34cdc2/cyclin B, leading to cell cycle arrest at the G2 phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf9GA9ym9aW7Vg90H21EOLACvtfcHk0liBUQYbJmmjMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitV2nu7Y%253D&md5=43c580c830eb0c452c4f7c5666c3d4ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsao%26aufirst%3DY.%2BP.%26aulast%3DD%25E2%2580%2599Arpa%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DThe%2520involvement%2520of%2520active%2520DNA%2520synthesis%2520in%2520camptothecin-induced%2520G2%2520arrest%253A%2520altered%2520regulation%2520of%2520p34cdc2%252Fcyclin%2520B%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D1823%26epage%3D1829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Driver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. X.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacology of new camptothecin drugs</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=425-439&author=R.+W.+Driverauthor=L.+X.+Yang&title=Synthesis+and+pharmacology+of+new+camptothecin+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDriver%26aufirst%3DR.%2BW.%26aulast%3DYang%26aufirst%3DL.%2BX.%26atitle%3DSynthesis%2520and%2520pharmacology%2520of%2520new%2520camptothecin%2520drugs%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D425%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Li, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L. P.</span><span> </span><span class="NLM_article-title">Review camptothecin: current perspectives</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.2174%2F092986706777585004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16842195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2021-2039&author=Q.+Y.+Liauthor=Y.+G.+Zuauthor=R.+Z.+Shiauthor=L.+P.+Yao&title=Review+camptothecin%3A+current+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Review camptothecin: current perspectives</span></div><div class="casAuthors">Li, Qing-Yong; Zu, Yuan-Gang; Shi, Rong-Zhen; Yao, Li-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2021-2039</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The review provides a detailed discussion of recent advances in the medicinal chem. of camptothecin, a potent antitumor agent that targets topoisomerase I.  Thousands of CPT derivs. were synthesized.  Two of them, Topotecan and Irinotecan, are com. approved for use in clinic as antitumor agents while more are still in clinic trials.  This review summarizes the current status of the modern synthetic approaches to CPT, the mechanism of action of CPT, the structure-activity relationship(SAR), a no. of novel CPT analogs and their biol. activity.  There is a systematic evaluation of A-, B- and E-ring- modified camptothecins reported recently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXlT0TDdItJbVg90H21EOLACvtfcHk0liBUQYbJmmjMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrg%253D&md5=36450ef038d9ee8409645bd3e8b6c397</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986706777585004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777585004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BY.%26aulast%3DZu%26aufirst%3DY.%2BG.%26aulast%3DShi%26aufirst%3DR.%2BZ.%26aulast%3DYao%26aufirst%3DL.%2BP.%26atitle%3DReview%2520camptothecin%253A%2520current%2520perspectives%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2021%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahier, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span> </span><span class="NLM_article-title">Camptothecin: current perspectives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2Fj.bmc.2003.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=15028252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFeqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1585-1604&author=C.+J.+Thomasauthor=N.+J.+Rahierauthor=S.+M.+Hecht&title=Camptothecin%3A+current+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin: current perspectives</span></div><div class="casAuthors">Thomas, Craig J.; Rahier, Nicolas J.; Hecht, Sidney M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1585-1604</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review provides a detailed discussion of recent advances in the medicinal chem. of camptothecin, a potent antitumor antibiotic.  Two camptothecin analogs are presently approved for use in the clinic as antitumor agents and several others are in clin. trials.  Camptothecin possesses a novel mechanism of action involving the inhibition of DNA relaxation by DNA topoisomerase I, and more specifically the stabilization of a covalent binary complex formed between topoisomerase I and DNA.  This review summarizes the current status of studies of the mechanism of action of camptothecin, including topoisomerase I inhibition and addnl. cellular responses.  Modern synthetic approaches to camptothecin and several of the semi-synthetic methods are also discussed.  Finally, a systematic evaluation of novel and important analogs of camptothecin and their contribution to the current structure-activity profile are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrONd-LUGaIVbVg90H21EOLACvtfcHk0lgwxVV4uKByrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFeqtrw%253D&md5=4f312a14c7813ff4067a111200ed1da5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2003.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2003.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DRahier%26aufirst%3DN.%2BJ.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DCamptothecin%253A%2520current%2520perspectives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D1585%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kingsbury, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caranfa, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucette, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=98-107&author=W.+D.+Kingsburyauthor=J.+C.+Boehmauthor=D.+R.+Jakasauthor=K.+G.+Holdenauthor=S.+M.+Hechtauthor=G.+Gallagherauthor=M.+J.+Caranfaauthor=F.+L.+McCabeauthor=L.+F.+Faucetteauthor=R.+K.+Johnson&title=Synthesis+of+water-soluble+%28aminoalkyl%29camptothecin+analogues%3A+inhibition+of+topoisomerase+I+and+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a017%26sid%3Dliteratum%253Aachs%26aulast%3DKingsbury%26aufirst%3DW.%2BD.%26aulast%3DBoehm%26aufirst%3DJ.%2BC.%26aulast%3DJakas%26aufirst%3DD.%2BR.%26aulast%3DHolden%26aufirst%3DK.%2BG.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DGallagher%26aufirst%3DG.%26aulast%3DCaranfa%26aufirst%3DM.%2BJ.%26aulast%3DMcCabe%26aufirst%3DF.%2BL.%26aulast%3DFaucette%26aufirst%3DL.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520of%2520water-soluble%2520%2528aminoalkyl%2529camptothecin%2520analogues%253A%2520inhibition%2520of%2520topoisomerase%2520I%2520and%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D98%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Garcia-Carbonero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J. G.</span><span> </span><span class="NLM_article-title">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1385%2F1592591604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=11895891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=641-661&author=R.+Garcia-Carboneroauthor=J.+G.+Supko&title=Current+perspectives+on+the+clinical+experience%2C+pharmacology%2C+and+continued+development+of+the+camptothecins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Supko, Jeffrey G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">641-661</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review, discussing the pharmacol. and antitumor activities of the camptothecin analogs that are approved for clin. use and those investigational agents undergoing clin. evaluation.  Camptothecin is a naturally occurring cytotoxic alkaloid that has a unique intracellular target, topoisomerase I, a nuclear enzyme that reduces the torsional stress of supercoiled DNA during the replication, recombination, transcription, and repair of DNA.  Topotecan and irinotecan are synthetic analogs designed to facilitate parenteral administration of the active lactone form of the compd. by introducing functional groups to enhance soly.  They are now well-established components in the chemotherapeutic management of several neoplasms.  Topotecan has modest activity in previously treated patients with ovarian and small-cell lung cancer and is currently approved for use in the United States as 2nd-line therapy in these diseases.  Preliminary evidence of activity against hematol. malignancies is also promising.  Irinotecan is a prodrug that undergoes enzymic conversion to the biol. active metabolite 7-ethyl-10-hydroxycamptothecin.  It is presently the treatment of choice when used in combination with fluoropyrimidines as 1st-line therapy for patients with advanced colorectal cancer or as a single agent after failure of 5-fluorouracil-based chemotherapy.  Encouraging preliminary results suggest that irinotecan may have an increasing role in the treatment of other solid tumors, including small- and non-small-cell lung cancer, cervical cancer, ovarian cancer, gastric cancer, and malignant gliomas.  Several addnl. camptothecin analogs are in various stages of clin. development, including 9-aminocamptothecin, 9-nitrocamptothecin, 7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(S)-camptothecin, exatecan mesylate, and karenitecin.  Efforts to further optimize therapeutic effectiveness through drug-delivery strategies that prolong tumor exposure to these S phase-specific agents, such as improving oral bioavailability through structure modification and innovative formulation approaches, alternative parenteral dosage forms, and administration schedules, are being actively pursued.  Combining camptothecins with other anticancer drugs and treatment modalities, as well as gaining a better understanding of the factors contributing to tumor sensitivity and resistance, continues to be of considerable interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrarJT9tdw_17Vg90H21EOLACvtfcHk0lgwxVV4uKByrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D&md5=6ef49a8a00a46110224d01506043f0bb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1385%2F1592591604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1592591604%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26atitle%3DCurrent%2520perspectives%2520on%2520the%2520clinical%2520experience%252C%2520pharmacology%252C%2520and%2520continued%2520development%2520of%2520the%2520camptothecins%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D641%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehlin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozielski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardeman, D. M.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(<i>S</i>)-camptothecin (rubitecan)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=11743646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=81-88&author=B.+C.+Giovanellaauthor=J.+S.+Stehlinauthor=H.+R.+Hinzauthor=A.+J.+Kozielskiauthor=N.+J.+Harrisauthor=D.+M.+Vardeman&title=Preclinical+evaluation+of+the+anticancer+activity+and+toxicity+of+9-nitro-20%28S%29-camptothecin+%28rubitecan%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan)</span></div><div class="casAuthors">Giovanella, Beppino C.; Stehlin, John S.; Hinz, Hellmuth R.; Kozielski, Anthony J.; Harris, Nicholas J.; Vardeman, Dana M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Nude mice received increasing doses of Rubitecan by intragastric injection until the max. tolerated dose (MTD) had been established for both a single dose and multiple doses at the schedule of 5 days on, 2 days off.  By extrapolating from the mouse data, the MTD was detd. for oral administration to dogs and man.  By using max. tolerated multiple doses, the sensitivity of human cancer xenografts in nude mice to Rubitecan was detd.  The MTD of Rubitecan in mice for multiple intragastric doses at the schedule of 5 days on, 2 days off was 1 mg/kg/day.  The MTD in dogs was also 1 mg/kg/day, administered orally but at the schedule of 4 days on, 3 days off.  In man, it was 1 mg/m2/day at the schedule of 5 days on, 2 days off.  Treatment of human cancer xenografts in nude mice with the MTD of Rubitecan resulted in growth inhibition in all 30 of 30 tumors tested and in the total disappearance of 24 of these.  These 30 tumors included all the most common human cancers: lung, colorectal, breast, pancreatic, ovarian, prostate, stomach, melanoma and a leukemia.  It appears that Rubitecan is a very promising anticancer drug with high potency against a wide spectrum of human cancers.  These cancers, growing as xenografts in nude mice, were always (30/30) inhibited and frequently completely (24/30) destroyed by nontoxic doses of Rubitecan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEKJHcSWLTmLVg90H21EOLACvtfcHk0lgwxVV4uKByrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFeisQ%253D%253D&md5=1de8de4dea18ab5ecc2252bcad67d555</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DStehlin%26aufirst%3DJ.%2BS.%26aulast%3DHinz%26aufirst%3DH.%2BR.%26aulast%3DKozielski%26aufirst%3DA.%2BJ.%26aulast%3DHarris%26aufirst%3DN.%2BJ.%26aulast%3DVardeman%26aufirst%3DD.%2BM.%26atitle%3DPreclinical%2520evaluation%2520of%2520the%2520anticancer%2520activity%2520and%2520toxicity%2520of%25209-nitro-20%2528S%2529-camptothecin%2520%2528rubitecan%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2002%26volume%3D20%26spage%3D81%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckardt, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlefield, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinsky, E. K.</span><span> </span><span class="NLM_article-title">Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=9533526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK1cXit1aquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=595-604&author=S.+G.+Eckhardtauthor=S.+D.+Bakerauthor=J.+R.+Eckardtauthor=T.+G.+Burkeauthor=D.+L.+Warnerauthor=J.+G.+Kuhnauthor=G.+Rodriguezauthor=S.+Fieldsauthor=A.+Thurmanauthor=L.+Smithauthor=M.+L.+Rothenbergauthor=L.+Whiteauthor=P.+Wisselauthor=R.+Kunkaauthor=S.+DePeeauthor=D.+Littlefieldauthor=H.+A.+Burrisauthor=D.+D.+Von+Hoffauthor=E.+K.+Rowinsky&title=Phase+I+and+pharmacokinetic+study+of+GI147211%2C+a+water-soluble+camptothecin+analogue%2C+administered+for+five+consecutive+days+every+three+weeks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analog, administered for five consecutive days every three weeks</span></div><div class="casAuthors">Eckhardt, S. Gail; Baker, Sharyn D.; Eckardt, John R.; Burke, Thomas G.; Warner, Deanna L.; Kuhn, John G.; Rodriguez, Gladys; Fields, Suzanne; Thurman, Allison; Smith, Lon; Rothenberg, Mace L.; White, Linda; Wissel, Paul; Kunka, Robert; Depee, Scott; Littlefield, Diane; Burris, Howard A.; Von Hoff, Daniel D.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">595-604</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GI147211 is a 7-substituted 10,11-ethylenedioxy-20(S)-camptothecin analog that inhibits the nuclear enzyme topoisomerase I.  In this study, 24 patients with advanced solid malignancies received a total of 72 courses of GI147211 as a 30-min infusion daily for 5 consecutive days, at doses ranging 0.3-1.75 mg/m2/day.  Severe neutropenia precluded dose escalation above 1.5 mg/m2/day in minimally pretreated patients, and both severe neutropenia and thrombocytopenia were dose limiting in heavily pretreated patients at doses >1.0 mg/m2/day.  These doses are, therefore, recommended for subsequent Phase II evaluations of GI147211 in patients with comparable prior therapy.  Nonhematol. toxicities, including nausea, vomiting, fatigue, and anorexia, were mild to moderate.  The disposition of GI147211 in blood was described by a linear 3-compartment model, with renal elimination accounting for only 11% of drug distribution.  No relationship was obsd. between the pharmacol. exposure to GI147211 and effects on neutrophils; however, patients who developed dose-limiting myelosuppression did experience greater exposure to both the lactone and total forms of the drug.  The hydrolysis kinetics of GI147211 revealed not only a shift of the drug to the inactive carboxylate form in human serum albumin but also stabilization of the lactone in erythrocytes, perhaps accounting for the obsd. lactone:total area under the concn.-time curve ratio of 0.27.  These results indicate that GI147211 exhibits predictable toxicities and that further studies are warranted to det. the distinct role of this compd. among currently available camptothecin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdrYBTb0Jue7Vg90H21EOLACvtfcHk0li_KUVaYUIcOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1aquro%253D&md5=c2b74eb7199ef6027fb061af3e1ed2c4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DBaker%26aufirst%3DS.%2BD.%26aulast%3DEckardt%26aufirst%3DJ.%2BR.%26aulast%3DBurke%26aufirst%3DT.%2BG.%26aulast%3DWarner%26aufirst%3DD.%2BL.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DRodriguez%26aufirst%3DG.%26aulast%3DFields%26aufirst%3DS.%26aulast%3DThurman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DRothenberg%26aufirst%3DM.%2BL.%26aulast%3DWhite%26aufirst%3DL.%26aulast%3DWissel%26aufirst%3DP.%26aulast%3DKunka%26aufirst%3DR.%26aulast%3DDePee%26aufirst%3DS.%26aulast%3DLittlefield%26aufirst%3DD.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26atitle%3DPhase%2520I%2520and%2520pharmacokinetic%2520study%2520of%2520GI147211%252C%2520a%2520water-soluble%2520camptothecin%2520analogue%252C%2520administered%2520for%2520five%2520consecutive%2520days%2520every%2520three%2520weeks%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D595%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Minami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span> </span><span class="NLM_article-title">Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3056</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=11595695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvF2kurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=3056-3064&author=H.+Minamiauthor=H.+Fujiiauthor=T.+Igarashiauthor=K.+Itohauthor=K.+Tamanoiauthor=T.+Ogumaauthor=Y.+Sasaki&title=Phase+I+and+pharmacological+study+of+a+new+camptothecin+derivative%2C+exatecan+mesylate+%28DX-8951f%29%2C+infused+over+30+minutes+every+three+weeks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks</span></div><div class="casAuthors">Minami, Hironobu; Fujii, Hirofumi; Igarashi, Tadahiko; Itoh, Kuniaki; Tamanoi, Kyoji; Oguma, Toshihiro; Sasaki, Yasutsuna</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3056-3064</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A Phase I study of exatecan, a new water-sol. camptothecin deriv., was conducted to det. the max. tolerated dose and a recommended dose, according to an internationally standardized core protocol.  Pharmacol. profiles of lactone and total (lactone + carboxylate) exatecan were also investigated.  Fifteen patients with advanced solid malignancies were treated with 3, 5, and 6.65 mg/M2 of exatecan infused over 30 min every 3 wk.  Concns. of lactone, total drug, and a metabolite in plasma and urine were detd. during the first course.  Dose-limiting neutropenia and liver dysfunction were obsd. in two of six patients at 6.65 mg/M2, but no grade 3 or worse diarrhea was obsd.  Emesis was moderate, and no grade 3 or worse nausea and vomiting were obsd. at a recommended dose of 5 mg/M2, with prophylactic use of granisetron.  Pharmacokinetics were linear and had moderate variability; clearances of lactone and total drug were 6.8±2.8 and 2.1±1.1 (mean ± SD) l/h/M2, resp.  The ratio of lactone concn. to total drug concn. in plasma decreased from 0.81±0.06 at the end of infusion to 0.15±0.06 10 h after the infusion.  The lactone:total ratio of drug exposure was 0.30±0.08, ranging from 0.16 to 0.43.  Neutropenia was related to the drug exposure of both lactone and total drug.  The recommended dose of exatecan infused over 30 min every 3 wk is 5 mg/M2, with a favorable toxicity profile of mild and infrequent diarrhea.  Interpatient variability of pharmacokinetics was similar to or smaller than that with other camptothecin derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2I-SQU0lC-7Vg90H21EOLACvtfcHk0li_KUVaYUIcOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvF2kurc%253D&md5=63659ca4182e8792337d0ad41c1f3981</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinami%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DH.%26aulast%3DIgarashi%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTamanoi%26aufirst%3DK.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26atitle%3DPhase%2520I%2520and%2520pharmacological%2520study%2520of%2520a%2520new%2520camptothecin%2520derivative%252C%2520exatecan%2520mesylate%2520%2528DX-8951f%2529%252C%2520infused%2520over%252030%2520minutes%2520every%2520three%2520weeks%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D3056%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Burke, T. G.</span><span> </span><span class="NLM_article-title">Chemistry of the camptothecins in the bloodstream. Drug stabilization and optimization of activity</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">803</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=803&publication_year=1996&pages=29-31&author=T.+G.+Burke&title=Chemistry+of+the+camptothecins+in+the+bloodstream.+Drug+stabilization+and+optimization+of+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BG.%26atitle%3DChemistry%2520of%2520the%2520camptothecins%2520in%2520the%2520bloodstream.%2520Drug%2520stabilization%2520and%2520optimization%2520of%2520activity%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1996%26volume%3D803%26spage%3D29%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bailly, C.</span><span> </span><span class="NLM_article-title">Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2FS1040-8428%2802%2900090-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=12482574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A280%3ADC%252BD38jitVGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2003&pages=91-108&author=C.+Bailly&title=Homocamptothecins%3A+potent+topoisomerase+I+inhibitors+and+promising+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs</span></div><div class="casAuthors">Bailly Christian</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-108</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Homocamptothecins (hCPTs) represent a new generation of antitumor agents targeting DNA topoisomerase I.  The expanded seven-membered lactone E-ring that characterizes hCPTs enhances the plasma stability of the drug and reinforces the inhibition of topoisomerase I compared with conventional six-membered CPTs. hCPTs are more efficient than the CPTs at promoting cleavage at T/G sites and induce additional cleavage at C/G sites.  Compound BN80765 and its difluoro analogue diflomotecan (DN80915) are potent cytotoxic agents and efficiently induce apoptosis in tumor cells.  They display strong antiproliferative activities against specific tumor types.  Diflomotecan is remarkably efficient at inhibiting the growth of human colon cancer cells in vivo and, administered orally, it also shows superior activities against human prostate cancers compared with the benchmark products topotecan (TPT) and irinotecan (IRT).  Diflomotecan has entered phase I clinical testing and antitumor activity has been observed in patients.  This 9,10-difluoro-hCPTs derivative is one of the most promising new members of the 'tecan' family.  This review summarizes the recent discoveries in the topoisomerase I field and presents the different camptothecin (CPT) analogues currently evaluated as anticancer agents.  The specific properties of hCPTs are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTG93omgw1Se2BAiYWy6n3SfW6udTcc2eZL6M6-D2_Gybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jitVGmtA%253D%253D&md5=ac53aaed4a1ccdad95a5f6ba52d0ef45</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1040-8428%2802%2900090-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-8428%252802%252900090-2%26sid%3Dliteratum%253Aachs%26aulast%3DBailly%26aufirst%3DC.%26atitle%3DHomocamptothecins%253A%2520potent%2520topoisomerase%2520I%2520inhibitors%2520and%2520promising%2520anticancer%2520drugs%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2003%26volume%3D45%26spage%3D91%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. G.</span><span> </span><span class="NLM_article-title">Novel A,B,E-ring-modified camptothecins displaying high lipophilicity and markedly improved human blood stabilities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3018</span><span class="NLM_x">–</span> <span class="NLM_lpage">3022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9902279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3018-3022&author=D.+Bomauthor=D.+P.+Curranauthor=A.+J.+Chavanauthor=S.+Kruszewskiauthor=S.+G.+Zimmerauthor=K.+A.+Fraleyauthor=T.+G.+Burke&title=Novel+A%2CB%2CE-ring-modified+camptothecins+displaying+high+lipophilicity+and+markedly+improved+human+blood+stabilities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm9902279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902279%26sid%3Dliteratum%253Aachs%26aulast%3DBom%26aufirst%3DD.%26aulast%3DCurran%26aufirst%3DD.%2BP.%26aulast%3DChavan%26aufirst%3DA.%2BJ.%26aulast%3DKruszewski%26aufirst%3DS.%26aulast%3DZimmer%26aufirst%3DS.%2BG.%26aulast%3DFraley%26aufirst%3DK.%2BA.%26aulast%3DBurke%26aufirst%3DT.%2BG.%26atitle%3DNovel%2520A%252CB%252CE-ring-modified%2520camptothecins%2520displaying%2520high%2520lipophilicity%2520and%2520markedly%2520improved%2520human%2520blood%2520stabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3018%26epage%3D3022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lavergne, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarquay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huchet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulomb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroggi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manginot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazaux, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigg, D. C.</span><span> </span><span class="NLM_article-title">Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2285</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000129j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2285-2289&author=O.+Lavergneauthor=D.+Demarquayauthor=C.+Baillyauthor=C.+Lancoauthor=A.+Rollandauthor=M.+Huchetauthor=H.+Coulombauthor=N.+Mullerauthor=N.+Baroggiauthor=J.+Camaraauthor=C.+Le+Bretonauthor=E.+Manginotauthor=J.+B.+Cazauxauthor=D.+C.+Bigg&title=Topoisomerase+I-mediated+antiproliferative+activity+of+enantiomerically+pure+fluorinated+homocamptothecins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm000129j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000129j%26sid%3Dliteratum%253Aachs%26aulast%3DLavergne%26aufirst%3DO.%26aulast%3DDemarquay%26aufirst%3DD.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLanco%26aufirst%3DC.%26aulast%3DRolland%26aufirst%3DA.%26aulast%3DHuchet%26aufirst%3DM.%26aulast%3DCoulomb%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DN.%26aulast%3DBaroggi%26aufirst%3DN.%26aulast%3DCamara%26aufirst%3DJ.%26aulast%3DLe%2BBreton%26aufirst%3DC.%26aulast%3DManginot%26aufirst%3DE.%26aulast%3DCazaux%26aufirst%3DJ.%2BB.%26aulast%3DBigg%26aufirst%3DD.%2BC.%26atitle%3DTopoisomerase%2520I-mediated%2520antiproliferative%2520activity%2520of%2520enantiomerically%2520pure%2520fluorinated%2520homocamptothecins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2285%26epage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lavergne, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesueur-Ginot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pla Rodas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarquay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulibarri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiano-Liberatore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harnett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigg, D. C.</span><span> </span><span class="NLM_article-title">Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5419</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980400l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5410-5419&author=O.+Lavergneauthor=L.+Lesueur-Ginotauthor=F.+Pla+Rodasauthor=P.+G.+Kasprzykauthor=J.+Pommierauthor=D.+Demarquayauthor=G.+Prevostauthor=G.+Ulibarriauthor=A.+Rollandauthor=A.+M.+Schiano-Liberatoreauthor=J.+Harnettauthor=D.+Ponsauthor=J.+Camaraauthor=D.+C.+Bigg&title=Homocamptothecins%3A+synthesis+and+antitumor+activity+of+novel+E-ring-modified+camptothecin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm980400l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980400l%26sid%3Dliteratum%253Aachs%26aulast%3DLavergne%26aufirst%3DO.%26aulast%3DLesueur-Ginot%26aufirst%3DL.%26aulast%3DPla%2BRodas%26aufirst%3DF.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPommier%26aufirst%3DJ.%26aulast%3DDemarquay%26aufirst%3DD.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DUlibarri%26aufirst%3DG.%26aulast%3DRolland%26aufirst%3DA.%26aulast%3DSchiano-Liberatore%26aufirst%3DA.%2BM.%26aulast%3DHarnett%26aufirst%3DJ.%26aulast%3DPons%26aufirst%3DD.%26aulast%3DCamara%26aufirst%3DJ.%26aulast%3DBigg%26aufirst%3DD.%2BC.%26atitle%3DHomocamptothecins%253A%2520synthesis%2520and%2520antitumor%2520activity%2520of%2520novel%2520E-ring-modified%2520camptothecin%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5410%26epage%3D5419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tangirala, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, D. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6202</span><span class="NLM_x">–</span> <span class="NLM_lpage">6212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6202-6212&author=R.+S.+Tangiralaauthor=S.+Antonyauthor=K.+Agamaauthor=Y.+Pommierauthor=B.+D.+Andersonauthor=R.+Bevinsauthor=D.+P.+Curran&title=Synthesis+and+biological+assays+of+E-ring+analogs+of+camptothecin+and+homocamptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTangirala%26aufirst%3DR.%2BS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DB.%2BD.%26aulast%3DBevins%26aufirst%3DR.%26aulast%3DCurran%26aufirst%3DD.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520assays%2520of%2520E-ring%2520analogs%2520of%2520camptothecin%2520and%2520homocamptothecin%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6202%26epage%3D6212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gelderblom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentheroudakis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hooije, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seguy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prunonosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Principe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4101</span><span class="NLM_x">–</span> <span class="NLM_lpage">4107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=14519632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1OjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=4101-4107&author=H.+Gelderblomauthor=R.+Salazarauthor=J.+Verweijauthor=G.+Pentheroudakisauthor=M.+J.+de+Jongeauthor=M.+Devlinauthor=C.+van+Hooijeauthor=F.+Seguyauthor=R.+Obachauthor=J.+Prunonosaauthor=P.+Principeauthor=C.+Twelves&title=Phase+I+pharmacological+and+bioavailability+study+of+oral+diflomotecan+%28BN80915%29%2C+a+novel+E-ring-modified+camptothecin+analogue+in+adults+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Pharmacological and Bioavailability Study of Oral Diflomotecan (BN80915), a Novel E-Ring-modified Camptothecin Analogue in Adults with Solid Tumors</span></div><div class="casAuthors">Gelderblom, Hans; Salazar, Ramon; Verweij, Jaap; Pentheroudakis, George; de Jonge, Maja J. A.; Devlin, Martin; van Hooije, Christel; Seguy, Francis; Obach, Rosendo; Prunonosa, Joan; Principe, Paola; Twelves, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4101-4107</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Diflomotecan (BN80915) is an E-ring modified camptothecin analog that possesses greater lactone stability in plasma compared with other topoisomerase I inhibitors, a potential advantage for antitumor activity.  As with other camptothecins, oral administration has pharmacol. and clin. advantages.  This Phase I study was performed to assess the feasibility of the administration of oral diflomotecan, to det. the max.-tolerated, dose its bioavailability, and to explore the pharmacokinetics.  An initial i.v. bolus was administered to assess the bioavailability of diflomotecan.  Fourteen days later, diflomotecan was administered p.o. once daily for 5 days to adult patients with solid malignant tumors and repeated every 3 wk.  BN80915 and its open lactone form BN80942 were measured.  Twenty-two patients entered the study and received a total of 57 cycles of oral diflomotecan at flat dose levels of 0.10, 0.20, 0.27, and 0.35 mg.  The main toxicity was hematol., but some patients experienced alopecia, mild gastrointestinal toxicity, and fatigue.  At the 0.35-mg dose level, 2 of 4 patients experienced dose-limiting toxicity comprising grade 3 thrombocytopenia with epistaxis and febrile neutropenia in 1 patient and uncomplicated grade 4 neutropenia lasting for >7 days in another.  Toxicity was acceptable at the 0.27-mg dose level at which dose-limiting toxicities were obsd. in 3 of 12 patients (grade 4 neutropenia > 7 days, complicated by fever in 1 patient but without other signs of infection).  After two cycles of diflomotecan, 6 patients had disease stabilization, which was maintained in 2 patients for 9 mo and >1 yr, resp.  Diflomotecan pharmacokinetics were linear over the dose range studied.  Systemic exposure correlated with the fall in WBC counts.  The mean oral bioavailability (±SD) was 72.24 ± 59.2% across all dose levels.  Urinary excretion of BN80915 was very low.  The recommended oral diflomotecan dose for Phase II studies is 0.27 mg/day x 5 every 3 wk.  This regimen is convenient and generally well tolerated with a favorable pharmacokinetic profile and high but variable bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSiDIg38_dBbVg90H21EOLACvtfcHk0lgt9pQC_o54hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1OjtLg%253D&md5=83f8727db7117be4cbe2925ededc6d0d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGelderblom%26aufirst%3DH.%26aulast%3DSalazar%26aufirst%3DR.%26aulast%3DVerweij%26aufirst%3DJ.%26aulast%3DPentheroudakis%26aufirst%3DG.%26aulast%3Dde%2BJonge%26aufirst%3DM.%2BJ.%26aulast%3DDevlin%26aufirst%3DM.%26aulast%3Dvan%2BHooije%26aufirst%3DC.%26aulast%3DSeguy%26aufirst%3DF.%26aulast%3DObach%26aufirst%3DR.%26aulast%3DPrunonosa%26aufirst%3DJ.%26aulast%3DPrincipe%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520pharmacological%2520and%2520bioavailability%2520study%2520of%2520oral%2520diflomotecan%2520%2528BN80915%2529%252C%2520a%2520novel%2520E-ring-modified%2520camptothecin%2520analogue%2520in%2520adults%2520with%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D4101%26epage%3D4107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Demarquay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huchet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulomb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesueur-Ginot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavergne, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigg, D. C.</span><span> </span><span class="NLM_article-title">BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4942</span><span class="NLM_x">–</span> <span class="NLM_lpage">4949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4942-4949&author=D.+Demarquayauthor=M.+Huchetauthor=H.+Coulombauthor=L.+Lesueur-Ginotauthor=O.+Lavergneauthor=J.+Camaraauthor=P.+G.+Kasprzykauthor=G.+Prevostauthor=D.+C.+Bigg&title=BN80927%3A+a+novel+homocamptothecin+that+inhibits+proliferation+of+human+tumor+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemarquay%26aufirst%3DD.%26aulast%3DHuchet%26aufirst%3DM.%26aulast%3DCoulomb%26aufirst%3DH.%26aulast%3DLesueur-Ginot%26aufirst%3DL.%26aulast%3DLavergne%26aufirst%3DO.%26aulast%3DCamara%26aufirst%3DJ.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DBigg%26aufirst%3DD.%2BC.%26atitle%3DBN80927%253A%2520a%2520novel%2520homocamptothecin%2520that%2520inhibits%2520proliferation%2520of%2520human%2520tumor%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4942%26epage%3D4949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hautefaye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimetiere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2731</span><span class="NLM_x">–</span> <span class="NLM_lpage">2735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2731-2735&author=P.+Hautefayeauthor=B.+Cimetiereauthor=A.+Pierreauthor=S.+Leonceauthor=J.+Hickmanauthor=W.+Laineauthor=C.+Baillyauthor=G.+Lavielle&title=Synthesis+and+pharmacological+evaluation+of+novel+non-lactone+analogues+of+camptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHautefaye%26aufirst%3DP.%26aulast%3DCimetiere%26aufirst%3DB.%26aulast%3DPierre%26aufirst%3DA.%26aulast%3DLeonce%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DJ.%26aulast%3DLaine%26aufirst%3DW.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLavielle%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520novel%2520non-lactone%2520analogues%2520of%2520camptothecin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2731%26epage%3D2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3229</span><span class="NLM_x">–</span> <span class="NLM_lpage">3238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1158%2F1535-7163.MCT-07-0441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=18089716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3229-3238&author=K.+Takagiauthor=T.+S.+Dexheimerauthor=C.+Redonauthor=O.+Sordetauthor=K.+Agamaauthor=G.+Lavielleauthor=A.+Pierreauthor=S.+E.+Batesauthor=Y.+Pommier&title=Novel+E-ring+camptothecin+keto+analogues+%28S38809+and+S39625%29+are+stable%2C+potent%2C+and+selective+topoisomerase+I+inhibitors+without+being+substrates+of+drug+efflux+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters</span></div><div class="casAuthors">Takagi, Kazutaka; Dexheimer, Thomas S.; Redon, Christophe; Sordet, Olivier; Agama, Keli; Lavielle, Gilbert; Pierre, Alain; Bates, Susan E.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3229-3238</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Camptothecin (CPT) analogs are powerful anticancer agents but are chem. unstable due to their α-hydroxylactone six-membered E-ring structure, which is essential for trapping topoisomerase I (Top1)-DNA cleavage complexes.  To stabilize the E-ring, CPT keto analogs with a five-membered E-ring lacking the oxygen of the lactone ring (S38809 and S39625) have been synthesized.  S39625 has been selected for advanced preclin. development based on its promising activity in tumor models.  Here, we show that both keto analogs are active against purified Top1 and selective against Top1 in yeast and human cancer cells.  The keto analogs show improved cytotoxicity toward colon, breast, and prostate cancer cells and leukemia cells compared with CPT.  The drug-induced Top1-DNA cleavage complexes induced by the keto analogs show remarkable persistence both with purified Top1 and in cells following 1-h drug treatments.  Moreover, we find that S39625 is not a substrate for either the ABCB1 (multidrug resistance-1/P-glycoprotein) or ABCG2 (mitoxantrone resistance/breast cancer resistance protein) drug efflux transporters, which sets S39625 apart from the clin. used CPT analogs topotecan or SN-38 (active metabolite of irinotecan).  Finally, we show that nanomolar concns. of S38809 or S39625 induce intense and persistent histone γ-H2AX.  The chem. stability of the keto analogs and the ability of S39625 to produce high levels of persistent Top1-DNA cleavage complex and its potent antiproliferative activity against human cancer cell lines make S39625 a promising new anticancer drug candidate.  Histone γ-H2AX could be used as a biomarker for the upcoming clin. trials of S39625.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsAvXCcUmkvLVg90H21EOLACvtfcHk0ljdiifdWbgP4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3L&md5=3a428d2a4871232a86096569c4550fb2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0441%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DRedon%26aufirst%3DC.%26aulast%3DSordet%26aufirst%3DO.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DLavielle%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DA.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNovel%2520E-ring%2520camptothecin%2520keto%2520analogues%2520%2528S38809%2520and%2520S39625%2529%2520are%2520stable%252C%2520potent%252C%2520and%2520selective%2520topoisomerase%2520I%2520inhibitors%2520without%2520being%2520substrates%2520of%2520drug%2520efflux%2520transporters%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D3229%26epage%3D3238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=429-434&author=Y.+Pommier&title=Camptothecins+and+topoisomerase+I%3A+a+foot+in+the+door.+Targeting+the+genome+beyond+topoisomerase+I+with+camptothecins+and+novel+anticancer+drugs%3A+importance+of+DNA+replication%2C+repair+and+cell+cycle+checkpoints"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCamptothecins%2520and%2520topoisomerase%2520I%253A%2520a%2520foot%2520in%2520the%2520door.%2520Targeting%2520the%2520genome%2520beyond%2520topoisomerase%2520I%2520with%2520camptothecins%2520and%2520novel%2520anticancer%2520drugs%253A%2520importance%2520of%2520DNA%2520replication%252C%2520repair%2520and%2520cell%2520cycle%2520checkpoints%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2004%26volume%3D4%26spage%3D429%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1158%2F1535-7163.MCT-08-0706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=19383846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlGqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1008-1014&author=Y.+Pommierauthor=M.+Cushman&title=The+indenoisoquinoline+noncamptothecin+topoisomerase+I+inhibitors%3A+update+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives</span></div><div class="casAuthors">Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1008-1014</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Because camptothecins are effective against previously resistant tumors and are the only class of topoisomerase I (Top 1) inhibitors approved for cancer treatment, we developed the indenoisoquinolines.  Like camptothecins, the indenoisoquinolines selectively trap Top1-DNA cleavage complexes and have been cocrystd. with the Top1-DNA cleavage complexes.  Indenoisoquinolines show antitumor activity in animal models.  They have several advantages over the camptothecins: (a) They are synthetic and chem. stable.  (b) The Top1 cleavage sites trapped by the indenoisoquinolines have different genomic locations, implying differential targeting of cancer cell genomes.  (c) The Top1 cleavage complexes trapped by indenoisoquinolines are more stable, indicative of prolonged drug action.  (d) They are seldom or not used as substrates for the multidrug resistance efflux pumps (ABCG2 and MDR-1).  Among the >400 indenoisoquinolines synthesized and evaluated, three have been retained as leads for clin. development by the National Cancer Institute: NSC 706744, NSC 725776 (Indimitecan), and NSC 724998 (Indotecan).  The trapping of Top1 cleavage complexes by indenoisoquinolines in cells results in the rapid and sustained phosphorylation of histone H2AX (γ-H2AX).  We discuss the use of γ-H2AX as a pharmacodynamic biomarker for the clin. development of the indenoisoquinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouXo9kT-6EHbVg90H21EOLACvtfcHk0ljZVs0puNqlpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlGqs7c%253D&md5=ed8a6657372e0ef2169b7df22129b3a3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0706%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DThe%2520indenoisoquinoline%2520noncamptothecin%2520topoisomerase%2520I%2520inhibitors%253A%2520update%2520and%2520perspectives%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1008%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hsiang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1722</span><span class="NLM_x">–</span> <span class="NLM_lpage">1726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=2832051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaL1cXhsl2ks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1988&pages=1722-1726&author=Y.+H.+Hsiangauthor=L.+F.+Liu&title=Identification+of+mammalian+DNA+topoisomerase+I+as+an+intracellular+target+of+the+anticancer+drug+camptothecin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin</span></div><div class="casAuthors">Hsiang, Yaw Huei; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1722-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Camptothecin, a plant alkaloid with antitumor activity, was previously shown to be a potent inhibitor of nucleic acid synthesis and a strong inducer of DNA strand breaks in mammalian cells.  In addn., previous studies have shown that camptothecin inhibits purified mammalian DNA topoisomerase I by trapping a reversible enzyme-DNA "cleavable complex".  In L1210 cells and SV40-infected monkey cells, camptothecin-induced strand breaks were shown to be protein linked.  The linked protein is most likely DNA topoisomerase I, as revealed by immunoblot anal., using antibodies against purified mammalian DNA topoisomerase I.  Brief heating of camptothecin-treated cells to 65° resulted in a rapid redn. of the no. of protein-linked DNA breaks.  Reversal of the camptothecin-induced topoisomerase I-DNA complex by heat was also obsd. in an in vitro system by using purified mammalian DNA topoisomerase I.  The results suggest that camptothecin interferes with DNA topoisomerase I both in cultured mammalian cells and in the purified system by trapping an enzyme-DNA complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpgCHupGLH7Vg90H21EOLACvtfcHk0ljZVs0puNqlpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhsl2ks7Y%253D&md5=950eeb566fe78ecd9143d7edc093d943</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiang%26aufirst%3DY.%2BH.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DIdentification%2520of%2520mammalian%2520DNA%2520topoisomerase%2520I%2520as%2520an%2520intracellular%2520target%2520of%2520the%2520anticancer%2520drug%2520camptothecin%26jtitle%3DCancer%2520Res.%26date%3D1988%26volume%3D48%26spage%3D1722%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Brangi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5938</span><span class="NLM_x">–</span> <span class="NLM_lpage">5946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5938-5946&author=M.+Brangiauthor=T.+Litmanauthor=M.+Ciottiauthor=K.+Nishiyamaauthor=G.+Kohlhagenauthor=C.+Takimotoauthor=R.+Robeyauthor=Y.+Pommierauthor=T.+Fojoauthor=S.+E.+Bates&title=Camptothecin+resistance%3A+role+of+the+ATP-binding+cassette+%28ABC%29%2C+mitoxantrone-resistance+half-transporter+%28MXR%29%2C+and+potential+for+glucuronidation+in+MXR-expressing+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrangi%26aufirst%3DM.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DCiotti%26aufirst%3DM.%26aulast%3DNishiyama%26aufirst%3DK.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DTakimoto%26aufirst%3DC.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DCamptothecin%2520resistance%253A%2520role%2520of%2520the%2520ATP-binding%2520cassette%2520%2528ABC%2529%252C%2520mitoxantrone-resistance%2520half-transporter%2520%2528MXR%2529%252C%2520and%2520potential%2520for%2520glucuronidation%2520in%2520MXR-expressing%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5938%26epage%3D5946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Liao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guirouilh-Barbat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=490-497&author=Z.+Liaoauthor=R.+W.+Robeyauthor=J.+Guirouilh-Barbatauthor=K.+K.+Toauthor=O.+Polgarauthor=S.+E.+Batesauthor=Y.+Pommier&title=Reduced+expression+of+DNA+topoisomerase+I+in+SF295+human+glioblastoma+cells+selected+for+resistance+to+homocamptothecin+and+diflomotecan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DGuirouilh-Barbat%26aufirst%3DJ.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DPolgar%26aufirst%3DO.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DReduced%2520expression%2520of%2520DNA%2520topoisomerase%2520I%2520in%2520SF295%2520human%2520glioblastoma%2520cells%2520selected%2520for%2520resistance%2520to%2520homocamptothecin%2520and%2520diflomotecan%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D490%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aida-Hyugaji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span> </span><span class="NLM_article-title">Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2Fj.canlet.2005.05.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16309825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit12itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2006&pages=81-89&author=H.+Nakagawaauthor=H.+Saitoauthor=Y.+Ikegamiauthor=S.+Aida-Hyugajiauthor=S.+Sawadaauthor=T.+Ishikawa&title=Molecular+modeling+of+new+camptothecin+analogues+to+circumvent+ABCG2-mediated+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer</span></div><div class="casAuthors">Nakagawa, Hiroshi; Saito, Hikaru; Ikegami, Yoji; Aida-Hyugaji, Sachiko; Sawada, Seigo; Ishikawa, Toshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Irinotecan (CPT-11) is a widely used potent antitumor drug that inhibits mammalian DNA topoisomerase I (Topo I).  However, overexpression of ABCG2 (BCRP/MXR/ABCP) reportedly confers cancer cells resistance to SN-38, the active form of CPT-11.  To circumvent the ABCG2-assocd. drug resistance, the structure-activity-relationship (SAR) of 14 new camptothecin (CPT) analogs has been studied with respect to the substrate specificity of ABCG2.  While the lactone E ring is a prerequisite for anticancer activity, modifications of the A or B rings do not significantly affect Topo I inhibition.  Based on the substrate specificity of ABCG2, it is strongly suggested that CPT analogs with a hydroxyl group at position 10 or 11 of the A ring are recognized by ABCG2 and are thereby effectively extruded from cancer cells.  To develop a platform for the mol. modeling to circumvent anticancer drug resistance, we have carried out quantum chem. calcns. and neural network SAR anal.  Electrostatic potential iso-surfaces generated by ab initio MO calcns. using RHF method have revealed that neg. potential localized at positions 10 or 11 in the A ring is important for recognition by ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo49fog41xxd7Vg90H21EOLACvtfcHk0ljZVs0puNqlpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit12itb8%253D&md5=f56d9a592b46908ae09b94c1b5859413</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DIkegami%26aufirst%3DY.%26aulast%3DAida-Hyugaji%26aufirst%3DS.%26aulast%3DSawada%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DMolecular%2520modeling%2520of%2520new%2520camptothecin%2520analogues%2520to%2520circumvent%2520ABCG2-mediated%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D234%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fujimori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1339</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=1339-1346&author=A.+Fujimoriauthor=W.+G.+Harkerauthor=G.+Kohlhagenauthor=Y.+Hokiauthor=Y.+Pommier&title=Mutation+at+the+catalytic+site+of+topoisomerase+I+in+CEM%2FC2%2C+a+human+leukemia+cell+line+resistant+to+camptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujimori%26aufirst%3DA.%26aulast%3DHarker%26aufirst%3DW.%2BG.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DHoki%26aufirst%3DY.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DMutation%2520at%2520the%2520catalytic%2520site%2520of%2520topoisomerase%2520I%2520in%2520CEM%252FC2%252C%2520a%2520human%2520leukemia%2520cell%2520line%2520resistant%2520to%2520camptothecin%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D1339%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Urasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laco, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourquier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gioffre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantazis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=1964-1969&author=Y.+Urasakiauthor=G.+S.+Lacoauthor=P.+Pourquierauthor=Y.+Takebayashiauthor=G.+Kohlhagenauthor=C.+Gioffreauthor=H.+Zhangauthor=D.+Chatterjeeauthor=P.+Pantazisauthor=Y.+Pommier&title=Characterization+of+a+novel+topoisomerase+I+mutation+from+a+camptothecin-resistant+human+prostate+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrasaki%26aufirst%3DY.%26aulast%3DLaco%26aufirst%3DG.%2BS.%26aulast%3DPourquier%26aufirst%3DP.%26aulast%3DTakebayashi%26aufirst%3DY.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DGioffre%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DPantazis%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520topoisomerase%2520I%2520mutation%2520from%2520a%2520camptothecin-resistant%2520human%2520prostate%2520cancer%2520cell%2520line%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D1964%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Meng, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.2174%2F1568026033452546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=12570765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=305-320&author=L.+H.+Mengauthor=Z.+Y.+Liaoauthor=Y.+Pommier&title=Non-camptothecin+DNA+topoisomerase+I+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy</span></div><div class="casAuthors">Meng, Ling-Hua; Liao, Zhi-Yong; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-320</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human DNA topoisomerase I is the target of camptothecins, which have been recently introduced in the clinic for cancer chemotherapy.  The discovery of novel non-camptothecin inhibitors is facilitated by the availability of biochem. and cellular assays for testing topoisomerase I activity.  Among the non-camptothecin inhibitors, the indolocarbazoles (NB-506 and J-107088) are the most advanced in their development, and are in clin. trials.  A no. of indenoisoquinolines and minor groove binders (benzimidazoles) have been reported recently.  Their antitumor activity is promising for further development.  The potential binding site(s) of topoisomerase I inhibitors in the enzyme I-DNA complex is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIJ1OCISjUd7Vg90H21EOLACvtfcHk0lgoltCxTJxPIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksg%253D%253D&md5=606576e24f65454321fb06904319695c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F1568026033452546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452546%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DL.%2BH.%26aulast%3DLiao%26aufirst%3DZ.%2BY.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNon-camptothecin%2520DNA%2520topoisomerase%2520I%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D305%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusaba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanigawara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGovren, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natsumeda, Y.</span><span> </span><span class="NLM_article-title">Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1007%2Fs00280-005-0149-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16308697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFGitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=173-182&author=Y.+Yamadaauthor=T.+Tamuraauthor=N.+Yamamotoauthor=T.+Shimoyamaauthor=Y.+Uedaauthor=H.+Murakamiauthor=H.+Kusabaauthor=Y.+Kamiyaauthor=H.+Sakaauthor=Y.+Tanigawaraauthor=J.+P.+McGovrenauthor=Y.+Natsumeda&title=Phase+I+and+pharmacokinetic+study+of+edotecarin%2C+a+novel+topoisomerase+I+inhibitor%2C+administered+once+every+3+weeks+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors</span></div><div class="casAuthors">Yamada, Yasuhide; Tamura, Tomohide; Yamamoto, Noboru; Shimoyama, Tatsu; Ueda, Yutaka; Murakami, Haruyasu; Kusaba, Hitoshi; Kamiya, Yoshikazu; Saka, Hideo; Tanigawara, Yusuke; McGovren, J. Patrick; Natsumeda, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-182</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Edotecarin (J-107088) is a potent indolocarbazole topoisomerase I inhibitor which is structurally distinct from the camptothecins.  This study aimed to det. the max. tolerated dose (MTD), the recommended dose for future Phase II studies and the safety, pharmacokinetic profile, and preliminary antitumor activity of edotecarin in a population of patients with advanced solid tumors.  Exptl. design: Edotecarin was administered as a single dose by IV infusion over 2 h every 21 days (with 1 wk permitted for recovery from toxicities, if needed) in patients with advanced solid tumors.  Doses ranged from 8 to 15 mg/m2.  Pharmacokinetic assessments were performed during and after the first administration.  Results: Twenty-four patients received 61 cycles of therapy.  Dose-limiting toxicities (infection, febrile neutropenia, constipation, ileus, and prolonged grade 4 granulocytopenia) were obsd. in 3 of 5 evaluable patients at the 15 mg/m2 dose, defining the MTD.  The most commonly reported non-hematol. toxicities were anorexia, nausea, malaise, and constipation.  Diarrhea was neither frequent nor severe.  Neutropenia was the most common hematol. toxicity (grade 3-4 in 21/23 patients during cycle 1).  Plasma concns. of edotecarin rose rapidly following the start of the 2-h infusion, reaching Cmax values of 103±17 ng/mL at the 13 mg/m2 dose, and decreased steeply after the end of the infusion.  Plasma concns. declined to approx. 1-2 ng/mL at 26 h post start of infusion, the last PK sampling time point.  The mean apparent plasma half-life of the drug was 20 h, which should be considered a preliminary est. until results from studies with a longer duration of plasma sampling are available.  A mean of 1.4-3.6% of the dose was recovered as unchanged drug in the urine over 48 h.  Unconfirmed tumor regression ≥50% was obsd. in 2 patients, 1 with metastatic gastric carcinoma and 1 with esophageal cancer.  Conclusions: The MTD of edotecarin administered IV over 2 h every 21 days was 15 mg/m2.  The recommended dose for Phase II studies with a 3-wk schedule (with 1 wk permitted for recovery from toxicities, if needed) is 13 mg/m2.  The obsd. safety profile and preliminary evidence of antitumor activity warrant further investigation of this drug in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiGySWL2mKV7Vg90H21EOLACvtfcHk0lgoltCxTJxPIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFGitrY%253D&md5=0b404d1baac4479af06b22560491a122</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-0149-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-0149-6%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DShimoyama%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DKusaba%26aufirst%3DH.%26aulast%3DKamiya%26aufirst%3DY.%26aulast%3DSaka%26aufirst%3DH.%26aulast%3DTanigawara%26aufirst%3DY.%26aulast%3DMcGovren%26aufirst%3DJ.%2BP.%26aulast%3DNatsumeda%26aufirst%3DY.%26atitle%3DPhase%2520I%2520and%2520pharmacokinetic%2520study%2520of%2520edotecarin%252C%2520a%2520novel%2520topoisomerase%2520I%2520inhibitor%252C%2520administered%2520once%2520every%25203%2520weeks%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2006%26volume%3D58%26spage%3D173%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Redinbo, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champoux, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span> </span><span class="NLM_article-title">Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1504-1513&author=M.+R.+Redinboauthor=L.+Stewartauthor=P.+Kuhnauthor=J.+J.+Champouxauthor=W.+G.+Hol&title=Crystal+structures+of+human+topoisomerase+I+in+covalent+and+noncovalent+complexes+with+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRedinbo%26aufirst%3DM.%2BR.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%26atitle%3DCrystal%2520structures%2520of%2520human%2520topoisomerase%2520I%2520in%2520covalent%2520and%2520noncovalent%2520complexes%2520with%2520DNA%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1504%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Staker, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feese, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembower, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgin, A. B.</span><span> </span><span class="NLM_article-title">Structures of three classes of anticancer agents bound to the human topoisomerase I−DNA covalent complex</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2336</span><span class="NLM_x">–</span> <span class="NLM_lpage">2345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049146p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2336-2345&author=B.+L.+Stakerauthor=M.+D.+Feeseauthor=M.+Cushmanauthor=Y.+Pommierauthor=D.+Zembowerauthor=L.+Stewartauthor=A.+B.+Burgin&title=Structures+of+three+classes+of+anticancer+agents+bound+to+the+human+topoisomerase+I%E2%88%92DNA+covalent+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm049146p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049146p%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DZembower%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26atitle%3DStructures%2520of%2520three%2520classes%2520of%2520anticancer%2520agents%2520bound%2520to%2520the%2520human%2520topoisomerase%2520I%25E2%2588%2592DNA%2520covalent%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2336%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Staker, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjerrild, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feese, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgin, A. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span> </span><span class="NLM_article-title">The mechanism of topoisomerase I poisoning by a camptothecin analog</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">15387</span><span class="NLM_x">–</span> <span class="NLM_lpage">15392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1073%2Fpnas.242259599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=12426403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15387-15392&author=B.+L.+Stakerauthor=K.+Hjerrildauthor=M.+D.+Feeseauthor=C.+A.+Behnkeauthor=A.+B.+Burginauthor=L.+Stewart&title=The+mechanism+of+topoisomerase+I+poisoning+by+a+camptothecin+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of topoisomerase I poisoning by a camptothecin analog</span></div><div class="casAuthors">Staker, Bart L.; Hjerrild, Kathryn; Feese, Michael D.; Behnke, Craig A.; Burgin, Alex B., Jr.; Stewart, Lance</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15387-15392</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report the x-ray crystal structure of human topoisomerase I covalently joined to double-stranded DNA and bound to the clin. approved anticancer agent topotecan.  Topotecan mimics a DNA base pair and binds at the site of DNA cleavage by intercalating between the upstream (-1) and downstream (+1) base pairs.  Intercalation displaces the downstream DNA, thus preventing re-ligation of the cleaved strand.  By specifically binding to the enzyme-substrate complex, topotecan acts as an uncompetitive inhibitor.  The structure can explain several of the known structure-activity relationships of the camptothecin family of anticancer drugs and suggests that there are at least two classes of mutations that can produce a drug-resistant enzyme.  The first class includes changes to residues that contribute to direct interactions with the drug, whereas a second class would alter interactions with the DNA and thereby destabilize the drug-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6ZhyvRMWZBLVg90H21EOLACvtfcHk0lgTxXJWCQx_kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVGh&md5=fe1f9e01f0277f8d46e8726ba7866bdb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.242259599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.242259599%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DHjerrild%26aufirst%3DK.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DStewart%26aufirst%3DL.%26atitle%3DThe%2520mechanism%2520of%2520topoisomerase%2520I%2520poisoning%2520by%2520a%2520camptothecin%2520analog%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D15387%26epage%3D15392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Ioanoviciu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staker, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4803</span><span class="NLM_x">–</span> <span class="NLM_lpage">4814</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050076b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4803-4814&author=A.+Ioanoviciuauthor=S.+Antonyauthor=Y.+Pommierauthor=B.+L.+Stakerauthor=L.+Stewartauthor=M.+Cushman&title=Synthesis+and+mechanism+of+action+studies+of+a+series+of+norindenoisoquinoline+topoisomerase+I+poisons+reveal+an+inhibitor+with+a+flipped+orientation+in+the+ternary+DNA-enzyme-inhibitor+complex+as+determined+by+X-ray+crystallographic+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050076b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050076b%26sid%3Dliteratum%253Aachs%26aulast%3DIoanoviciu%26aufirst%3DA.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520mechanism%2520of%2520action%2520studies%2520of%2520a%2520series%2520of%2520norindenoisoquinoline%2520topoisomerase%2520I%2520poisons%2520reveal%2520an%2520inhibitor%2520with%2520a%2520flipped%2520orientation%2520in%2520the%2520ternary%2520DNA-enzyme-inhibitor%2520complex%2520as%2520determined%2520by%2520X-ray%2520crystallographic%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4803%26epage%3D4814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kolb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Structure-based discovery of beta2-adrenergic receptor ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">6843</span><span class="NLM_x">–</span> <span class="NLM_lpage">6848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=6843-6848&author=P.+Kolbauthor=D.+M.+Rosenbaumauthor=J.+J.+Irwinauthor=J.+J.+Fungauthor=B.+K.+Kobilkaauthor=B.+K.+Shoichet&title=Structure-based+discovery+of+beta2-adrenergic+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DP.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DFung%26aufirst%3DJ.%2BJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DStructure-based%2520discovery%2520of%2520beta2-adrenergic%2520receptor%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D6843%26epage%3D6848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span> </span><span class="NLM_article-title">Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4940</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801622x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot1GntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4936-4940&author=H.+Liauthor=J.+Huangauthor=L.+Chenauthor=X.+Liuauthor=T.+Chenauthor=J.+Zhuauthor=W.+Luauthor=X.+Shenauthor=J.+Liauthor=R.+Hilgenfeldauthor=H.+Jiang&title=Identification+of+novel+falcipain-2+inhibitors+as+potential+antimalarial+agents+through+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Falcipain-2 Inhibitors as Potential Antimalarial Agents through Structure-Based Virtual Screening</span></div><div class="casAuthors">Li, Honglin; Huang, Jin; Chen, Lili; Liu, Xiaofeng; Chen, Tong; Zhu, Jin; Lu, Weiqiang; Shen, Xu; Li, Jian; Hilgenfeld, Rolf; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4936-4940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The SPECS database was screened against falcipain-2 with two different docking methods to identify structurally diverse nonpeptidic inhibitors.  Twenty-eight nonpeptidic mols. among 81 compds. tested were identified as potential inhibitors of falcipain-2.  One of the inhibitors exhibited in vitro activity with an IC50 value of 2.4 μM.  Furthermore, the similarity anal. has demonstrated that it is feasible to find novel diverse falcipain-2 inhibitors with similar steric shape through virtual screening of large-scale chem. libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNgaoOqTLV97Vg90H21EOLACvtfcHk0litRTlKukDh1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot1GntLs%253D&md5=92c45808a829996aa45280f6225fe990</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm801622x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801622x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHilgenfeld%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520novel%2520falcipain-2%2520inhibitors%2520as%2520potential%2520antimalarial%2520agents%2520through%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4936%26epage%3D4940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Virtual screening of chemical libraries</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1038%2Fnature03197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=15602552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=862-865&author=B.+K.+Shoichet&title=Virtual+screening+of+chemical+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening of chemical libraries</span></div><div class="casAuthors">Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7019</span>),
    <span class="NLM_cas:pages">862-865</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Virtual screening uses computer-based methods to discover new ligands on the basis of biol. structures.  Although widely heralded in the 1970s and 1980s, the technique has since struggled to meet its initial promise, and drug discovery remains dominated by empirical screening.  Recent successes in predicting new ligands and their receptor-bound structures, and better rates of ligand discovery compared to empirical screening, have reignited interest in virtual screening, which is now widely used in drug discovery, albeit on a more limited scale than empirical screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSY9IbbFldkrVg90H21EOLACvtfcHk0litRTlKukDh1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jK&md5=e351e226e8985d7c304a05fb67dfdc60</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature03197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03197%26sid%3Dliteratum%253Aachs%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DVirtual%2520screening%2520of%2520chemical%2520libraries%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D862%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Toshiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saburo, T.</span><span> </span><span class="NLM_article-title">Stucture eludidation and synthesis of alkaloids isolated from fruits of <i>Evodia rutaecarpa</i></span> <span class="citation_source-journal">Agric. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1271%2Fbbb1961.42.1515" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1978&pages=1515-1519&author=K.+Toshiyaauthor=M.+Shigeoauthor=T.+Saburo&title=Stucture+eludidation+and+synthesis+of+alkaloids+isolated+from+fruits+of+Evodia+rutaecarpa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1271%2Fbbb1961.42.1515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb1961.42.1515%26sid%3Dliteratum%253Aachs%26aulast%3DToshiya%26aufirst%3DK.%26aulast%3DShigeo%26aufirst%3DM.%26aulast%3DSaburo%26aufirst%3DT.%26atitle%3DStucture%2520eludidation%2520and%2520synthesis%2520of%2520alkaloids%2520isolated%2520from%2520fruits%2520of%2520Evodia%2520rutaecarpa%26jtitle%3DAgric.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D42%26spage%3D1515%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Kametani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, M.</span><span> </span><span class="NLM_article-title">A one-step synthesis of evodiamine and rutecarpine</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1976&pages=23-28&author=T.+Kametaniauthor=T.+Higaauthor=K.+Fukumotoauthor=M.+Koizumi&title=A+one-step+synthesis+of+evodiamine+and+rutecarpine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKametani%26aufirst%3DT.%26aulast%3DHiga%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DK.%26aulast%3DKoizumi%26aufirst%3DM.%26atitle%3DA%2520one-step%2520synthesis%2520of%2520evodiamine%2520and%2520rutecarpine%26jtitle%3DHeterocycles%26date%3D1976%26volume%3D4%26spage%3D23%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Whittaker, N.</span><span> </span><span class="NLM_article-title">The synthesis of emetine and related compounds. Part VI. Improvements in the synthesis of 3-alkyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxybenzo[<i>a</i>]quinolizin-2-ones and 3-alkyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-<i>a</i>]quinolizin-2-ones. Formation of some related diazabicyclo[3,3,1]nonanes</span> <span class="citation_source-journal">J. Chem. Soc. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaF1MXkslKmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1969&pages=85-89&author=N.+Whittaker&title=The+synthesis+of+emetine+and+related+compounds.+Part+VI.+Improvements+in+the+synthesis+of+3-alkyl-1%2C3%2C4%2C6%2C7%2C11b-hexahydro-9%2C10-dimethoxybenzo%5Ba%5Dquinolizin-2-ones+and+3-alkyl-1%2C2%2C3%2C4%2C6%2C7%2C12%2C12b-octahydroindolo%5B2%2C3-a%5Dquinolizin-2-ones.+Formation+of+some+related+diazabicyclo%5B3%2C3%2C1%5Dnonanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of emetine and related compounds.  VI.  Improvements in the synthesis of 3-alkyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxybenzo[a]quinolizin-2-ones and 3-alkyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-ones.  Formation of some related diazabicyclo[3.3.1]nonanes</span></div><div class="casAuthors">Whittaker, Norman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-9</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">A simplified procedure is reported for the almost quantitative conversion of 3,4-dihydro-6,7-di-methoxyisoquinoline (I) into benzo[a]quinolizines.  A byproduct formed in the prepn. of 1,3,4,6,7,11b-hexahydro-9,10-dimethoxybenzo[a]quinolizin-2-one is assigned the diisoquinopy-rimidine structure.  3,4-Dihydro-β-carboline condenses with Mannich bases in the presence of CO2 to give the indolo[2,3-a]quinolizines in good yield.  4-Dimethylamino-3-(dimethylaminomethyl)-2-butanone condenses with two mols. I to give 9,18-methanodiisoquino[2,1-a:1',2'-d][1,5]diazocine; similarly was prepd. the substituted 9,18-methanodiisoquino[2,1-a:2',1'-e]-[1,5]diazocine, together with a trace of a dipentacyclic ketone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7q6tHFtYe4LVg90H21EOLACvtfcHk0litRTlKukDh1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkslKmuw%253D%253D&md5=43ff9e3bddc72eb532bd4fc8e536ac93</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DN.%26atitle%3DThe%2520synthesis%2520of%2520emetine%2520and%2520related%2520compounds.%2520Part%2520VI.%2520Improvements%2520in%2520the%2520synthesis%2520of%25203-alkyl-1%252C3%252C4%252C6%252C7%252C11b-hexahydro-9%252C10-dimethoxybenzo%255Ba%255Dquinolizin-2-ones%2520and%25203-alkyl-1%252C2%252C3%252C4%252C6%252C7%252C12%252C12b-octahydroindolo%255B2%252C3-a%255Dquinolizin-2-ones.%2520Formation%2520of%2520some%2520related%2520diazabicyclo%255B3%252C3%252C1%255Dnonanes%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1969%26spage%3D85%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Schöpf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H.</span><span> </span><span class="NLM_article-title">Zur frage der biogenese des rutaecarpins und evodamins. Die synthese des rutaecarpins unter zellmöglichen bedingungen</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1947</span><span class="NLM_x">, </span> <span class="NLM_volume">558</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=1947&pages=124-36&author=C.+Sch%C3%B6pfauthor=H.+Steuer&title=Zur+frage+der+biogenese+des+rutaecarpins+und+evodamins.+Die+synthese+des+rutaecarpins+unter+zellm%C3%B6glichen+bedingungen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6pf%26aufirst%3DC.%26aulast%3DSteuer%26aufirst%3DH.%26atitle%3DZur%2520frage%2520der%2520biogenese%2520des%2520rutaecarpins%2520und%2520evodamins.%2520Die%2520synthese%2520des%2520rutaecarpins%2520unter%2520zellm%25C3%25B6glichen%2520bedingungen%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1947%26volume%3D558%26spage%3D124%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Heilbron, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitchen, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, G. D.</span><span> </span><span class="NLM_article-title">CCXCII.—Chemical reactivity and conjugation. Part II. The reactivity of the 2-methyl group in the 4-quinazolone series</span> <span class="citation_source-journal">J. Chem. Soc., Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1925</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2167</span><span class="NLM_x">–</span> <span class="NLM_lpage">2175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1039%2Fct9252702167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaB28XhslSi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1925&pages=2167-2175&author=I.+M.+Heilbronauthor=F.+N.+Kitchenauthor=E.+B.+Parkesauthor=G.+D.+Sutton&title=CCXCII.%E2%80%94Chemical+reactivity+and+conjugation.+Part+II.+The+reactivity+of+the+2-methyl+group+in+the+4-quinazolone+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical reactivity and conjugation. II. The reactivity of the 2-methyl group in the 4-quinazoline series</span></div><div class="casAuthors">Heilbron, I. M.; Kitchen, F. N.; Parkes, E. B.; Sutton, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Transactions</span>
        (<span class="NLM_cas:date">1925</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2167-75</span>CODEN:
                <span class="NLM_cas:coden">JCHTA3</span>;
        ISSN:<span class="NLM_cas:issn">0368-1645</span>.
    </div><div class="casAbstract">cf. C. A. 18, 267.  2,3-Dimethyl-4-quinazolone (I) contains a reactive Me group, the following condensation products being prepd.: 2-styryl-3-methyl-4-quinazolone, pale yellow, m. 167°; 4'-methoxy-2-styryl, bright yellow, m. 146°, giving an orange soln. in dil. HCl; 3',4'-dimethoxy-2-styryl, yellow, m. 208°; 3',4'-methylenedioxy-2-styryl, bright yellow, m. 185°; 4'-dimethylamino-2-styryl, orange-red, m. 175°.  o-MeNHC6H4CO2H gives a carbethoxy deriv., m. 108°.  The acid in ClCO2Et and AcCl gives quant. methylisatoic anhydride, m. 180°, which, with 0.88% NH4OH, gives quant.  o-MeNHC6H4CONH2, m. 162°, from which Ac2O gives an excellent yield of 1,2-dimethyl-4-quinazolone (II), m. 203°.  2-Styryl-1-methyl-4-quinazolone, cream-colored, m.245°; 4'-MeO deriv., bright yellow, m. 94° (contains 2H2O); anhyd., m. 156°; 3',4'-methylenedioxy deriv., yellow, m. 264°; 4'-dimethylamino deriv., orange, m. 274°.  5-Methoxyacetanthranil, m. 124°, in quant, yield from the acid and Ac2O; with excess NH4OH (0.88) there results 6-methoxy-2-methyl-4-quinazolone, m. 270°, and with MeNH2 the corresponding 2,3-di-Me deriv., m. (with 1H2O), 87°; anhyd., 133°; the latter does not condense with aromatic aldehydes.  5-Methoxymethylanthranilic acid, yellow, m. 163°; the amide, m. 145°, results by the action of NH4OH upon 6-methoxymethylisatoic anhydride, m. 233°.  6-Methoxy-1,2-dimethyl-4-quinazolone, m. 220°; piperonal gives the 3',4'-methylenedioxy-2-styryl deriv., yellow, m. 284°.  7-Methoxy-1,2-dimethyl-4-quinazolone,m. 193° or with 1H2O, m. 135°; 3',4'-methylenedioxy-2-styryl deriv., yellow, m. 280°; 4'-dimethylamino deriv., bright red, m. 266°.  7-Methoxy-2-methyl-4-quinazolone, m. 272°; Me2SO4 gives the 2,3-di-Me deriv., m. 149° or with 1H2O, m. 80°; 3',4'-methylenedioxy-2-styryl deriv., yellow, m. 193°.  5-Chloro-2-amino-4-methoxytoluene, m. 112°; Ac deriv., m. 183-4°.  The II appear to be more reactive than the I, probably because of the presence of the conjugated system O:CN:CMe; a certain retardation of activity is found in the case of the 7-MeO deriv. of II, thus showing that neutralization effects, although not sufficient to prevent reaction, do nevertheless come into play.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfOMDHLxZJzrVg90H21EOLACvtfcHk0lhiDThQeksO_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB28XhslSi&md5=0b85ea5563c0bed17661dc1150221015</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2Fct9252702167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fct9252702167%26sid%3Dliteratum%253Aachs%26aulast%3DHeilbron%26aufirst%3DI.%2BM.%26aulast%3DKitchen%26aufirst%3DF.%2BN.%26aulast%3DParkes%26aufirst%3DE.%2BB.%26aulast%3DSutton%26aufirst%3DG.%2BD.%26atitle%3DCCXCII.%25E2%2580%2594Chemical%2520reactivity%2520and%2520conjugation.%2520Part%2520II.%2520The%2520reactivity%2520of%2520the%25202-methyl%2520group%2520in%2520the%25204-quinazolone%2520series%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Trans.%26date%3D1925%26volume%3D127%26spage%3D2167%26epage%3D2175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.</span><span> </span><span class="NLM_article-title">Evodiamine: a novel anti-cancer alkaloid from <i>Evodia rutaecarpa</i></span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1852</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.3390%2Fmolecules14051852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=19471205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1852-1859&author=J.+Jiangauthor=C.+Hu&title=Evodiamine%3A+a+novel+anti-cancer+alkaloid+from+Evodia+rutaecarpa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa</span></div><div class="casAuthors">Jiang, Junlin; Hu, Changping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1852-1859</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Traditional Chinese herbs are regarded as a new and promising source of potential anti-cancer remedies and new chemotherapy adjuvants to enhance the efficacy of chemotherapy and/or to ameliorate its side effects.  Extensive investigations have been undertaken both in the exptl. and clin. studies over the years to augment the efficacy of chemotherapy.  Evodia rutaecarpa is a very popular multi-purpose herb traditionally used in China for the treatment of headaches, abdominal pain, postpartum hemorrhage, dysentery and amenorrhea.  The major constituents of Evodia rutaecarpa are evodiamine and rutaecarpine.  Growing evidence demonstrates that evodiamine possesses anti-cancer activities both in vitro and in vivo by inhibiting proliferation, invasion and metastasis, inducing apoptosis of a variety of tumor cell lines.  This review is aimed to summarize the recent researches on evodiamine focusing on anti-cancer activity and to highlight mol. mechanisms during the past ten years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygUJ8nEBYU7Vg90H21EOLACvtfcHk0lhiDThQeksO_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D&md5=ce11dc87f32f3db73b2462180521e9fa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3390%2Fmolecules14051852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules14051852%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DC.%26atitle%3DEvodiamine%253A%2520a%2520novel%2520anti-cancer%2520alkaloid%2520from%2520Evodia%2520rutaecarpa%26jtitle%3DMolecules%26date%3D2009%26volume%3D14%26spage%3D1852%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Yoshizumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minakuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, T.</span><span> </span><span class="NLM_article-title">Effect of evodiamine on catecholamine secretion from bovine adrenal medulla</span> <span class="citation_source-journal">J. Med. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1997&pages=79-82&author=M.+Yoshizumiauthor=H.+Houchiauthor=Y.+Ishimuraauthor=M.+Hiroseauthor=T.+Kitagawaauthor=K.+Tsuchiyaauthor=K.+Minakuchiauthor=T.+Tamaki&title=Effect+of+evodiamine+on+catecholamine+secretion+from+bovine+adrenal+medulla"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizumi%26aufirst%3DM.%26aulast%3DHouchi%26aufirst%3DH.%26aulast%3DIshimura%26aufirst%3DY.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DT.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DMinakuchi%26aufirst%3DK.%26aulast%3DTamaki%26aufirst%3DT.%26atitle%3DEffect%2520of%2520evodiamine%2520on%2520catecholamine%2520secretion%2520from%2520bovine%2520adrenal%2520medulla%26jtitle%3DJ.%2520Med.%2520Invest.%26date%3D1997%26volume%3D44%26spage%3D79%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span> </span><span class="NLM_article-title">Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells</span> <span class="citation_source-journal">Metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2FS0026-0495%2899%2990241-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=10599984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFKlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1532-1535&author=H.+Linauthor=S.+C.+Tsaiauthor=J.+J.+Chenauthor=Y.+C.+Chiaoauthor=S.+W.+Wangauthor=G.+J.+Wangauthor=C.+F.+Chenauthor=P.+S.+Wang&title=Effects+of+evodiamine+on+the+secretion+of+testosterone+in+rat+testicular+interstitial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells</span></div><div class="casAuthors">Lin, Ho; Tsai, Shiow-Chwen; Chen, Jiann-Jong; Chiao, Yu-Chung; Wang, Shyi-Wu; Wang, Guei-Jane; Chen, Chieh-Fu; Wang, Paulus S.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1532-1535</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Evodiamine, a bioactive component isolated from the Chinese medicine Wu-chu-yu, exhibits vasodilative and antianoxic action.  Although evodiamine indeed has many biol. effects, its effects on the endocrine system are not clear.  The present study explored the effects of evodiamine on testosterone secretion in vitro.  Rat collagenase-dispersed testicular interstitial cells (TICs) were incubated with evodiamine (0 to 10-4 mol/L) in the presence or absence of human chorionic gonadotropin (hCG), forskolin, 8-bromo-adenosine 3':5'-cyclic monophosphate (8-Br-cAMP), or steroidogenic precursors (including 25-hydroxycholesterol, pregnenolone, progesterone, 17α-hydroxyprogesterone, and androstenedione) at 34° for 1 h.  The testosterone concn. in the media samples was measured by RIA.  Evodiamine 10-4 mol/L was effective to reduce both basal and hCG-stimulated testosterone secretion in rat TICs after 1, 2, and 4 h of incubation.  The stimulatory effect of forskolin on testosterone release in TICs was prevented by administration of evodiamine.  Evodiamine 10-4 mol/L also decreased 8-Br-cAMP- and androstenedione-stimulated testosterone secretion.  These results suggest that evodiamine reduces testosterone secretion in rat TICs via a mechanism involving reduced activity of cAMP-related pathways and 17β-hydroxysteroid dehydrogenase (17β-HSD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPLvcqWNq3SbVg90H21EOLACvtfcHk0lhiDThQeksO_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFKlsrw%253D&md5=dc76a4fb28a26ba146d6ca82b7d5b479</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2899%2990241-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252899%252990241-X%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DH.%26aulast%3DTsai%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DChiao%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BF.%26aulast%3DWang%26aufirst%3DP.%2BS.%26atitle%3DEffects%2520of%2520evodiamine%2520on%2520the%2520secretion%2520of%2520testosterone%2520in%2520rat%2520testicular%2520interstitial%2520cells%26jtitle%3DMetabolism%26date%3D1999%26volume%3D48%26spage%3D1532%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshikuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, T.</span><span> </span><span class="NLM_article-title">Capsaicin-like anti-obese activities of evodiamine from fruits of <i>Evodia rutaecarpa</i>, a vanilloid receptor agonist</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2001&pages=628-633&author=Y.+Kobayashiauthor=Y.+Nakanoauthor=M.+Kizakiauthor=K.+Hoshikumaauthor=Y.+Yokooauthor=T.+Kamiya&title=Capsaicin-like+anti-obese+activities+of+evodiamine+from+fruits+of+Evodia+rutaecarpa%2C+a+vanilloid+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DKizaki%26aufirst%3DM.%26aulast%3DHoshikuma%26aufirst%3DK.%26aulast%3DYokoo%26aufirst%3DY.%26aulast%3DKamiya%26aufirst%3DT.%26atitle%3DCapsaicin-like%2520anti-obese%2520activities%2520of%2520evodiamine%2520from%2520fruits%2520of%2520Evodia%2520rutaecarpa%252C%2520a%2520vanilloid%2520receptor%2520agonist%26jtitle%3DPlanta%2520Med.%26date%3D2001%26volume%3D67%26spage%3D628%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Chiou, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shum, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span> </span><span class="NLM_article-title">Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/doi/10.1021/np960495z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=708-711&author=W.+F.+Chiouauthor=Y.+J.+Sungauthor=J.+F.+Liaoauthor=A.+Y.+Shumauthor=C.+F.+Chen&title=Inhibitory+effect+of+dehydroevodiamine+and+evodiamine+on+nitric+oxide+production+in+cultured+murine+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fnp960495z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp960495z%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DW.%2BF.%26aulast%3DSung%26aufirst%3DY.%2BJ.%26aulast%3DLiao%26aufirst%3DJ.%2BF.%26aulast%3DShum%26aufirst%3DA.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BF.%26atitle%3DInhibitory%2520effect%2520of%2520dehydroevodiamine%2520and%2520evodiamine%2520on%2520nitric%2520oxide%2520production%2520in%2520cultured%2520murine%2520macrophages%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1997%26volume%3D60%26spage%3D708%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span> </span><span class="NLM_article-title">Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=44-56&author=S.+F.+Kanauthor=C.+H.+Yuauthor=H.+F.+Puauthor=J.+M.+Hsuauthor=M.+J.+Chenauthor=P.+S.+Wang&title=Anti-proliferative+effects+of+evodiamine+on+human+prostate+cancer+cell+lines+DU145+and+PC3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKan%26aufirst%3DS.%2BF.%26aulast%3DYu%26aufirst%3DC.%2BH.%26aulast%3DPu%26aufirst%3DH.%2BF.%26aulast%3DHsu%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DP.%2BS.%26atitle%3DAnti-proliferative%2520effects%2520of%2520evodiamine%2520on%2520human%2520prostate%2520cancer%2520cell%2520lines%2520DU145%2520and%2520PC3%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D101%26spage%3D44%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Yang, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205)</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=924-933&author=Z.+G.+Yangauthor=A.+Q.+Chenauthor=B.+Liu&title=Antiproliferation+and+apoptosis+induced+by+evodiamine+in+human+colorectal+carcinoma+cells+%28COLO-205%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BG.%26aulast%3DChen%26aufirst%3DA.%2BQ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DAntiproliferation%2520and%2520apoptosis%2520induced%2520by%2520evodiamine%2520in%2520human%2520colorectal%2520carcinoma%2520cells%2520%2528COLO-205%2529%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D924%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Kobayashi, Y.</span><span> </span><span class="NLM_article-title">The nociceptive and anti-nociceptive effects of evodiamine from fruits of <i>Evodia rutaecarpa</i> in mice</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=425-428&author=Y.+Kobayashi&title=The+nociceptive+and+anti-nociceptive+effects+of+evodiamine+from+fruits+of+Evodia+rutaecarpa+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26atitle%3DThe%2520nociceptive%2520and%2520anti-nociceptive%2520effects%2520of%2520evodiamine%2520from%2520fruits%2520of%2520Evodia%2520rutaecarpa%2520in%2520mice%26jtitle%3DPlanta%2520Med.%26date%3D2003%26volume%3D69%26spage%3D425%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Chiou, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shum, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span> </span><span class="NLM_article-title">The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2F0014-2999%2892%2990039-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=1327805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK38XksVSis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=1992&pages=277-283&author=W.+F.+Chiouauthor=C.+J.+Chouauthor=A.+Y.+Shumauthor=C.+F.+Chen&title=The+vasorelaxant+effect+of+evodiamine+in+rat+isolated+mesenteric+arteries%3A+mode+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries:  mode of action</span></div><div class="casAuthors">Chiou, Wen Fei; Chou, Cheng Jen; Shum, Andrew Yau Chik; Chen, Chieh Fu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">277-83</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The roles of the endothelium, Ca2+ and K+ fluxes in the evodiamine-induced attenuation of vascular contractile responses to vasoactive agents were examd.  The results showed that: (1) in rat mesenteric artery rings, evodiamine elicited a concn.-dependent attenuation in the contractile response generated by phenylephrine.  The inhibitory potency was greater for intact than for endothelium-denuded prepns.  Thus, the vasodilator action of evodiamine appeared to be partially endothelium-interactive (dependent).  (2) Evodiamine pretreatment had a greater inhibitory effect on the phenylephrine-induced tonic contraction (via Ca2+ influx) than on the phasic contraction (via Ca2+ release).  In addn., evodiamine more potently inhibited the restoration by CaCl2 of contractile responses to phenylephrine than a potassium depolarizing soln. in media that had been kept calcium-free.  These results suggest that block of the Ca2+ influx through receptor-mediated Ca2+ channels may be the major mechanism underlying the vasodilator effect of evodiamine.  (3) A K+ channel blocker, tetraethylammonium, almost completely abolished the vasodilatation induced by minoxidil (a known K+ channel opener) but no evodiamine.  The possible involvement of K+ channel activation of the vasodilator effect produced by evodiamine was therefore excluded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPa3bmNnmaz7Vg90H21EOLACvtfcHk0lj3dzA6otsPhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XksVSis7o%253D&md5=f542d494562c74600bc0f006d2d4dd1b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2892%2990039-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252892%252990039-7%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DW.%2BF.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DShum%26aufirst%3DA.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BF.%26atitle%3DThe%2520vasorelaxant%2520effect%2520of%2520evodiamine%2520in%2520rat%2520isolated%2520mesenteric%2520arteries%253A%2520mode%2520of%2520action%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D215%26spage%3D277%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Tsai, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. C.</span><span> </span><span class="NLM_article-title">Thermoregulatory effects of alkaloids isolated from Wu-chu-yu in afebrile and febrile rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=293-298&author=T.+H.+Tsaiauthor=T.+F.+Leeauthor=C.+F.+Chenauthor=L.+C.+Wang&title=Thermoregulatory+effects+of+alkaloids+isolated+from+Wu-chu-yu+in+afebrile+and+febrile+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DT.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BF.%26aulast%3DChen%26aufirst%3DC.%2BF.%26aulast%3DWang%26aufirst%3DL.%2BC.%26atitle%3DThermoregulatory%2520effects%2520of%2520alkaloids%2520isolated%2520from%2520Wu-chu-yu%2520in%2520afebrile%2520and%2520febrile%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1995%26volume%3D50%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lj8-srmgjAQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Thomsen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. H.</span><span> </span><span class="NLM_article-title">MolDock: a new technique for high-accuracy molecular docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3315</span><span class="NLM_x">–</span> <span class="NLM_lpage">3321</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051197e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFyiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3315-3321&author=R.+Thomsenauthor=M.+H.+Christensen&title=MolDock%3A+a+new+technique+for+high-accuracy+molecular+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">MolDock: A New Technique for High-Accuracy Molecular Docking</span></div><div class="casAuthors">Thomsen, Rene; Christensen, Mikael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3315-3321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this article we introduce a mol. docking algorithm called MolDock.  MolDock is based on a new heuristic search algorithm that combines differential evolution with a cavity prediction algorithm.  The docking scoring function of MolDock is an extension of the piecewise linear potential (PLP) including new hydrogen bonding and electrostatic terms.  To further improve docking accuracy, a re-ranking scoring function is introduced, which identifies the most promising docking soln. from the solns. obtained by the docking algorithm.  The docking accuracy of MolDock has been evaluated by docking flexible ligands to 77 protein targets.  MolDock was able to identify the correct binding mode of 87% of the complexes.  In comparison, the accuracy of Glide and Surflex is 82% and 75%, resp.  FlexX obtained 58% and GOLD 78% on subsets contg. 76 and 55 cases, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwtjNdC1qG7Vg90H21EOLACvtfcHk0lj8-srmgjAQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFyiu7w%253D&md5=e800cc1d47cb87d896ba080067faaaff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm051197e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051197e%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DR.%26aulast%3DChristensen%26aufirst%3DM.%2BH.%26atitle%3DMolDock%253A%2520a%2520new%2520technique%2520for%2520high-accuracy%2520molecular%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3315%26epage%3D3321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+docking+using+a+Lamarckian+genetic+algorithm+and+empirical+binding+free+energy+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0lj8-srmgjAQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520docking%2520using%2520a%2520Lamarckian%2520genetic%2520algorithm%2520and%2520empirical%2520binding%2520free%2520energy%2520function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S. A</span><span> </span><span class="NLM_article-title">Semiempirical free energy force field with charge-based desolvation</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1145-1152&author=R.+Hueyauthor=G.+M.+Morrisauthor=A.+J.+Olsonauthor=D.+S.+A+Goodsell&title=Semiempirical+free+energy+force+field+with+charge-based+desolvation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%2BA%26atitle%3DSemiempirical%2520free%2520energy%2520force%2520field%2520with%2520charge-based%2520desolvation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2007%26volume%3D28%26spage%3D1145%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 76 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xinglin Li, Shanchao Wu, Guoqiang Dong, Shuqiang Chen, Zonglin Ma, Dan Liu, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 439-444. <a href="https://doi.org/10.1021/acsmedchemlett.9b00513" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00513%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNatural%252BProduct%252BEvodiamine%252Bwith%252BBorate%252BTrigger%252BUnit%25253A%252BDiscovery%252Bof%252BPotent%252BAntitumor%252BAgents%252Bagainst%252BColon%252BCancer%26aulast%3DLi%26aufirst%3DXinglin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D06112019%26date%3D28022020%26date%3D04032020%26date%3D28022020%26volume%3D11%26issue%3D4%26spage%3D439%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Wang, Kun Fang, Junfei Cheng, Yu Li, Yahui Huang, Shuqiang Chen, Guoqiang Dong, Shanchao Wu, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 696-713. <a href="https://doi.org/10.1021/acs.jmedchem.9b01626" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01626%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScaffold%252BHopping%252Bof%252BNatural%252BProduct%252BEvodiamine%25253A%252BDiscovery%252Bof%252Ba%252BNovel%252BAntitumor%252BScaffold%252Bwith%252BExcellent%252BPotency%252Bagainst%252BColon%252BCancer%26aulast%3DWang%26aufirst%3DLei%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D02102019%26date%3D10012020%26date%3D27122019%26volume%3D63%26issue%3D2%26spage%3D696%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ruben Buendia, Thierry Kogej, Ola Engkvist, Lars Carlsson, Henrik Linusson, Ulf Johansson, Paolo Toccaceli, <span class="NLM_string-name hlFld-ContribAuthor">Ernst Ahlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Accurate Hit Estimation for Iterative Screening Using Venn–ABERS Predictors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (3)
                                     , 1230-1237. <a href="https://doi.org/10.1021/acs.jcim.8b00724" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00724%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAccurate%252BHit%252BEstimation%252Bfor%252BIterative%252BScreening%252BUsing%252BVenn%2525E2%252580%252593ABERS%252BPredictors%26aulast%3DBuendia%26aufirst%3DRuben%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D17102018%26date%3D22022019%26date%3D06022019%26volume%3D59%26issue%3D3%26spage%3D1230%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vunnam Srinivasulu, Ihsan Shehadeh, Monther A. Khanfar, Omar G. Malik, Hamadeh Tarazi, Imad A. Abu-Yousef, Anusha Sebastian, Nabil Baniowda, Matthew John O’Connor, <span class="NLM_string-name hlFld-ContribAuthor">Taleb H. Al-Tel</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of Diverse Collections of Benzoxazepine and Indolopyrazine Fused to Heterocyclic Systems. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (2)
                                     , 934-948. <a href="https://doi.org/10.1021/acs.joc.8b02878" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02878%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-Pot%252BSynthesis%252Bof%252BDiverse%252BCollections%252Bof%252BBenzoxazepine%252Band%252BIndolopyrazine%252BFused%252Bto%252BHeterocyclic%252BSystems%26aulast%3DSrinivasulu%26aufirst%3DVunnam%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D10112018%26date%3D04012019%26date%3D24122018%26volume%3D84%26issue%3D2%26spage%3D934%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zi-Xuan Wang, Jia-Chen Xiang, Miao Wang, Jin-Tian Ma, Yan-Dong Wu, <span class="NLM_string-name hlFld-ContribAuthor">An-Xin Wu</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Total Synthesis of Evodiamine and Its Analogues through a Continuous Biscyclization Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (20)
                                     , 6380-6383. <a href="https://doi.org/10.1021/acs.orglett.8b02667" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02667%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOne-Pot%252BTotal%252BSynthesis%252Bof%252BEvodiamine%252Band%252BIts%252BAnalogues%252Bthrough%252Ba%252BContinuous%252BBiscyclization%252BReaction%26aulast%3DWang%26aufirst%3DZi-Xuan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21082018%26date%3D04102018%26volume%3D20%26issue%3D20%26spage%3D6380%26epage%3D6383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunrui  Cai</span>, <span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Zaccary  Alperstein</span>, <span class="hlFld-ContribAuthor ">Wenjun  Yu</span>, <span class="hlFld-ContribAuthor ">Artem  Cherkasov</span>, and <span class="hlFld-ContribAuthor ">Hongbin  Zou</span>  . </span><span class="cited-content_cbyCitation_article-title">Strictosidine Synthase Triggered Enantioselective Synthesis of N-Substituted (S)-3,14,18,19-Tetrahydroangustines as Novel Topoisomerase I Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (12)
                                     , 3086-3092. <a href="https://doi.org/10.1021/acschembio.7b00740" title="DOI URL">https://doi.org/10.1021/acschembio.7b00740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00740%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStrictosidine%252BSynthase%252BTriggered%252BEnantioselective%252BSynthesis%252Bof%252BN-Substituted%252B%252528S%252529-3%25252C14%25252C18%25252C19-Tetrahydroangustines%252Bas%252BNovel%252BTopoisomerase%252BI%252BInhibitors%26aulast%3DCai%26aufirst%3DYunrui%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23082017%26date%3D15112017%26date%3D22112017%26date%3D15122017%26date%3D15112017%26volume%3D12%26issue%3D12%26spage%3D3086%26epage%3D3092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessia  Bertamino</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Lauro</span>, <span class="hlFld-ContribAuthor ">Carmine  Ostacolo</span>, <span class="hlFld-ContribAuthor ">Veronica  Di Sarno</span>, <span class="hlFld-ContribAuthor ">Simona  Musella</span>, <span class="hlFld-ContribAuthor ">Tania  Ciaglia</span>, <span class="hlFld-ContribAuthor ">Pietro  Campiglia</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>, and <span class="hlFld-ContribAuthor ">Isabel M.  Gomez-Monterrey</span>  . </span><span class="cited-content_cbyCitation_article-title">Ring-Fused Cyclic Aminals from Tetrahydro-β-carboline-Based Dipeptide Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12014-12027. <a href="https://doi.org/10.1021/acs.joc.7b01656" title="DOI URL">https://doi.org/10.1021/acs.joc.7b01656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b01656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b01656%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRing-Fused%252BCyclic%252BAminals%252Bfrom%252BTetrahydro-%2525CE%2525B2-carboline-Based%252BDipeptide%252BCompounds%26aulast%3DBertamino%26aufirst%3DAlessia%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03072017%26date%3D14112017%26date%3D01122017%26date%3D01112017%26volume%3D82%26issue%3D23%26spage%3D12014%26epage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Xinglin  Yang</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Wang</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 7965-7983. <a href="https://doi.org/10.1021/acs.jmedchem.7b00467" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00467%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BInhibitors%252BSimultaneously%252BTargeting%252BCancer%252BMetabolism%252Band%252BEpigenetics%25253A%252BDiscovery%252Bof%252BNovel%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BDual%252BInhibitors%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27032017%26date%3D21092017%26date%3D12102017%26date%3D08092017%26volume%3D60%26issue%3D19%26spage%3D7965%26epage%3D7983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Fang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6678-6696. <a href="https://doi.org/10.1021/acs.jmedchem.5b00910" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00910%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScaffold%252BDiversity%252BInspired%252Bby%252Bthe%252BNatural%252BProduct%252BEvodiamine%25253A%252BDiscovery%252Bof%252BHighly%252BPotent%252Band%252BMultitargeting%252BAntitumor%252BAgents%26aulast%3DWang%26aufirst%3DShengzheng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D14062015%26date%3D19082015%26date%3D27082015%26date%3D30072015%26volume%3D58%26issue%3D16%26spage%3D6678%26epage%3D6696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel E.  Beck</span>, <span class="hlFld-ContribAuthor ">Monica  Abdelmalak</span>, <span class="hlFld-ContribAuthor ">Wei  Lv</span>, <span class="hlFld-ContribAuthor ">P. V. Narasimha  Reddy</span>, <span class="hlFld-ContribAuthor ">Gabrielle S.  Tender</span>, <span class="hlFld-ContribAuthor ">Elizaveta  O’Neill</span>, <span class="hlFld-ContribAuthor ">Keli  Agama</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, and <span class="hlFld-ContribAuthor ">Mark  Cushman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Indenoisoquinoline Topoisomerase I Poisons Lacking the 3-Nitro Toxicophore. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (9)
                                     , 3997-4015. <a href="https://doi.org/10.1021/acs.jmedchem.5b00303" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00303%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BIndenoisoquinoline%252BTopoisomerase%252BI%252BPoisons%252BLacking%252Bthe%252B3-Nitro%252BToxicophore%26aulast%3DBeck%26aufirst%3DDaniel%2BE.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21022015%26date%3D24042015%26date%3D14052015%26volume%3D58%26issue%3D9%26spage%3D3997%26epage%3D4015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Zhibin  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengang  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 239-243. <a href="https://doi.org/10.1021/ml500327q" title="DOI URL">https://doi.org/10.1021/ml500327q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500327q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500327q%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BNovel%252BMultiacting%252BTopoisomerase%252BI%25252FII%252Band%252BHistone%252BDeacetylase%252BInhibitors%26aulast%3DHe%26aufirst%3DShipeng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05082014%26date%3D14012015%26date%3D20012015%26date%3D12032015%26date%3D14012015%26volume%3D6%26issue%3D3%26spage%3D239%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Lingjian  Zhu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Yuelin  Wu</span>, <span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zizao  Guo</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Shiping  Zhu</span>, <span class="hlFld-ContribAuthor ">Kun  Fang</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, and <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">A New Strategy To Improve the Metabolic Stability of Lactone: Discovery of (20S,21S)-21-Fluorocamptothecins as Novel, Hydrolytically Stable Topoisomerase I Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7902-7910. <a href="https://doi.org/10.1021/jm400906z" title="DOI URL">https://doi.org/10.1021/jm400906z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400906z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400906z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNew%252BStrategy%252BTo%252BImprove%252Bthe%252BMetabolic%252BStability%252Bof%252BLactone%25253A%252BDiscovery%252Bof%252B%25252820S%25252C21S%252529-21-Fluorocamptothecins%252Bas%252BNovel%25252C%252BHydrolytically%252BStable%252BTopoisomerase%252BI%252BInhibitors%26aulast%3DMiao%26aufirst%3DZhenyuan%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D18062013%26date%3D09102013%26date%3D24102013%26date%3D26092013%26volume%3D56%26issue%3D20%26spage%3D7902%26epage%3D7910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William P.  Unsworth</span>, <span class="hlFld-ContribAuthor ">Christiana  Kitsiou</span>, and <span class="hlFld-ContribAuthor ">Richard J. K.  Taylor</span>  . </span><span class="cited-content_cbyCitation_article-title">An Expedient Protecting-Group-Free Total Synthesis of (±)-Dievodiamine. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (13)
                                     , 3302-3305. <a href="https://doi.org/10.1021/ol4013469" title="DOI URL">https://doi.org/10.1021/ol4013469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol4013469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol4013469%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAn%252BExpedient%252BProtecting-Group-Free%252BTotal%252BSynthesis%252Bof%252B%252528%2525C2%2525B1%252529-Dievodiamine%26aulast%3DUnsworth%26aufirst%3DWilliam%2BP.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D14052013%26date%3D20062013%26date%3D05072013%26volume%3D15%26issue%3D13%26spage%3D3302%26epage%3D3305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Shiping  Zhu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, and <span class="hlFld-ContribAuthor ">Wei  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Facile Construction of Structurally Diverse Thiazolidinedione-Derived Compounds via Divergent Stereoselective Cascade Organocatalysis and Their Biological Exploratory Studies. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2013,</strong> <em>15 </em>
                                    (6)
                                     , 298-308. <a href="https://doi.org/10.1021/co400022r" title="DOI URL">https://doi.org/10.1021/co400022r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co400022r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco400022r%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DFacile%252BConstruction%252Bof%252BStructurally%252BDiverse%252BThiazolidinedione-Derived%252BCompounds%252Bvia%252BDivergent%252BStereoselective%252BCascade%252BOrganocatalysis%252Band%252BTheir%252BBiological%252BExploratory%252BStudies%26aulast%3DZhang%26aufirst%3DYongqiang%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D18022013%26date%3D15042013%26date%3D08052013%26date%3D10062013%26date%3D24042013%26volume%3D15%26issue%3D6%26spage%3D298%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William P.  Unsworth</span>, <span class="hlFld-ContribAuthor ">Christiana  Kitsiou</span>, and <span class="hlFld-ContribAuthor ">Richard J. K.  Taylor</span>  . </span><span class="cited-content_cbyCitation_article-title">Direct Imine Acylation: Rapid Access to Diverse Heterocyclic Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (2)
                                     , 258-261. <a href="https://doi.org/10.1021/ol303073b" title="DOI URL">https://doi.org/10.1021/ol303073b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol303073b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol303073b%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirect%252BImine%252BAcylation%25253A%252BRapid%252BAccess%252Bto%252BDiverse%252BHeterocyclic%252BScaffolds%26aulast%3DUnsworth%26aufirst%3DWilliam%2BP.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D08112012%26date%3D24122012%26date%3D18012013%26volume%3D15%26issue%3D2%26spage%3D258%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Yongqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Zizhao  Guo</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7593-7613. <a href="https://doi.org/10.1021/jm300605m" title="DOI URL">https://doi.org/10.1021/jm300605m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300605m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300605m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BTricks%252Bfor%252Ban%252BOld%252BNatural%252BProduct%25253A%252BDiscovery%252Bof%252BHighly%252BPotent%252BEvodiamine%252BDerivatives%252Bas%252BNovel%252BAntitumor%252BAgents%252Bby%252BSystemic%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BAnalysis%252Band%252BBiological%252BEvaluations%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02052012%26date%3D22082012%26date%3D13092012%26date%3D06082012%26volume%3D55%26issue%3D17%26spage%3D7593%26epage%3D7613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Sarah  Ollio</span>, <span class="hlFld-ContribAuthor ">Eberhardt  Herdtweck</span>, and <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>  . </span><span class="cited-content_cbyCitation_article-title">Polycyclic Compounds by Ugi−Pictet−Spengler Sequence. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (2)
                                     , 637-644. <a href="https://doi.org/10.1021/jo102058s" title="DOI URL">https://doi.org/10.1021/jo102058s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo102058s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo102058s%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPolycyclic%252BCompounds%252Bby%252BUgi%2525E2%252588%252592Pictet%2525E2%252588%252592Spengler%252BSequence%26aulast%3DWang%26aufirst%3DWei%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D03112010%26date%3D29122010%26date%3D21012011%26volume%3D76%26issue%3D2%26spage%3D637%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohong  Fan</span>, <span class="hlFld-ContribAuthor ">Jiedan  Deng</span>, <span class="hlFld-ContribAuthor ">Tao  Shi</span>, <span class="hlFld-ContribAuthor ">Huaixiu  Wen</span>, <span class="hlFld-ContribAuthor ">Junfang  Li</span>, <span class="hlFld-ContribAuthor ">Ziyi  Liang</span>, <span class="hlFld-ContribAuthor ">Fang  Lei</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Honghua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Liang</span>, <span class="hlFld-ContribAuthor ">Xiangyong  Hao</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105154. <a href="https://doi.org/10.1016/j.bioorg.2021.105154" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105154%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioactivity%252Bstudy%252Bof%252Bevodiamine%252Bderivatives%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatocellular%252Bcarcinoma%26aulast%3DFan%26aufirst%3DXiaohong%26date%3D2021%26volume%3D114%26spage%3D105154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Kaijian  Bi</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113544. <a href="https://doi.org/10.1016/j.ejmech.2021.113544" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113544%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWater-soluble%252Bderivatives%252Bof%252Bevodiamine%25253A%252BDiscovery%252Bof%252Bevodiamine-10-phosphate%252Bas%252Ban%252Borally%252Bactive%252Bantitumor%252Blead%252Bcompound%26aulast%3DChen%26aufirst%3DShuqiang%26date%3D2021%26volume%3D220%26spage%3D113544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucy Ellen  Kapp</span>, <span class="hlFld-ContribAuthor ">Marietjie  Schutte-Smith</span>, <span class="hlFld-ContribAuthor ">Linette  Twigge</span>, <span class="hlFld-ContribAuthor ">Hendrik Gideon  Visser</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and DNA binding of four imidazo[4,5-f]1,10-phenanthroline derivatives.. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>45 </em>, 131235. <a href="https://doi.org/10.1016/j.molstruc.2021.131235" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131235%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252BDNA%252Bbinding%252Bof%252Bfour%252Bimidazo%25255B4%25252C5-f%25255D1%25252C10-phenanthroline%252Bderivatives.%26aulast%3DKapp%26aufirst%3DLucy%2BEllen%26date%3D2021%26volume%3D45%26spage%3D131235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zonglin  Ma</span>, <span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Kun  Wan</span>, <span class="hlFld-ContribAuthor ">Fugui  Zhu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>40 </em>, 127954. <a href="https://doi.org/10.1016/j.bmcl.2021.127954" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127954%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252Bsimplification%252Bof%252Bevodiamine%25253A%252BDiscovery%252Bof%252Bnovel%252Btetrahydro-%2525CE%2525B2-carboline%252Bderivatives%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DMa%26aufirst%3DZonglin%26date%3D2021%26volume%3D40%26spage%3D127954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serhii  Patrykei</span>, <span class="hlFld-ContribAuthor ">Yulia  Korobko</span>, <span class="hlFld-ContribAuthor ">Oleksandr  Ogorodniichuk</span>, <span class="hlFld-ContribAuthor ">Myroslav  Garazd</span>, <span class="hlFld-ContribAuthor ">Pavel  Polishchuk</span>, <span class="hlFld-ContribAuthor ">Petr  Džubák</span>, <span class="hlFld-ContribAuthor ">Soňa  Gurská</span>, <span class="hlFld-ContribAuthor ">Marián  Hajdúch</span>, <span class="hlFld-ContribAuthor ">Roman  Lesyk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of the anticancer activity of some semisynthetic derivatives of rutaecarpine and evodiamine. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>16 </em>, 1-9. <a href="https://doi.org/10.1080/00397911.2021.1919712" title="DOI URL">https://doi.org/10.1080/00397911.2021.1919712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2021.1919712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2021.1919712%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bthe%252Banticancer%252Bactivity%252Bof%252Bsome%252Bsemisynthetic%252Bderivatives%252Bof%252Brutaecarpine%252Band%252Bevodiamine%26aulast%3DPatrykei%26aufirst%3DSerhii%26date%3D2021%26date%3D2021%26volume%3D16%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Ottaviani</span>, <span class="hlFld-ContribAuthor ">Federico  Iacovelli</span>, <span class="hlFld-ContribAuthor ">Paola  Fiorani</span>, <span class="hlFld-ContribAuthor ">Alessandro  Desideri</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 4138. <a href="https://doi.org/10.3390/ijms22084138" title="DOI URL">https://doi.org/10.3390/ijms22084138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22084138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22084138%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNatural%252BCompounds%252Bas%252BTherapeutic%252BAgents%25253A%252BThe%252BCase%252Bof%252BHuman%252BTopoisomerase%252BIB%26aulast%3DOttaviani%26aufirst%3DAlessio%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D4138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan  Peng</span>, <span class="hlFld-ContribAuthor ">Qiaohong  Liu</span>, <span class="hlFld-ContribAuthor ">Fucheng  Yin</span>, <span class="hlFld-ContribAuthor ">Cunjian  Shi</span>, <span class="hlFld-ContribAuthor ">Limei  Ji</span>, <span class="hlFld-ContribAuthor ">Lailiang  Qu</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Heng  Luo</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(
              iii
              ) catalyzed olefination and deuteration of tetrahydrocarbazole. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (14)
                                     , 8356-8361. <a href="https://doi.org/10.1039/D1RA00236H" title="DOI URL">https://doi.org/10.1039/D1RA00236H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA00236H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA00236H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRhodium%252528%252Biii%252B%252529%252Bcatalyzed%252Bolefination%252Band%252Bdeuteration%252Bof%252Btetrahydrocarbazole%26aulast%3DPeng%26aufirst%3DWan%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D14%26spage%3D8356%26epage%3D8361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Tian</span>, <span class="hlFld-ContribAuthor ">Jiapeng  Guo</span>, <span class="hlFld-ContribAuthor ">Qingsen  Zhang</span>, <span class="hlFld-ContribAuthor ">Shaoyu  Fang</span>, <span class="hlFld-ContribAuthor ">Ruolan  Zhou</span>, <span class="hlFld-ContribAuthor ">Jian  Hu</span>, <span class="hlFld-ContribAuthor ">Mingping  Wang</span>, <span class="hlFld-ContribAuthor ">Yuefan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin-Min  Guo</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Ju  Zhu</span>, <span class="hlFld-ContribAuthor ">Canhui  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of novel small molecule allosteric activators of aldehyde dehydrogenase 2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113119. <a href="https://doi.org/10.1016/j.ejmech.2020.113119" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113119%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Bnovel%252Bsmall%252Bmolecule%252Ballosteric%252Bactivators%252Bof%252Baldehyde%252Bdehydrogenase%252B2%26aulast%3DTian%26aufirst%3DWei%26date%3D2021%26volume%3D212%26spage%3D113119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serhii  Holota</span>, <span class="hlFld-ContribAuthor ">Sergiy  Komykhov</span>, <span class="hlFld-ContribAuthor ">Stepan  Sysak</span>, <span class="hlFld-ContribAuthor ">Andrzej  Gzella</span>, <span class="hlFld-ContribAuthor ">Andriy  Cherkas</span>, <span class="hlFld-ContribAuthor ">Roman  Lesyk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization and In Vitro Evaluation of Novel 5-Ene-thiazolo[3,2-b][1,2,4]triazole-6(5H)-ones as Possible Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1162. <a href="https://doi.org/10.3390/molecules26041162" title="DOI URL">https://doi.org/10.3390/molecules26041162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041162%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BCharacterization%252Band%252BIn%252BVitro%252BEvaluation%252Bof%252BNovel%252B5-Ene-thiazolo%25255B3%25252C2-b%25255D%25255B1%25252C2%25252C4%25255Dtriazole-6%2525285H%252529-ones%252Bas%252BPossible%252BAnticancer%252BAgents%26aulast%3DHolota%26aufirst%3DSerhii%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yusra Habib  Khan</span>, <span class="hlFld-ContribAuthor ">Ambreen Malik  Uttra</span>, <span class="hlFld-ContribAuthor ">Sumera  Qasim</span>, <span class="hlFld-ContribAuthor ">Tauqeer Hussain  Mallhi</span>, <span class="hlFld-ContribAuthor ">Nasser Hadal  Alotaibi</span>, <span class="hlFld-ContribAuthor ">Maria  Rasheed</span>, <span class="hlFld-ContribAuthor ">Abdulaziz Ibrahim  Alzarea</span>, <span class="hlFld-ContribAuthor ">Muhammad Shahid  Iqbal</span>, <span class="hlFld-ContribAuthor ">Nabil Khulaif  Alruwaili</span>, <span class="hlFld-ContribAuthor ">Salah-Ud-Din  Khan</span>, <span class="hlFld-ContribAuthor ">Abdullah Salah  Alanazi</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Role of Phytochemicals Against Matrix Metalloproteinase Induced Breast Cancer; An Explanatory Review. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.592152" title="DOI URL">https://doi.org/10.3389/fchem.2020.592152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.592152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.592152%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DPotential%252BRole%252Bof%252BPhytochemicals%252BAgainst%252BMatrix%252BMetalloproteinase%252BInduced%252BBreast%252BCancer%25253B%252BAn%252BExplanatory%252BReview%26aulast%3DKhan%26aufirst%3DYusra%2BHabib%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma  Baglini</span>, <span class="hlFld-ContribAuthor ">Silvia  Salerno</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Barresi</span>, <span class="hlFld-ContribAuthor ">Marco  Robello</span>, <span class="hlFld-ContribAuthor ">Federico  Da Settimo</span>, <span class="hlFld-ContribAuthor ">Sabrina  Taliani</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Marini</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>156 </em>, 105594. <a href="https://doi.org/10.1016/j.ejps.2020.105594" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105594%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMultiple%252BTopoisomerase%252BI%252B%252528TopoI%252529%25252C%252BTopoisomerase%252BII%252B%252528TopoII%252529%252Band%252BTyrosyl-DNA%252BPhosphodiesterase%252B%252528TDP%252529%252Binhibitors%252Bin%252Bthe%252Bdevelopment%252Bof%252Banticancer%252Bdrugs%26aulast%3DBaglini%26aufirst%3DEmma%26date%3D2021%26volume%3D156%26spage%3D105594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhua  Liu</span>, <span class="hlFld-ContribAuthor ">Yuchen  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Si</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxamic acid hybrids as the potential anticancer agents: An Overview. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112679. <a href="https://doi.org/10.1016/j.ejmech.2020.112679" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112679%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHydroxamic%252Bacid%252Bhybrids%252Bas%252Bthe%252Bpotential%252Banticancer%252Bagents%25253A%252BAn%252BOverview%26aulast%3DLiu%26aufirst%3DWenhua%26date%3D2020%26volume%3D205%26spage%3D112679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (7)
                                     , 1294-1308. <a href="https://doi.org/10.1016/j.apsb.2019.11.011" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DEvodiamine-inspired%252Bdual%252Binhibitors%252Bof%252Bhistone%252Bdeacetylase%252B1%252B%252528HDAC1%252529%252Band%252Btopoisomerase%252B2%252B%252528TOP2%252529%252Bwith%252Bpotent%252Bantitumor%252Bactivity%26aulast%3DHuang%26aufirst%3DYahui%26date%3D2020%26volume%3D10%26issue%3D7%26spage%3D1294%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Fanglong  Li</span>, <span class="hlFld-ContribAuthor ">Shangxian  Luan</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Guizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Jing</span>. </span><span class="cited-content_cbyCitation_article-title">Autophagy-regulating N-heterocycles derivatives as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (3)
                                     , 223-242. <a href="https://doi.org/10.4155/fmc-2019-0294" title="DOI URL">https://doi.org/10.4155/fmc-2019-0294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0294%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAutophagy-regulating%252BN-heterocycles%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D223%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amin  Thawabteh</span>, <span class="hlFld-ContribAuthor ">Salma  Juma</span>, <span class="hlFld-ContribAuthor ">Mariam  Bader</span>, <span class="hlFld-ContribAuthor ">Donia  Karaman</span>, <span class="hlFld-ContribAuthor ">Laura  Scrano</span>, <span class="hlFld-ContribAuthor ">Sabino  Bufo</span>, <span class="hlFld-ContribAuthor ">Rafik  Karaman</span>. </span><span class="cited-content_cbyCitation_article-title">The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Toxins</span><span> <strong>2019,</strong> <em>11 </em>
                                    (11)
                                     , 656. <a href="https://doi.org/10.3390/toxins11110656" title="DOI URL">https://doi.org/10.3390/toxins11110656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/toxins11110656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Ftoxins11110656%26sid%3Dliteratum%253Aachs%26jtitle%3DToxins%26atitle%3DThe%252BBiological%252BActivity%252Bof%252BNatural%252BAlkaloids%252Bagainst%252BHerbivores%25252C%252BCancerous%252BCells%252Band%252BPathogens%26aulast%3DThawabteh%26aufirst%3DAmin%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiting  Su</span>, <span class="hlFld-ContribAuthor ">Gaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Fu  Ye</span>, <span class="hlFld-ContribAuthor ">Panpan  Qiao</span>, <span class="hlFld-ContribAuthor ">Jinxiang  Ye</span>, <span class="hlFld-ContribAuthor ">Yu  Gao</span>, <span class="hlFld-ContribAuthor ">Haijun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Facile access to evodiakine enabled by aerobic copper-catalyzed oxidative rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (39)
                                     , 8811-8815. <a href="https://doi.org/10.1039/C9OB01832H" title="DOI URL">https://doi.org/10.1039/C9OB01832H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01832H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01832H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DFacile%252Baccess%252Bto%252Bevodiakine%252Benabled%252Bby%252Baerobic%252Bcopper-catalyzed%252Boxidative%252Brearrangement%26aulast%3DSu%26aufirst%3DYiting%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D39%26spage%3D8811%26epage%3D8815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maris A.  Cinelli</span>. </span><span class="cited-content_cbyCitation_article-title">Topoisomerase 1B poisons: Over a half‐century of drug leads, clinical candidates, and serendipitous discoveries. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (4)
                                     , 1294-1337. <a href="https://doi.org/10.1002/med.21546" title="DOI URL">https://doi.org/10.1002/med.21546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21546%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTopoisomerase%252B1B%252Bpoisons%25253A%252BOver%252Ba%252Bhalf%2525E2%252580%252590century%252Bof%252Bdrug%252Bleads%25252C%252Bclinical%252Bcandidates%25252C%252Band%252Bserendipitous%252Bdiscoveries%26aulast%3DCinelli%26aufirst%3DMaris%2BA.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D4%26spage%3D1294%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Diethelm-Varela</span>, <span class="hlFld-ContribAuthor ">Yong  Ai</span>, <span class="hlFld-ContribAuthor ">Dongdong  Liang</span>, <span class="hlFld-ContribAuthor ">Fengtian  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (9)
                                     , 691-712. <a href="https://doi.org/10.2174/1568026619666190401100519" title="DOI URL">https://doi.org/10.2174/1568026619666190401100519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190401100519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190401100519%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DNitrogen%252BMustards%252Bas%252BAnticancer%252BChemotherapies%25253A%252BHistoric%252BPerspective%25252C%252BCurrent%252BDevelopments%252Band%252BFuture%252BTrends%26aulast%3DDiethelm-Varela%26aufirst%3DBenjamin%26date%3D2019%26volume%3D19%26issue%3D9%26spage%3D691%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wu</span>, <span class="hlFld-ContribAuthor ">Shangxian  Luan</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Yuan</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Min  He</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 129-168. <a href="https://doi.org/10.1016/j.ejmech.2019.03.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bof%252Btopoisomerase%252Binhibitors%252Bas%252Banticancer%252Bagents%252Bin%252Bthe%252Bpast%252Bdecade%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2019%26volume%3D171%26spage%3D129%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie-Dan  Deng</span>, <span class="hlFld-ContribAuthor ">Shuai  Lei</span>, <span class="hlFld-ContribAuthor ">Yi  Jiang</span>, <span class="hlFld-ContribAuthor ">Hong-Hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ling  Hu</span>, <span class="hlFld-ContribAuthor ">Huai-Xiu  Wen</span>, <span class="hlFld-ContribAuthor ">Wen  Tan</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A concise synthesis and biological study of evodiamine and its analogues. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (21)
                                     , 3089-3092. <a href="https://doi.org/10.1039/C9CC00434C" title="DOI URL">https://doi.org/10.1039/C9CC00434C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC00434C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC00434C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bconcise%252Bsynthesis%252Band%252Bbiological%252Bstudy%252Bof%252Bevodiamine%252Band%252Bits%252Banalogues%26aulast%3DDeng%26aufirst%3DJie-Dan%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D21%26spage%3D3089%26epage%3D3092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Jiangsheng  Gao</span>, <span class="hlFld-ContribAuthor ">Jian  Guo</span>, <span class="hlFld-ContribAuthor ">Zimeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-lung cancer activity and inhibitory mechanisms of a novel Calothrixin A derivative. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2019,</strong> <em>219 </em>, 20-30. <a href="https://doi.org/10.1016/j.lfs.2018.12.052" title="DOI URL">https://doi.org/10.1016/j.lfs.2018.12.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2018.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2018.12.052%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DAnti-lung%252Bcancer%252Bactivity%252Band%252Binhibitory%252Bmechanisms%252Bof%252Ba%252Bnovel%252BCalothrixin%252BA%252Bderivative%26aulast%3DYang%26aufirst%3DXiaohong%26date%3D2019%26volume%3D219%26spage%3D20%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     , 144-156. <a href="https://doi.org/10.1016/j.apsb.2018.08.003" title="DOI URL">https://doi.org/10.1016/j.apsb.2018.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2018.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2018.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DNovel%252Bfluorescent%252Bprobes%252Bof%252B10-hydroxyevodiamine%25253A%252Bautophagy%252Band%252Bapoptosis-inducing%252Banticancer%252Bmechanisms%26aulast%3DChen%26aufirst%3DShuqiang%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D144%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guan  Sun</span>, <span class="hlFld-ContribAuthor ">Chuang  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongmao  Song</span>, <span class="hlFld-ContribAuthor ">Jun  Guo</span>, <span class="hlFld-ContribAuthor ">Min  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">WZY‑321, a novel evodiamine analog, inhibits glioma cell growth in an autophagy‑associated manner. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ol.2018.9847" title="DOI URL">https://doi.org/10.3892/ol.2018.9847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2018.9847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2018.9847%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DWZY%2525E2%252580%252591321%25252C%252Ba%252Bnovel%252Bevodiamine%252Banalog%25252C%252Binhibits%252Bglioma%252Bcell%252Bgrowth%252Bin%252Ban%252Bautophagy%2525E2%252580%252591associated%252Bmanner%26aulast%3DSun%26aufirst%3DGuan%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Jie  Tu</span>, <span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Novel non-peptidic small molecule inhibitors of secreted aspartic protease 2 (SAP2) for the treatment of resistant fungal infections. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (96)
                                     , 13535-13538. <a href="https://doi.org/10.1039/C8CC07810F" title="DOI URL">https://doi.org/10.1039/C8CC07810F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC07810F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC07810F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DNovel%252Bnon-peptidic%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bsecreted%252Baspartic%252Bprotease%252B2%252B%252528SAP2%252529%252Bfor%252Bthe%252Btreatment%252Bof%252Bresistant%252Bfungal%252Binfections%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D96%26spage%3D13535%26epage%3D13538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh D.  Patil</span>, <span class="hlFld-ContribAuthor ">Gideon  Grogan</span>, <span class="hlFld-ContribAuthor ">Hyungdon  Yun</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalyzed C−C Bond Formation for the Production of Alkaloids. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2018,</strong> <em>10 </em>
                                    (21)
                                     , 4783-4804. <a href="https://doi.org/10.1002/cctc.201801130" title="DOI URL">https://doi.org/10.1002/cctc.201801130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201801130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201801130%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DBiocatalyzed%252BC%2525E2%252588%252592C%252BBond%252BFormation%252Bfor%252Bthe%252BProduction%252Bof%252BAlkaloids%26aulast%3DPatil%26aufirst%3DMahesh%2BD.%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D21%26spage%3D4783%26epage%3D4804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>, <span class="hlFld-ContribAuthor ">Chun  Chu</span>, <span class="hlFld-ContribAuthor ">Xu  Li</span>, <span class="hlFld-ContribAuthor ">Xianhua  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Jia</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Fanxing  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (11)
                                     , 3403. <a href="https://doi.org/10.3390/ijms19113403" title="DOI URL">https://doi.org/10.3390/ijms19113403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19113403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19113403%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DAntiproliferative%252BEffects%252Bof%252BAlkaloid%252BEvodiamine%252Band%252BIts%252BDerivatives%26aulast%3DHu%26aufirst%3DXu%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D11%26spage%3D3403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">KirkE.  Hevener</span>, <span class="hlFld-ContribAuthor ">Tatsiana A.  Verstak</span>, <span class="hlFld-ContribAuthor ">Katie E.  Lutat</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Riggsbee</span>, <span class="hlFld-ContribAuthor ">Jeremiah W.  Mooney</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in topoisomerase-targeted cancer chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2018,</strong> <em>8 </em>
                                    (6)
                                     , 844-861. <a href="https://doi.org/10.1016/j.apsb.2018.07.008" title="DOI URL">https://doi.org/10.1016/j.apsb.2018.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2018.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2018.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DRecent%252Bdevelopments%252Bin%252Btopoisomerase-targeted%252Bcancer%252Bchemotherapy%26aulast%3DHevener%26aufirst%3DKirkE.%26date%3D2018%26volume%3D8%26issue%3D6%26spage%3D844%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Runwei  Jiao</span>, <span class="hlFld-ContribAuthor ">Haonan  Li</span>, <span class="hlFld-ContribAuthor ">Xianhua  Wang</span>, <span class="hlFld-ContribAuthor ">Haoda  Lyu</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Fanxing  Xu</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 376-388. <a href="https://doi.org/10.1016/j.ejmech.2018.04.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntiproliferative%252Bhydrogen%252Bsulfide%252Breleasing%252Bevodiamine%252Bderivatives%252Band%252Btheir%252Bapoptosis%252Binducing%252Bproperties%26aulast%3DHu%26aufirst%3DXu%26date%3D2018%26volume%3D151%26spage%3D376%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potent catalytic inhibitors of human DNA topoisomerase II by structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 1142-1146. <a href="https://doi.org/10.1039/C8MD00219C" title="DOI URL">https://doi.org/10.1039/C8MD00219C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00219C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00219C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252Bpotent%252Bcatalytic%252Binhibitors%252Bof%252Bhuman%252BDNA%252Btopoisomerase%252BII%252Bby%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D7%26spage%3D1142%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujuan  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Wang</span>, <span class="hlFld-ContribAuthor ">Chuan  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Shufang  Liang</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Leilei  Fu</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of HSP90 sensitizes a novel Raf/ERK dual inhibitor CY-9d in triple-negative breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (61)
                                     , 104193-104205. <a href="https://doi.org/10.18632/oncotarget.22119" title="DOI URL">https://doi.org/10.18632/oncotarget.22119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22119%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibition%252Bof%252BHSP90%252Bsensitizes%252Ba%252Bnovel%252BRaf%25252FERK%252Bdual%252Binhibitor%252BCY-9d%252Bin%252Btriple-negative%252Bbreast%252Bcancer%252Bcells%26aulast%3DChen%26aufirst%3DYujuan%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D61%26spage%3D104193%26epage%3D104205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Jingjing  Xue</span>, <span class="hlFld-ContribAuthor ">Tong  Han</span>, <span class="hlFld-ContribAuthor ">Runwei  Jiao</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Weiwei  Liu</span>, <span class="hlFld-ContribAuthor ">Fanxing  Xu</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (22)
                                     , 4989-4993. <a href="https://doi.org/10.1016/j.bmcl.2017.10.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bnitrogen%252Bmustard-evodiamine%252Bhybrids%252Bwith%252Bselective%252Bantiproliferative%252Bactivity%26aulast%3DHu%26aufirst%3DXu%26date%3D2017%26volume%3D27%26issue%3D22%26spage%3D4989%26epage%3D4993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grigoriy Ya.  Remennikov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Condensed Heterocycles, Containing Partially Saturated Pyrimidine Nuclei, from Aromatic Pyrimidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2017,</strong> <em>54 </em>
                                    (5)
                                     , 2575-2597. <a href="https://doi.org/10.1002/jhet.2864" title="DOI URL">https://doi.org/10.1002/jhet.2864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2864%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BCondensed%252BHeterocycles%25252C%252BContaining%252BPartially%252BSaturated%252BPyrimidine%252BNuclei%25252C%252Bfrom%252BAromatic%252BPyrimidine%252BDerivatives%26aulast%3DRemennikov%26aufirst%3DGrigoriy%2BYa.%26date%3D2017%26date%3D2017%26volume%3D54%26issue%3D5%26spage%3D2575%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kairui  Feng</span>, <span class="hlFld-ContribAuthor ">Yujie  Ren</span>, <span class="hlFld-ContribAuthor ">Ren  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Combined pharmacophore-guided 3D-QSAR, molecular docking and molecular dynamics studies for evodiamine analogs as DNA topoisomerase I inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Taiwan Institute of Chemical Engineers</span><span> <strong>2017,</strong> <em>78 </em>, 81-95. <a href="https://doi.org/10.1016/j.jtice.2017.06.027" title="DOI URL">https://doi.org/10.1016/j.jtice.2017.06.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtice.2017.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtice.2017.06.027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Taiwan%2520Institute%2520of%2520Chemical%2520Engineers%26atitle%3DCombined%252Bpharmacophore-guided%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bstudies%252Bfor%252Bevodiamine%252Banalogs%252Bas%252BDNA%252Btopoisomerase%252BI%252Binhibitors%26aulast%3DFeng%26aufirst%3DKairui%26date%3D2017%26volume%3D78%26spage%3D81%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong-geng  Fu</span>, <span class="hlFld-ContribAuthor ">Yuan  Sun</span>, <span class="hlFld-ContribAuthor ">Wen-bing  Sheng</span>, <span class="hlFld-ContribAuthor ">Duan-fang  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Designing multi-targeted agents: An emerging anticancer drug discovery paradigm. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>136 </em>, 195-211. <a href="https://doi.org/10.1016/j.ejmech.2017.05.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252Bmulti-targeted%252Bagents%25253A%252BAn%252Bemerging%252Banticancer%252Bdrug%252Bdiscovery%252Bparadigm%26aulast%3DFu%26aufirst%3DRong-geng%26date%3D2017%26volume%3D136%26spage%3D195%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Somchai  Sriwiriyajan</span>, <span class="hlFld-ContribAuthor ">Yaowapa  Sukpondma</span>, <span class="hlFld-ContribAuthor ">Theera  Srisawat</span>, <span class="hlFld-ContribAuthor ">Siribhorn  Madla</span>, <span class="hlFld-ContribAuthor ">Potchanapond  Graidist</span>. </span><span class="cited-content_cbyCitation_article-title">(−)-Kusunokinin and piperloguminine from Piper nigrum: An alternative option to treat breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2017,</strong> <em>92 </em>, 732-743. <a href="https://doi.org/10.1016/j.biopha.2017.05.130" title="DOI URL">https://doi.org/10.1016/j.biopha.2017.05.130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2017.05.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2017.05.130%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3D%252528%2525E2%252588%252592%252529-Kusunokinin%252Band%252Bpiperloguminine%252Bfrom%252BPiper%252Bnigrum%25253A%252BAn%252Balternative%252Boption%252Bto%252Btreat%252Bbreast%252Bcancer%26aulast%3DSriwiriyajan%26aufirst%3DSomchai%26date%3D2017%26volume%3D92%26spage%3D732%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan-Ting  Xin</span>, <span class="hlFld-ContribAuthor ">Lu  Liu</span>, <span class="hlFld-ContribAuthor ">Chang-Lun  Shao</span>, <span class="hlFld-ContribAuthor ">Ri-Lei  Yu</span>, <span class="hlFld-ContribAuthor ">Fang-Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Shi-Jun  Yue</span>, <span class="hlFld-ContribAuthor ">Mei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Long  Guo</span>, <span class="hlFld-ContribAuthor ">Ya-Chu  Fan</span>, <span class="hlFld-ContribAuthor ">Hua-Shi  Guan</span>, <span class="hlFld-ContribAuthor ">Chang-Yun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2017,</strong> <em>15 </em>
                                    (7)
                                     , 217. <a href="https://doi.org/10.3390/md15070217" title="DOI URL">https://doi.org/10.3390/md15070217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md15070217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd15070217%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DDiscovery%252Bof%252BDNA%252BTopoisomerase%252BI%252BInhibitors%252Bwith%252BLow-Cytotoxicity%252BBased%252Bon%252BVirtual%252BScreening%252Bfrom%252BNatural%252BProducts%26aulast%3DXin%26aufirst%3DLan-Ting%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D7%26spage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Yuxin  Fang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (9)
                                     , 1929-1933. <a href="https://doi.org/10.1016/j.bmcl.2017.03.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B4-substituted%252Banthra%25255B2%25252C1-c%25255D%25255B1%25252C2%25252C5%25255Dthiadiazole-6%25252C11-dione%252Bderivatives%252Bas%252Bnovel%252Bnon-camptothecin%252Btopoisomerase%252BI%252Binhibitors%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2017%26volume%3D27%26issue%3D9%26spage%3D1929%26epage%3D1933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir A.  D'yakonov</span>, <span class="hlFld-ContribAuthor ">Lilya U.  Dzhemileva</span>, <span class="hlFld-ContribAuthor ">Usein M.  Dzhemilev</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Chemistry of Natural and Semisynthetic Topoisomerase I/II Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 21-86. <a href="https://doi.org/10.1016/B978-0-444-63929-5.00002-4" title="DOI URL">https://doi.org/10.1016/B978-0-444-63929-5.00002-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63929-5.00002-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63929-5.00002-4%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252Bthe%252BChemistry%252Bof%252BNatural%252Band%252BSemisynthetic%252BTopoisomerase%252BI%25252FII%252BInhibitors%26aulast%3DD%2527yakonov%26aufirst%3DVladimir%2BA.%26date%3D2017%26spage%3D21%26epage%3D86%26pub%3DElsevier%26date%3D2017%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Shin  Wu</span>, <span class="hlFld-ContribAuthor ">Chih-Chiang  Chien</span>, <span class="hlFld-ContribAuthor ">Kao-Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Yen-Chou  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Ta  Chiu</span>. </span><span class="cited-content_cbyCitation_article-title">Evodiamine Prevents Glioma Growth, Induces Glioblastoma Cell Apoptosis and Cell Cycle Arrest through JNK Activation. </span><span class="cited-content_cbyCitation_journal-name">The American Journal of Chinese Medicine</span><span> <strong>2017,</strong> <em>45 </em>
                                    (04)
                                     , 879-899. <a href="https://doi.org/10.1142/S0192415X17500471" title="DOI URL">https://doi.org/10.1142/S0192415X17500471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1142/S0192415X17500471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1142%2FS0192415X17500471%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520American%2520Journal%2520of%2520Chinese%2520Medicine%26atitle%3DEvodiamine%252BPrevents%252BGlioma%252BGrowth%25252C%252BInduces%252BGlioblastoma%252BCell%252BApoptosis%252Band%252BCell%252BCycle%252BArrest%252Bthrough%252BJNK%252BActivation%26aulast%3DWu%26aufirst%3DWen-Shin%26date%3D2017%26date%3D2017%26volume%3D45%26issue%3D04%26spage%3D879%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiangwei  Tian</span>, <span class="hlFld-ContribAuthor ">Yingping  Luo</span>, <span class="hlFld-ContribAuthor ">Liwei  Huang</span>, <span class="hlFld-ContribAuthor ">Yaqiang  Feng</span>, <span class="hlFld-ContribAuthor ">Huangxian  Ju</span>, <span class="hlFld-ContribAuthor ">Bo-Yang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Pegylated folate and peptide-decorated graphene oxide nanovehicle for in vivo targeted delivery of anticancer drugs and therapeutic self-monitoring. </span><span class="cited-content_cbyCitation_journal-name">Biosensors and Bioelectronics</span><span> <strong>2016,</strong> <em>80 </em>, 519-524. <a href="https://doi.org/10.1016/j.bios.2016.02.018" title="DOI URL">https://doi.org/10.1016/j.bios.2016.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bios.2016.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bios.2016.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBiosensors%2520and%2520Bioelectronics%26atitle%3DPegylated%252Bfolate%252Band%252Bpeptide-decorated%252Bgraphene%252Boxide%252Bnanovehicle%252Bfor%252Bin%252Bvivo%252Btargeted%252Bdelivery%252Bof%252Banticancer%252Bdrugs%252Band%252Btherapeutic%252Bself-monitoring%26aulast%3DTian%26aufirst%3DJiangwei%26date%3D2016%26volume%3D80%26spage%3D519%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 765-768. <a href="https://doi.org/10.1016/j.bmcl.2015.12.101" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.101%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bbenzothiophene%252Bamides%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%26aulast%3DChen%26aufirst%3DWei%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D765%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Topoisomerase I Inhibitors Derived from Natural Products: Structure–Activity Relationships and Antitumor Potency. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-28. <a href="https://doi.org/10.1016/B978-0-444-63603-4.00001-2" title="DOI URL">https://doi.org/10.1016/B978-0-444-63603-4.00001-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63603-4.00001-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63603-4.00001-2%26sid%3Dliteratum%253Aachs%26atitle%3DTopoisomerase%252BI%252BInhibitors%252BDerived%252Bfrom%252BNatural%252BProducts%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BAntitumor%252BPotency%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2016%26spage%3D1%26epage%3D28%26pub%3DElsevier%26date%3D2016%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Fang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent Cascade Construction of Skeletally Diverse “Privileged” Pyrazole-Derived Molecular Architectures. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (9)
                                     , 2030-2037. <a href="https://doi.org/10.1002/ejoc.201403673" title="DOI URL">https://doi.org/10.1002/ejoc.201403673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403673%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDivergent%252BCascade%252BConstruction%252Bof%252BSkeletally%252BDiverse%252B%2525E2%252580%25259CPrivileged%2525E2%252580%25259D%252BPyrazole-Derived%252BMolecular%252BArchitectures%26aulast%3DZhang%26aufirst%3DYongqiang%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D9%26spage%3D2030%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Gang  Li</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Dong</span>, <span class="hlFld-ContribAuthor ">Sheng-Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zhen-Yuan  Miao</span>, <span class="hlFld-ContribAuthor ">Jian-Zhong  Yao</span>, <span class="hlFld-ContribAuthor ">Wan-Nian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chun-Quan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Optical evodiamine derivatives: Asymmetric synthesis and antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2015,</strong> <em>26 </em>
                                    (3)
                                     , 267-271. <a href="https://doi.org/10.1016/j.cclet.2014.11.011" title="DOI URL">https://doi.org/10.1016/j.cclet.2014.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2014.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2014.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DOptical%252Bevodiamine%252Bderivatives%25253A%252BAsymmetric%252Bsynthesis%252Band%252Bantitumor%252Bactivity%26aulast%3DLi%26aufirst%3DZhen-Gang%26date%3D2015%26volume%3D26%26issue%3D3%26spage%3D267%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Fei-Lan  Liu</span>, <span class="hlFld-ContribAuthor ">Chia-Chung  Lee</span>, <span class="hlFld-ContribAuthor ">Tsung-Chih  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  Chang</span>, <span class="hlFld-ContribAuthor ">Jih-Hwa  Guh</span>, <span class="hlFld-ContribAuthor ">Ahmed Atef  Ahmed Ali</span>, <span class="hlFld-ContribAuthor ">Deh-Ming  Chang</span>, <span class="hlFld-ContribAuthor ">Hsu-Shan  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 30-38. <a href="https://doi.org/10.1016/j.ejmech.2014.09.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRing%252Bfusion%252Bstrategy%252Bfor%252Bthe%252Bsynthesis%252Bof%252Banthra%25255B2%25252C3-d%25255Doxazole-2-thione-5%25252C10-dione%252Bhomologues%252Bas%252BDNA%252Btopoisomerase%252Binhibitors%252Band%252Bas%252Bantitumor%252Bagents%26aulast%3DChen%26aufirst%3DChun-Liang%26date%3D2014%26volume%3D87%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiana  Kitsiou</span>, <span class="hlFld-ContribAuthor ">William P.  Unsworth</span>, <span class="hlFld-ContribAuthor ">Graeme  Coulthard</span>, <span class="hlFld-ContribAuthor ">Richard J.K.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate scope in the direct imine acylation of ortho-substituted benzoic acid derivatives: the total synthesis (±)-cavidine. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (40)
                                     , 7172-7180. <a href="https://doi.org/10.1016/j.tet.2014.04.066" title="DOI URL">https://doi.org/10.1016/j.tet.2014.04.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.04.066%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSubstrate%252Bscope%252Bin%252Bthe%252Bdirect%252Bimine%252Bacylation%252Bof%252Bortho-substituted%252Bbenzoic%252Bacid%252Bderivatives%25253A%252Bthe%252Btotal%252Bsynthesis%252B%252528%2525C2%2525B1%252529-cavidine%26aulast%3DKitsiou%26aufirst%3DChristiana%26date%3D2014%26volume%3D70%26issue%3D40%26spage%3D7172%26epage%3D7180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Fang</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Dong</span>, <span class="hlFld-ContribAuthor ">Hai  Gong</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen-Gang  Li</span>, <span class="hlFld-ContribAuthor ">Shi-Ping  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhen-Yuan  Miao</span>, <span class="hlFld-ContribAuthor ">Jian-Zhong  Yao</span>, <span class="hlFld-ContribAuthor ">Wan-Nian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chun-Quan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of E-ring modified evodiamine derivatives as novel antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2014,</strong> <em>25 </em>
                                    (7)
                                     , 978-982. <a href="https://doi.org/10.1016/j.cclet.2014.03.043" title="DOI URL">https://doi.org/10.1016/j.cclet.2014.03.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2014.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2014.03.043%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BE-ring%252Bmodified%252Bevodiamine%252Bderivatives%252Bas%252Bnovel%252Bantitumor%252Bagents%26aulast%3DFang%26aufirst%3DKun%26date%3D2014%26volume%3D25%26issue%3D7%26spage%3D978%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bojidarka  Ivanova</span>, <span class="hlFld-ContribAuthor ">Michael  Spiteller</span>. </span><span class="cited-content_cbyCitation_article-title">Evodiamine and rutaecarpine alkaloids as highly selective transient receptor potential vanilloid 1 agonists. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2014,</strong> <em>65 </em>, 314-324. <a href="https://doi.org/10.1016/j.ijbiomac.2014.01.059" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2014.01.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2014.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2014.01.059%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DEvodiamine%252Band%252Brutaecarpine%252Balkaloids%252Bas%252Bhighly%252Bselective%252Btransient%252Breceptor%252Bpotential%252Bvanilloid%252B1%252Bagonists%26aulast%3DIvanova%26aufirst%3DBojidarka%26date%3D2014%26volume%3D65%26spage%3D314%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Chung  Tseng</span>, <span class="hlFld-ContribAuthor ">Peng-Yeh  Lai</span>, <span class="hlFld-ContribAuthor ">Lin  Shi</span>, <span class="hlFld-ContribAuthor ">Hsin-Yi  Li</span>, <span class="hlFld-ContribAuthor ">Min-Jen  Tseng</span>, <span class="hlFld-ContribAuthor ">Yen-Ho  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of batracylin and its N-sulfonamido analogues in [b-3C-im][NTf2] ionic liquid. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (16)
                                     , 2629-2633. <a href="https://doi.org/10.1016/j.tet.2014.02.076" title="DOI URL">https://doi.org/10.1016/j.tet.2014.02.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.02.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.02.076%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bbatracylin%252Band%252Bits%252BN-sulfonamido%252Banalogues%252Bin%2525C2%2525A0%25255Bb-3C-im%25255D%25255BNTf2%25255D%252Bionic%252Bliquid%26aulast%3DTseng%26aufirst%3DMing-Chung%26date%3D2014%26volume%3D70%26issue%3D16%26spage%3D2629%26epage%3D2633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Senchuan  Song</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Chen</span>, <span class="hlFld-ContribAuthor ">Shaoxue  Li</span>, <span class="hlFld-ContribAuthor ">Yanmin  Huang</span>, <span class="hlFld-ContribAuthor ">Yiqian  Wan</span>, <span class="hlFld-ContribAuthor ">Huacan  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (12)
                                     , 15750-15768. <a href="https://doi.org/10.3390/molecules181215750" title="DOI URL">https://doi.org/10.3390/molecules181215750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules181215750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules181215750%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BEvaluation%252Bof%252BN13-Substituted%252BEvodiamine%252BDerivatives%252Bagainst%252BHuman%252BCancer%252BCell%252BLines%26aulast%3DSong%26aufirst%3DSenchuan%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D12%26spage%3D15750%26epage%3D15768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Christodoulou</span>, <span class="hlFld-ContribAuthor ">Alessandro  Sacchetti</span>, <span class="hlFld-ContribAuthor ">Valentina  Ronchetti</span>, <span class="hlFld-ContribAuthor ">Stefania  Caufin</span>, <span class="hlFld-ContribAuthor ">Alessandra  Silvani</span>, <span class="hlFld-ContribAuthor ">Giordano  Lesma</span>, <span class="hlFld-ContribAuthor ">Gabriele  Fontana</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Minicone</span>, <span class="hlFld-ContribAuthor ">Benedetta  Riva</span>, <span class="hlFld-ContribAuthor ">Micol  Ventura</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>, <span class="hlFld-ContribAuthor ">Elina  Jarho</span>, <span class="hlFld-ContribAuthor ">Valentina  Zuco</span>, <span class="hlFld-ContribAuthor ">Franco  Zunino</span>, <span class="hlFld-ContribAuthor ">Nadine  Martinet</span>, <span class="hlFld-ContribAuthor ">Federico  Dapiaggi</span>, <span class="hlFld-ContribAuthor ">Stefano  Pieraccini</span>, <span class="hlFld-ContribAuthor ">Maurizio  Sironi</span>, <span class="hlFld-ContribAuthor ">Lisa  Dalla Via</span>, <span class="hlFld-ContribAuthor ">Ornella Maria  Gia</span>, <span class="hlFld-ContribAuthor ">Daniele  Passarella</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (22)
                                     , 6920-6928. <a href="https://doi.org/10.1016/j.bmc.2013.09.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DQuinazolinecarboline%252Balkaloid%252Bevodiamine%252Bas%252Bscaffold%252Bfor%252Btargeting%252Btopoisomerase%252BI%252Band%252Bsirtuins%26aulast%3DChristodoulou%26aufirst%3DMichael%2BS.%26date%3D2013%26volume%3D21%26issue%3D22%26spage%3D6920%26epage%3D6928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning-Ning  Wei</span>, <span class="hlFld-ContribAuthor ">Adel  Hamza</span>, <span class="hlFld-ContribAuthor ">Ce  Hao</span>, <span class="hlFld-ContribAuthor ">Zhilong  Xiu</span>, <span class="hlFld-ContribAuthor ">Chang-Guo  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Microscopic modes and free energies for topoisomerase I-DNA covalent complex binding with non-camptothecin inhibitors by molecular docking and dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Theoretical Chemistry Accounts</span><span> <strong>2013,</strong> <em>132 </em>
                                    (8)
                                     <a href="https://doi.org/10.1007/s00214-013-1379-z" title="DOI URL">https://doi.org/10.1007/s00214-013-1379-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00214-013-1379-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00214-013-1379-z%26sid%3Dliteratum%253Aachs%26jtitle%3DTheoretical%2520Chemistry%2520Accounts%26atitle%3DMicroscopic%252Bmodes%252Band%252Bfree%252Benergies%252Bfor%252Btopoisomerase%252BI-DNA%252Bcovalent%252Bcomplex%252Bbinding%252Bwith%252Bnon-camptothecin%252Binhibitors%252Bby%252Bmolecular%252Bdocking%252Band%252Bdynamics%252Bsimulations%26aulast%3DWei%26aufirst%3DNing-Ning%26date%3D2013%26date%3D2013%26volume%3D132%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daulat B  Khadka</span>, <span class="hlFld-ContribAuthor ">Won-Jea  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Topoisomerase inhibitors as anticancer agents: a patent update. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (8)
                                     , 1033-1056. <a href="https://doi.org/10.1517/13543776.2013.790958" title="DOI URL">https://doi.org/10.1517/13543776.2013.790958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.790958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.790958%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTopoisomerase%252Binhibitors%252Bas%252Banticancer%252Bagents%25253A%252Ba%252Bpatent%252Bupdate%26aulast%3DKhadka%26aufirst%3DDaulat%2BB%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D8%26spage%3D1033%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei-ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Bi-yan  Pan</span>, <span class="hlFld-ContribAuthor ">Qiong-feng  Liao</span>, <span class="hlFld-ContribAuthor ">Mei-cun  Yao</span>, <span class="hlFld-ContribAuthor ">Xin-jun  Xu</span>, <span class="hlFld-ContribAuthor ">Jin-zhi  Wan</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhi-yong  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous Quantification of Limonin, Two Indolequinazoline Alkaloids, and Four Quinolone Alkaloids in
              Evodia rutaecarpa
              (Juss.) Benth by HPLC-DAD Method. </span><span class="cited-content_cbyCitation_journal-name">Journal of Analytical Methods in Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>, 1-9. <a href="https://doi.org/10.1155/2013/827361" title="DOI URL">https://doi.org/10.1155/2013/827361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/827361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F827361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Analytical%2520Methods%2520in%2520Chemistry%26atitle%3DSimultaneous%252BQuantification%252Bof%252BLimonin%25252C%252BTwo%252BIndolequinazoline%252BAlkaloids%25252C%252Band%252BFour%252BQuinolone%252BAlkaloids%252Bin%252BEvodia%252Brutaecarpa%252B%252528Juss.%252529%252BBenth%252Bby%252BHPLC-DAD%252BMethod%26aulast%3DZhang%26aufirst%3DPei-ting%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Hui  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Ye-Zhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Li-Yun  Yang</span>, <span class="hlFld-ContribAuthor ">Li-Li  Yuan</span>, <span class="hlFld-ContribAuthor ">Yi  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of human serum albumin with 10-hydroxycamptothecin: spectroscopic and molecular modeling studies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biology Reports</span><span> <strong>2012,</strong> <em>39 </em>
                                    (5)
                                     , 5115-5123. <a href="https://doi.org/10.1007/s11033-011-1307-z" title="DOI URL">https://doi.org/10.1007/s11033-011-1307-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11033-011-1307-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11033-011-1307-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biology%2520Reports%26atitle%3DInteraction%252Bof%252Bhuman%252Bserum%252Balbumin%252Bwith%252B10-hydroxycamptothecin%25253A%252Bspectroscopic%252Band%252Bmolecular%252Bmodeling%252Bstudies%26aulast%3DSun%26aufirst%3DHui-Hui%26date%3D2012%26date%3D2011%26volume%3D39%26issue%3D5%26spage%3D5115%26epage%3D5123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pritam  Thapa</span>, <span class="hlFld-ContribAuthor ">Radha  Karki</span>, <span class="hlFld-ContribAuthor ">Han Young  Yoo</span>, <span class="hlFld-ContribAuthor ">Pil-Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Eunyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Kyung-Hwa  Jeon</span>, <span class="hlFld-ContribAuthor ">Younghwa  Na</span>, <span class="hlFld-ContribAuthor ">Won-Jea  Cho</span>, <span class="hlFld-ContribAuthor ">Youngjoo  Kwon</span>, <span class="hlFld-ContribAuthor ">Eung-Seok  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">2,4-Diaryl-5,6-dihydro-1,10-phenanthroline and 2,4-diaryl-5,6-dihydrothieno[2,3-h] quinoline derivatives for topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2012,</strong> <em>40 </em>, 67-78. <a href="https://doi.org/10.1016/j.bioorg.2011.09.001" title="DOI URL">https://doi.org/10.1016/j.bioorg.2011.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2011.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D2%25252C4-Diaryl-5%25252C6-dihydro-1%25252C10-phenanthroline%252Band%252B2%25252C4-diaryl-5%25252C6-dihydrothieno%25255B2%25252C3-h%25255D%252Bquinoline%252Bderivatives%252Bfor%252Btopoisomerase%252BI%252Band%252BII%252Binhibitory%252Bactivity%25252C%252Bcytotoxicity%25252C%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudy%26aulast%3DThapa%26aufirst%3DPritam%26date%3D2012%26volume%3D40%26spage%3D67%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Jian  Lu</span>, <span class="hlFld-ContribAuthor ">Jiao-Lin  Bao</span>, <span class="hlFld-ContribAuthor ">Xiu-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Yi-Tao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Alkaloids Isolated from Natural Herbs as the Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Evidence-Based Complementary and Alternative Medicine</span><span> <strong>2012,</strong> <em>2012 </em>, 1-12. <a href="https://doi.org/10.1155/2012/485042" title="DOI URL">https://doi.org/10.1155/2012/485042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2012/485042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2012%2F485042%26sid%3Dliteratum%253Aachs%26jtitle%3DEvidence-Based%2520Complementary%2520and%2520Alternative%2520Medicine%26atitle%3DAlkaloids%252BIsolated%252Bfrom%252BNatural%252BHerbs%252Bas%252Bthe%252BAnticancer%252BAgents%26aulast%3DLu%26aufirst%3DJin-Jian%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frédéric  Pin</span>, <span class="hlFld-ContribAuthor ">Sébastien  Comesse</span>, <span class="hlFld-ContribAuthor ">Adam  Daïch</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular N-aza-amidoalkylation in association with Witkop–Winterfeldt oxidation as the key step to synthesize Luotonin-A analogues. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2011,</strong> <em>67 </em>
                                    (31)
                                     , 5564-5571. <a href="https://doi.org/10.1016/j.tet.2011.05.120" title="DOI URL">https://doi.org/10.1016/j.tet.2011.05.120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2011.05.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2011.05.120%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DIntramolecular%252BN-aza-amidoalkylation%252Bin%252Bassociation%252Bwith%252BWitkop%2525E2%252580%252593Winterfeldt%252Boxidation%252Bas%252Bthe%252Bkey%252Bstep%252Bto%252Bsynthesize%252BLuotonin-A%252Banalogues%26aulast%3DPin%26aufirst%3DFr%25C3%25A9d%25C3%25A9ric%26date%3D2011%26volume%3D67%26issue%3D31%26spage%3D5564%26epage%3D5571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Markus  Sitzmann</span>, <span class="hlFld-ContribAuthor ">Angelo  Pugliese</span>, <span class="hlFld-ContribAuthor ">Marc C  Nicklaus</span>. </span><span class="cited-content_cbyCitation_article-title">Software and resources for computational medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (8)
                                     , 1057-1085. <a href="https://doi.org/10.4155/fmc.11.63" title="DOI URL">https://doi.org/10.4155/fmc.11.63</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.63%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSoftware%252Band%252Bresources%252Bfor%252Bcomputational%252Bmedicinal%252Bchemistry%26aulast%3DLiao%26aufirst%3DChenzhong%26date%3D2011%26volume%3D3%26issue%3D8%26spage%3D1057%26epage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of clinical relevant topoisomerase I inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Flowchart of the virtual screening procedure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of the purchased compounds from virtual screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Gel electrophoresis of TopoI-induced DNA cleavage assay for hits from virtual screening. (A) Inhibition of TopoI relaxation activity at 500 μM: lane 1, DNA + TopoI; lane 2, supercoiled plasmid DNA; lane 3, DNA + TopoI + CPT; lanes 4−17, DNA + TopoI + hit (<b>1</b>, <b>3</b>, <b>5</b>, <b>6</b>, <b>8</b>, <b>11</b>, <b>12</b>, <b>13</b>, <b>14</b>, <b>16</b>, <b>19</b>, <b>20</b>, <b>21</b>, and <b>23</b>, respectively). (B) Inhibition of TopoI relaxation activity ranging from 50 to 500 μM: lane 1, supercoiled plasmid DNA; lane 2, DNA + TopoI; lanes 3−5, DNA + TopoI + compound <b>20</b> (500, 100, and 50 μM); lanes 6−8, DNA + TopoI + 1 (500, 100, and 50 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Schematic representation of the proposed binding mode for compounds <b>1</b> (A), <b>6</b> (B), <b>20</b> (C), and <b>21</b> (D) in the TopoI−DNA complex. The figure was generated using PyMol (<a href="http://pymol.sourceforge.net/" class="extLink">http://pymol.sourceforge.net/</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Superimposition of the docked conformations of <b>20</b> with CPT. (B) Superimposition of the docked conformations of <b>29u</b> with CPT. (C) Binding mode of compounds <b>29u</b> in the active site of TopoI−DNA complex. The figure was generated using PyMol (<a href="http://pymol.sourceforge.net/" class="extLink">http://pymol.sourceforge.net/</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/medium/jm-2010-00387d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-21/jm100387d/production/images/large/jm-2010-00387d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100387d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCOOEt, reflux, 12 h, yield 84%; (b) POCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 2 h, room temp 2 h, yield 55%; (c) ClCOOEt, reflux, 12 h, yield 60%; (d) <b>26</b>, CH<sub>2</sub>Cl<sub>2</sub>, 30−60 °C, 6 h, yield 70%; (e) RX, NaH, DMF, 80 °C, 24 h, yield 11−79%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Topoisomerase I inhibitors: camptothecins and beyond</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1038%2Fnrc1977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16990856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=789-802&author=Y.+Pommier&title=Topoisomerase+I+inhibitors%3A+camptothecins+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase I inhibitors: camptothecins and beyond</span></div><div class="casAuthors">Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">789-802</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear DNA topoisomerase I (TOP1) is an essential human enzyme.  It is the only known target of the alkaloid camptothecin, from which the potent anticancer agents irinotecan and topotecan are derived.  As camptothecins bind at the interface of the TOP1-DNA complex, they represent a paradigm for interfacial inhibitors that reversibly trap macromol. complexes.  Several camptothecin and noncamptothecin derivs. are being developed to further increase antitumor activity and reduce side effects.  The mechanisms and mol. determinants of tumor response to TOP1 inhibitors are reviewed, and rational combinations of TOP1 inhibitors with other drugs are considered based on current knowledge of repair and checkpoint pathways that are assocd. with TOP1-mediated DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5lxd3qfkwbVg90H21EOLACvtfcHk0lgQwRKuFta_uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVClsr0%253D&md5=a437970077c0edbbab602b296fcd092a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1977%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DTopoisomerase%2520I%2520inhibitors%253A%2520camptothecins%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D789%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tse, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkegaard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. C.</span><span> </span><span class="NLM_article-title">Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=5560-5565&author=Y.+C.+Tseauthor=K.+Kirkegaardauthor=J.+C.+Wang&title=Covalent+bonds+between+protein+and+DNA.+Formation+of+phosphotyrosine+linkage+between+certain+DNA+topoisomerases+and+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DY.%2BC.%26aulast%3DKirkegaard%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26atitle%3DCovalent%2520bonds%2520between%2520protein%2520and%2520DNA.%2520Formation%2520of%2520phosphotyrosine%2520linkage%2520between%2520certain%2520DNA%2520topoisomerases%2520and%2520DNA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D5560%26epage%3D5565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2894</span><span class="NLM_x">–</span> <span class="NLM_lpage">2902</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr900097c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2894-2902&author=Y.+Pommier&title=DNA+topoisomerase+I+inhibitors%3A+chemistry%2C+biology%2C+and+interfacial+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr900097c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900097c%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DDNA%2520topoisomerase%2520I%2520inhibitors%253A%2520chemistry%252C%2520biology%252C%2520and%2520interfacial%2520inhibition%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2894%26epage%3D2902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hsiang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">14873</span><span class="NLM_x">–</span> <span class="NLM_lpage">14878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=2997227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=14873-14878&author=Y.+H.+Hsiangauthor=R.+Hertzbergauthor=S.+Hechtauthor=L.+F.+Liu&title=Camptothecin+induces+protein-linked+DNA+breaks+via+mammalian+DNA+topoisomerase+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I</span></div><div class="casAuthors">Hsiang, Yaw Huei; Hertzberg, Robert; Hecht, Sidney; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14873-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Camptothecin (I)  [7689-03-4], a cytotoxic drug, is a strong inhibitor of nucleic acid synthesis in mammalian cells and a potent inducer of strand breaks in chromosomal DNA.  Neither equil. dialysis nor unwinding measurement indicated any interaction between camptothecin and purified DNA.  However, I induces extensive single-strand DNA breaks in systems contg. purified mammalian DNA topoisomerase  [80449-01-0] I.  DNA breakage in vitro is immediate and reversible.  Analyses of camptothecin-induced DNA breaks show that topoisomerase I is covalently linked to the 3' end of the broken DNA.  In addn., I inhibits the catalytic activity of mammalian DNA topoisomerase I.  Apparently, I blocks the rejoining step of the breakage-reunion reaction of mammalian DNA topoisomerase I; this blockade results in the accumulation of a cleavable complex which resembles the transient intermediate proposed for eukaryotic DNA topoisomerase I.  The inhibition of nucleic acid synthesis and the induction of DNA strand breaks obsd. in vivo may be related to the formation of this drug-induced cleavable complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4OWZ16tDJsbVg90H21EOLACvtfcHk0li1ZmrkZgyHlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFemt7c%253D&md5=d5811c51314199e69d2fad324720b1aa</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiang%26aufirst%3DY.%2BH.%26aulast%3DHertzberg%26aufirst%3DR.%26aulast%3DHecht%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DCamptothecin%2520induces%2520protein-linked%2520DNA%2520breaks%2520via%2520mammalian%2520DNA%2520topoisomerase%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D14873%26epage%3D14878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wall, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wani, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, G. A.</span><span> </span><span class="NLM_article-title">The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from <i>Camptotheca acuminata</i></span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">3888</span><span class="NLM_x">–</span> <span class="NLM_lpage">3890</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00968a057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1966&pages=3888-3890&author=M.+E.+Wallauthor=M.+C.+Waniauthor=C.+E.+Cookauthor=K.+H.+Palmerauthor=A.+T.+McPhailauthor=G.+A.+Sim&title=The+isolation+and+structure+of+camptothecin%2C+a+novel+alkaloidal+leukemia+and+tumor+inhibitor+from+Camptotheca+acuminata"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fja00968a057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00968a057%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DM.%2BE.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DCook%26aufirst%3DC.%2BE.%26aulast%3DPalmer%26aufirst%3DK.%2BH.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26aulast%3DSim%26aufirst%3DG.%2BA.%26atitle%3DThe%2520isolation%2520and%2520structure%2520of%2520camptothecin%252C%2520a%2520novel%2520alkaloidal%2520leukemia%2520and%2520tumor%2520inhibitor%2520from%2520Camptotheca%2520acuminata%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1966%26volume%3D88%26spage%3D3888%26epage%3D3890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">D’Arpa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardmore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6919</span><span class="NLM_x">–</span> <span class="NLM_lpage">6924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=1698546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK3MXivFQ%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=6919-6924&author=P.+D%E2%80%99Arpaauthor=C.+Beardmoreauthor=L.+F.+Liu&title=Involvement+of+nucleic+acid+synthesis+in+cell+killing+mechanisms+of+topoisomerase+poisons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons</span></div><div class="casAuthors">D'Arpa, Peter; Beardmore, Christopher; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6919-24</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The primary cytotoxic mechanism of camptothecin has been proposed to involve an interaction between the replication machinery and the camptothecin-mediated topoisomerase I-DNA cleavable complex.  The present study show that killing of V79 cells by the topoisomerase II poisons 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide may involve ongoing RNA synthesis in addn. to ongoing DNA synthesis.  V79 cells synchronized by mitotic shake-off were treated with topoisomerase poisons in the presence of inhibitors of nucleic acid synthesis.  S-Phase V79 cells were more sensitive to the topoisomerase I poison camptothecin and the topoisomerase II poison m-AMSA than G1-phase cells.  The greater sensitivity of S-phase cells to killing by m-AMSA and camptothecin was abolished during cotreatment, but not posttreatment, with aphidicolin, suggesting that ongoing DNA synthesis is involved in cell killing by both topoisomerase I and II poisons.  Cotreatment with transcription inhibitors, such as 5,6-dichloro-1-β-D-ribofuranosyl benzimidazole or cordycepin, partially protected cells from the cytotoxic effects of m-AMSA but had no effect on camptothecin-mediated cytotoxicity.  These results suggest that ongoing RNA transcription may be involved in cell killing by topoisomerase II poisons but not topoisomerase I poisons.  Cotreatment with camptothecin reduced m-AMSA-mediated cytotoxicity in G1-phase V79 cells, suggesting a possible antagonism between topoisomerase I and II poisons.  This antagonistic effect between topoisomerase I and II poisons could be explained by the strong inhibitory effect of camptothecin on RNA transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKbW8PDr36bVg90H21EOLACvtfcHk0li1ZmrkZgyHlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXivFQ%253D&md5=cdf75c946eb70fb695a5e6278178aaeb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arpa%26aufirst%3DP.%26aulast%3DBeardmore%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DInvolvement%2520of%2520nucleic%2520acid%2520synthesis%2520in%2520cell%2520killing%2520mechanisms%2520of%2520topoisomerase%2520poisons%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D6919%26epage%3D6924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Liu, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, S. P.</span><span> </span><span class="NLM_article-title">Mechanism of action of camptothecin</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">922</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=922&publication_year=2000&pages=1-10&author=L.+F.+Liuauthor=S.+D.+Desaiauthor=T.+K.+Liauthor=Y.+Maoauthor=M.+Sunauthor=S.+P.+Sim&title=Mechanism+of+action+of+camptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DDesai%26aufirst%3DS.%2BD.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DSim%26aufirst%3DS.%2BP.%26atitle%3DMechanism%2520of%2520action%2520of%2520camptothecin%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D922%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tsao, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arpa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1829</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=1312900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK38XitV2nu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=1823-1829&author=Y.+P.+Tsaoauthor=P.+D%E2%80%99Arpaauthor=L.+F.+Liu&title=The+involvement+of+active+DNA+synthesis+in+camptothecin-induced+G2+arrest%3A+altered+regulation+of+p34cdc2%2Fcyclin+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The involvement of active DNA synthesis in camptothecin-induced G2 arrest:  altered regulation of p34cdc2/cyclin B</span></div><div class="casAuthors">Tsao, Yeou Ping; D'Arpa, Peter; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1823-9</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Cell cycle arrest in G2 phase is a common response to a variety of DNA-damaging agents.  The coupling between DNA damage and G2 arrest was studied in synchronized HeLa cells using camptothecin, a highly specific inhibitor of topoisomerase I that damages DNA through the formation of reversible topoisomerase I-DNA cleavable complexes.  Brief camptothecin treatment of early S-phase HeLa cells caused arrest at G2 phase and abolished the activation of p34cdc2 protein kinase.  Both tyrosine dephosphorylation of p34cdc2 and cyclin B accumulation were altered.  These cell cycle-dependent changes were not obsd. when DNA replication was inhibited by aphidicolin during the brief camptothecin treatment.  The results suggest that to produce G2 arrest, active DNA synthesis is required at the time of camptothecin treatment, as was previously shown for camptothecin-induced cytotoxicity.  Furthermore, the results suggest that the interaction of the replication fork with DNA damage may ultimately trigger altered regulation of p34cdc2/cyclin B, leading to cell cycle arrest at the G2 phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf9GA9ym9aW7Vg90H21EOLACvtfcHk0ljgR8jN2ZQdQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitV2nu7Y%253D&md5=43c580c830eb0c452c4f7c5666c3d4ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsao%26aufirst%3DY.%2BP.%26aulast%3DD%25E2%2580%2599Arpa%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DThe%2520involvement%2520of%2520active%2520DNA%2520synthesis%2520in%2520camptothecin-induced%2520G2%2520arrest%253A%2520altered%2520regulation%2520of%2520p34cdc2%252Fcyclin%2520B%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D1823%26epage%3D1829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Driver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. X.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacology of new camptothecin drugs</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=425-439&author=R.+W.+Driverauthor=L.+X.+Yang&title=Synthesis+and+pharmacology+of+new+camptothecin+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDriver%26aufirst%3DR.%2BW.%26aulast%3DYang%26aufirst%3DL.%2BX.%26atitle%3DSynthesis%2520and%2520pharmacology%2520of%2520new%2520camptothecin%2520drugs%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D425%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Li, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L. P.</span><span> </span><span class="NLM_article-title">Review camptothecin: current perspectives</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.2174%2F092986706777585004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16842195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2021-2039&author=Q.+Y.+Liauthor=Y.+G.+Zuauthor=R.+Z.+Shiauthor=L.+P.+Yao&title=Review+camptothecin%3A+current+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Review camptothecin: current perspectives</span></div><div class="casAuthors">Li, Qing-Yong; Zu, Yuan-Gang; Shi, Rong-Zhen; Yao, Li-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2021-2039</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The review provides a detailed discussion of recent advances in the medicinal chem. of camptothecin, a potent antitumor agent that targets topoisomerase I.  Thousands of CPT derivs. were synthesized.  Two of them, Topotecan and Irinotecan, are com. approved for use in clinic as antitumor agents while more are still in clinic trials.  This review summarizes the current status of the modern synthetic approaches to CPT, the mechanism of action of CPT, the structure-activity relationship(SAR), a no. of novel CPT analogs and their biol. activity.  There is a systematic evaluation of A-, B- and E-ring- modified camptothecins reported recently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXlT0TDdItJbVg90H21EOLACvtfcHk0ljgR8jN2ZQdQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrg%253D&md5=36450ef038d9ee8409645bd3e8b6c397</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986706777585004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777585004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BY.%26aulast%3DZu%26aufirst%3DY.%2BG.%26aulast%3DShi%26aufirst%3DR.%2BZ.%26aulast%3DYao%26aufirst%3DL.%2BP.%26atitle%3DReview%2520camptothecin%253A%2520current%2520perspectives%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2021%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahier, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span> </span><span class="NLM_article-title">Camptothecin: current perspectives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2Fj.bmc.2003.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=15028252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFeqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1585-1604&author=C.+J.+Thomasauthor=N.+J.+Rahierauthor=S.+M.+Hecht&title=Camptothecin%3A+current+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin: current perspectives</span></div><div class="casAuthors">Thomas, Craig J.; Rahier, Nicolas J.; Hecht, Sidney M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1585-1604</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review provides a detailed discussion of recent advances in the medicinal chem. of camptothecin, a potent antitumor antibiotic.  Two camptothecin analogs are presently approved for use in the clinic as antitumor agents and several others are in clin. trials.  Camptothecin possesses a novel mechanism of action involving the inhibition of DNA relaxation by DNA topoisomerase I, and more specifically the stabilization of a covalent binary complex formed between topoisomerase I and DNA.  This review summarizes the current status of studies of the mechanism of action of camptothecin, including topoisomerase I inhibition and addnl. cellular responses.  Modern synthetic approaches to camptothecin and several of the semi-synthetic methods are also discussed.  Finally, a systematic evaluation of novel and important analogs of camptothecin and their contribution to the current structure-activity profile are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrONd-LUGaIVbVg90H21EOLACvtfcHk0ljch2OX70FIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFeqtrw%253D&md5=4f312a14c7813ff4067a111200ed1da5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2003.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2003.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DRahier%26aufirst%3DN.%2BJ.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DCamptothecin%253A%2520current%2520perspectives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D1585%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kingsbury, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caranfa, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucette, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=98-107&author=W.+D.+Kingsburyauthor=J.+C.+Boehmauthor=D.+R.+Jakasauthor=K.+G.+Holdenauthor=S.+M.+Hechtauthor=G.+Gallagherauthor=M.+J.+Caranfaauthor=F.+L.+McCabeauthor=L.+F.+Faucetteauthor=R.+K.+Johnson&title=Synthesis+of+water-soluble+%28aminoalkyl%29camptothecin+analogues%3A+inhibition+of+topoisomerase+I+and+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a017%26sid%3Dliteratum%253Aachs%26aulast%3DKingsbury%26aufirst%3DW.%2BD.%26aulast%3DBoehm%26aufirst%3DJ.%2BC.%26aulast%3DJakas%26aufirst%3DD.%2BR.%26aulast%3DHolden%26aufirst%3DK.%2BG.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DGallagher%26aufirst%3DG.%26aulast%3DCaranfa%26aufirst%3DM.%2BJ.%26aulast%3DMcCabe%26aufirst%3DF.%2BL.%26aulast%3DFaucette%26aufirst%3DL.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520of%2520water-soluble%2520%2528aminoalkyl%2529camptothecin%2520analogues%253A%2520inhibition%2520of%2520topoisomerase%2520I%2520and%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D98%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Garcia-Carbonero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J. G.</span><span> </span><span class="NLM_article-title">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1385%2F1592591604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=11895891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=641-661&author=R.+Garcia-Carboneroauthor=J.+G.+Supko&title=Current+perspectives+on+the+clinical+experience%2C+pharmacology%2C+and+continued+development+of+the+camptothecins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Supko, Jeffrey G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">641-661</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review, discussing the pharmacol. and antitumor activities of the camptothecin analogs that are approved for clin. use and those investigational agents undergoing clin. evaluation.  Camptothecin is a naturally occurring cytotoxic alkaloid that has a unique intracellular target, topoisomerase I, a nuclear enzyme that reduces the torsional stress of supercoiled DNA during the replication, recombination, transcription, and repair of DNA.  Topotecan and irinotecan are synthetic analogs designed to facilitate parenteral administration of the active lactone form of the compd. by introducing functional groups to enhance soly.  They are now well-established components in the chemotherapeutic management of several neoplasms.  Topotecan has modest activity in previously treated patients with ovarian and small-cell lung cancer and is currently approved for use in the United States as 2nd-line therapy in these diseases.  Preliminary evidence of activity against hematol. malignancies is also promising.  Irinotecan is a prodrug that undergoes enzymic conversion to the biol. active metabolite 7-ethyl-10-hydroxycamptothecin.  It is presently the treatment of choice when used in combination with fluoropyrimidines as 1st-line therapy for patients with advanced colorectal cancer or as a single agent after failure of 5-fluorouracil-based chemotherapy.  Encouraging preliminary results suggest that irinotecan may have an increasing role in the treatment of other solid tumors, including small- and non-small-cell lung cancer, cervical cancer, ovarian cancer, gastric cancer, and malignant gliomas.  Several addnl. camptothecin analogs are in various stages of clin. development, including 9-aminocamptothecin, 9-nitrocamptothecin, 7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(S)-camptothecin, exatecan mesylate, and karenitecin.  Efforts to further optimize therapeutic effectiveness through drug-delivery strategies that prolong tumor exposure to these S phase-specific agents, such as improving oral bioavailability through structure modification and innovative formulation approaches, alternative parenteral dosage forms, and administration schedules, are being actively pursued.  Combining camptothecins with other anticancer drugs and treatment modalities, as well as gaining a better understanding of the factors contributing to tumor sensitivity and resistance, continues to be of considerable interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrarJT9tdw_17Vg90H21EOLACvtfcHk0ljch2OX70FIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D&md5=6ef49a8a00a46110224d01506043f0bb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1385%2F1592591604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1592591604%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26atitle%3DCurrent%2520perspectives%2520on%2520the%2520clinical%2520experience%252C%2520pharmacology%252C%2520and%2520continued%2520development%2520of%2520the%2520camptothecins%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D641%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehlin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozielski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardeman, D. M.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(<i>S</i>)-camptothecin (rubitecan)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=11743646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=81-88&author=B.+C.+Giovanellaauthor=J.+S.+Stehlinauthor=H.+R.+Hinzauthor=A.+J.+Kozielskiauthor=N.+J.+Harrisauthor=D.+M.+Vardeman&title=Preclinical+evaluation+of+the+anticancer+activity+and+toxicity+of+9-nitro-20%28S%29-camptothecin+%28rubitecan%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan)</span></div><div class="casAuthors">Giovanella, Beppino C.; Stehlin, John S.; Hinz, Hellmuth R.; Kozielski, Anthony J.; Harris, Nicholas J.; Vardeman, Dana M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Nude mice received increasing doses of Rubitecan by intragastric injection until the max. tolerated dose (MTD) had been established for both a single dose and multiple doses at the schedule of 5 days on, 2 days off.  By extrapolating from the mouse data, the MTD was detd. for oral administration to dogs and man.  By using max. tolerated multiple doses, the sensitivity of human cancer xenografts in nude mice to Rubitecan was detd.  The MTD of Rubitecan in mice for multiple intragastric doses at the schedule of 5 days on, 2 days off was 1 mg/kg/day.  The MTD in dogs was also 1 mg/kg/day, administered orally but at the schedule of 4 days on, 3 days off.  In man, it was 1 mg/m2/day at the schedule of 5 days on, 2 days off.  Treatment of human cancer xenografts in nude mice with the MTD of Rubitecan resulted in growth inhibition in all 30 of 30 tumors tested and in the total disappearance of 24 of these.  These 30 tumors included all the most common human cancers: lung, colorectal, breast, pancreatic, ovarian, prostate, stomach, melanoma and a leukemia.  It appears that Rubitecan is a very promising anticancer drug with high potency against a wide spectrum of human cancers.  These cancers, growing as xenografts in nude mice, were always (30/30) inhibited and frequently completely (24/30) destroyed by nontoxic doses of Rubitecan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEKJHcSWLTmLVg90H21EOLACvtfcHk0ljsNR_iwfkG4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFeisQ%253D%253D&md5=1de8de4dea18ab5ecc2252bcad67d555</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DStehlin%26aufirst%3DJ.%2BS.%26aulast%3DHinz%26aufirst%3DH.%2BR.%26aulast%3DKozielski%26aufirst%3DA.%2BJ.%26aulast%3DHarris%26aufirst%3DN.%2BJ.%26aulast%3DVardeman%26aufirst%3DD.%2BM.%26atitle%3DPreclinical%2520evaluation%2520of%2520the%2520anticancer%2520activity%2520and%2520toxicity%2520of%25209-nitro-20%2528S%2529-camptothecin%2520%2528rubitecan%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2002%26volume%3D20%26spage%3D81%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckardt, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlefield, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinsky, E. K.</span><span> </span><span class="NLM_article-title">Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=9533526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK1cXit1aquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=595-604&author=S.+G.+Eckhardtauthor=S.+D.+Bakerauthor=J.+R.+Eckardtauthor=T.+G.+Burkeauthor=D.+L.+Warnerauthor=J.+G.+Kuhnauthor=G.+Rodriguezauthor=S.+Fieldsauthor=A.+Thurmanauthor=L.+Smithauthor=M.+L.+Rothenbergauthor=L.+Whiteauthor=P.+Wisselauthor=R.+Kunkaauthor=S.+DePeeauthor=D.+Littlefieldauthor=H.+A.+Burrisauthor=D.+D.+Von+Hoffauthor=E.+K.+Rowinsky&title=Phase+I+and+pharmacokinetic+study+of+GI147211%2C+a+water-soluble+camptothecin+analogue%2C+administered+for+five+consecutive+days+every+three+weeks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analog, administered for five consecutive days every three weeks</span></div><div class="casAuthors">Eckhardt, S. Gail; Baker, Sharyn D.; Eckardt, John R.; Burke, Thomas G.; Warner, Deanna L.; Kuhn, John G.; Rodriguez, Gladys; Fields, Suzanne; Thurman, Allison; Smith, Lon; Rothenberg, Mace L.; White, Linda; Wissel, Paul; Kunka, Robert; Depee, Scott; Littlefield, Diane; Burris, Howard A.; Von Hoff, Daniel D.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">595-604</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GI147211 is a 7-substituted 10,11-ethylenedioxy-20(S)-camptothecin analog that inhibits the nuclear enzyme topoisomerase I.  In this study, 24 patients with advanced solid malignancies received a total of 72 courses of GI147211 as a 30-min infusion daily for 5 consecutive days, at doses ranging 0.3-1.75 mg/m2/day.  Severe neutropenia precluded dose escalation above 1.5 mg/m2/day in minimally pretreated patients, and both severe neutropenia and thrombocytopenia were dose limiting in heavily pretreated patients at doses >1.0 mg/m2/day.  These doses are, therefore, recommended for subsequent Phase II evaluations of GI147211 in patients with comparable prior therapy.  Nonhematol. toxicities, including nausea, vomiting, fatigue, and anorexia, were mild to moderate.  The disposition of GI147211 in blood was described by a linear 3-compartment model, with renal elimination accounting for only 11% of drug distribution.  No relationship was obsd. between the pharmacol. exposure to GI147211 and effects on neutrophils; however, patients who developed dose-limiting myelosuppression did experience greater exposure to both the lactone and total forms of the drug.  The hydrolysis kinetics of GI147211 revealed not only a shift of the drug to the inactive carboxylate form in human serum albumin but also stabilization of the lactone in erythrocytes, perhaps accounting for the obsd. lactone:total area under the concn.-time curve ratio of 0.27.  These results indicate that GI147211 exhibits predictable toxicities and that further studies are warranted to det. the distinct role of this compd. among currently available camptothecin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdrYBTb0Jue7Vg90H21EOLACvtfcHk0ljsNR_iwfkG4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1aquro%253D&md5=c2b74eb7199ef6027fb061af3e1ed2c4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DBaker%26aufirst%3DS.%2BD.%26aulast%3DEckardt%26aufirst%3DJ.%2BR.%26aulast%3DBurke%26aufirst%3DT.%2BG.%26aulast%3DWarner%26aufirst%3DD.%2BL.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DRodriguez%26aufirst%3DG.%26aulast%3DFields%26aufirst%3DS.%26aulast%3DThurman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DRothenberg%26aufirst%3DM.%2BL.%26aulast%3DWhite%26aufirst%3DL.%26aulast%3DWissel%26aufirst%3DP.%26aulast%3DKunka%26aufirst%3DR.%26aulast%3DDePee%26aufirst%3DS.%26aulast%3DLittlefield%26aufirst%3DD.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26atitle%3DPhase%2520I%2520and%2520pharmacokinetic%2520study%2520of%2520GI147211%252C%2520a%2520water-soluble%2520camptothecin%2520analogue%252C%2520administered%2520for%2520five%2520consecutive%2520days%2520every%2520three%2520weeks%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D595%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Minami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span> </span><span class="NLM_article-title">Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3056</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=11595695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvF2kurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=3056-3064&author=H.+Minamiauthor=H.+Fujiiauthor=T.+Igarashiauthor=K.+Itohauthor=K.+Tamanoiauthor=T.+Ogumaauthor=Y.+Sasaki&title=Phase+I+and+pharmacological+study+of+a+new+camptothecin+derivative%2C+exatecan+mesylate+%28DX-8951f%29%2C+infused+over+30+minutes+every+three+weeks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks</span></div><div class="casAuthors">Minami, Hironobu; Fujii, Hirofumi; Igarashi, Tadahiko; Itoh, Kuniaki; Tamanoi, Kyoji; Oguma, Toshihiro; Sasaki, Yasutsuna</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3056-3064</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A Phase I study of exatecan, a new water-sol. camptothecin deriv., was conducted to det. the max. tolerated dose and a recommended dose, according to an internationally standardized core protocol.  Pharmacol. profiles of lactone and total (lactone + carboxylate) exatecan were also investigated.  Fifteen patients with advanced solid malignancies were treated with 3, 5, and 6.65 mg/M2 of exatecan infused over 30 min every 3 wk.  Concns. of lactone, total drug, and a metabolite in plasma and urine were detd. during the first course.  Dose-limiting neutropenia and liver dysfunction were obsd. in two of six patients at 6.65 mg/M2, but no grade 3 or worse diarrhea was obsd.  Emesis was moderate, and no grade 3 or worse nausea and vomiting were obsd. at a recommended dose of 5 mg/M2, with prophylactic use of granisetron.  Pharmacokinetics were linear and had moderate variability; clearances of lactone and total drug were 6.8±2.8 and 2.1±1.1 (mean ± SD) l/h/M2, resp.  The ratio of lactone concn. to total drug concn. in plasma decreased from 0.81±0.06 at the end of infusion to 0.15±0.06 10 h after the infusion.  The lactone:total ratio of drug exposure was 0.30±0.08, ranging from 0.16 to 0.43.  Neutropenia was related to the drug exposure of both lactone and total drug.  The recommended dose of exatecan infused over 30 min every 3 wk is 5 mg/M2, with a favorable toxicity profile of mild and infrequent diarrhea.  Interpatient variability of pharmacokinetics was similar to or smaller than that with other camptothecin derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2I-SQU0lC-7Vg90H21EOLACvtfcHk0ljoYsCXceOXmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvF2kurc%253D&md5=63659ca4182e8792337d0ad41c1f3981</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinami%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DH.%26aulast%3DIgarashi%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTamanoi%26aufirst%3DK.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26atitle%3DPhase%2520I%2520and%2520pharmacological%2520study%2520of%2520a%2520new%2520camptothecin%2520derivative%252C%2520exatecan%2520mesylate%2520%2528DX-8951f%2529%252C%2520infused%2520over%252030%2520minutes%2520every%2520three%2520weeks%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D3056%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Burke, T. G.</span><span> </span><span class="NLM_article-title">Chemistry of the camptothecins in the bloodstream. Drug stabilization and optimization of activity</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">803</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=803&publication_year=1996&pages=29-31&author=T.+G.+Burke&title=Chemistry+of+the+camptothecins+in+the+bloodstream.+Drug+stabilization+and+optimization+of+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BG.%26atitle%3DChemistry%2520of%2520the%2520camptothecins%2520in%2520the%2520bloodstream.%2520Drug%2520stabilization%2520and%2520optimization%2520of%2520activity%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1996%26volume%3D803%26spage%3D29%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bailly, C.</span><span> </span><span class="NLM_article-title">Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2FS1040-8428%2802%2900090-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=12482574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A280%3ADC%252BD38jitVGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2003&pages=91-108&author=C.+Bailly&title=Homocamptothecins%3A+potent+topoisomerase+I+inhibitors+and+promising+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs</span></div><div class="casAuthors">Bailly Christian</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-108</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Homocamptothecins (hCPTs) represent a new generation of antitumor agents targeting DNA topoisomerase I.  The expanded seven-membered lactone E-ring that characterizes hCPTs enhances the plasma stability of the drug and reinforces the inhibition of topoisomerase I compared with conventional six-membered CPTs. hCPTs are more efficient than the CPTs at promoting cleavage at T/G sites and induce additional cleavage at C/G sites.  Compound BN80765 and its difluoro analogue diflomotecan (DN80915) are potent cytotoxic agents and efficiently induce apoptosis in tumor cells.  They display strong antiproliferative activities against specific tumor types.  Diflomotecan is remarkably efficient at inhibiting the growth of human colon cancer cells in vivo and, administered orally, it also shows superior activities against human prostate cancers compared with the benchmark products topotecan (TPT) and irinotecan (IRT).  Diflomotecan has entered phase I clinical testing and antitumor activity has been observed in patients.  This 9,10-difluoro-hCPTs derivative is one of the most promising new members of the 'tecan' family.  This review summarizes the recent discoveries in the topoisomerase I field and presents the different camptothecin (CPT) analogues currently evaluated as anticancer agents.  The specific properties of hCPTs are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTG93omgw1Se2BAiYWy6n3SfW6udTcc2eYrdr7XpoBXFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jitVGmtA%253D%253D&md5=ac53aaed4a1ccdad95a5f6ba52d0ef45</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1040-8428%2802%2900090-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-8428%252802%252900090-2%26sid%3Dliteratum%253Aachs%26aulast%3DBailly%26aufirst%3DC.%26atitle%3DHomocamptothecins%253A%2520potent%2520topoisomerase%2520I%2520inhibitors%2520and%2520promising%2520anticancer%2520drugs%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2003%26volume%3D45%26spage%3D91%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. G.</span><span> </span><span class="NLM_article-title">Novel A,B,E-ring-modified camptothecins displaying high lipophilicity and markedly improved human blood stabilities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3018</span><span class="NLM_x">–</span> <span class="NLM_lpage">3022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9902279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3018-3022&author=D.+Bomauthor=D.+P.+Curranauthor=A.+J.+Chavanauthor=S.+Kruszewskiauthor=S.+G.+Zimmerauthor=K.+A.+Fraleyauthor=T.+G.+Burke&title=Novel+A%2CB%2CE-ring-modified+camptothecins+displaying+high+lipophilicity+and+markedly+improved+human+blood+stabilities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm9902279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902279%26sid%3Dliteratum%253Aachs%26aulast%3DBom%26aufirst%3DD.%26aulast%3DCurran%26aufirst%3DD.%2BP.%26aulast%3DChavan%26aufirst%3DA.%2BJ.%26aulast%3DKruszewski%26aufirst%3DS.%26aulast%3DZimmer%26aufirst%3DS.%2BG.%26aulast%3DFraley%26aufirst%3DK.%2BA.%26aulast%3DBurke%26aufirst%3DT.%2BG.%26atitle%3DNovel%2520A%252CB%252CE-ring-modified%2520camptothecins%2520displaying%2520high%2520lipophilicity%2520and%2520markedly%2520improved%2520human%2520blood%2520stabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3018%26epage%3D3022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lavergne, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarquay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huchet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulomb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroggi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manginot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazaux, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigg, D. C.</span><span> </span><span class="NLM_article-title">Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2285</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000129j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2285-2289&author=O.+Lavergneauthor=D.+Demarquayauthor=C.+Baillyauthor=C.+Lancoauthor=A.+Rollandauthor=M.+Huchetauthor=H.+Coulombauthor=N.+Mullerauthor=N.+Baroggiauthor=J.+Camaraauthor=C.+Le+Bretonauthor=E.+Manginotauthor=J.+B.+Cazauxauthor=D.+C.+Bigg&title=Topoisomerase+I-mediated+antiproliferative+activity+of+enantiomerically+pure+fluorinated+homocamptothecins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm000129j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000129j%26sid%3Dliteratum%253Aachs%26aulast%3DLavergne%26aufirst%3DO.%26aulast%3DDemarquay%26aufirst%3DD.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLanco%26aufirst%3DC.%26aulast%3DRolland%26aufirst%3DA.%26aulast%3DHuchet%26aufirst%3DM.%26aulast%3DCoulomb%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DN.%26aulast%3DBaroggi%26aufirst%3DN.%26aulast%3DCamara%26aufirst%3DJ.%26aulast%3DLe%2BBreton%26aufirst%3DC.%26aulast%3DManginot%26aufirst%3DE.%26aulast%3DCazaux%26aufirst%3DJ.%2BB.%26aulast%3DBigg%26aufirst%3DD.%2BC.%26atitle%3DTopoisomerase%2520I-mediated%2520antiproliferative%2520activity%2520of%2520enantiomerically%2520pure%2520fluorinated%2520homocamptothecins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2285%26epage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lavergne, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesueur-Ginot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pla Rodas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarquay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulibarri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiano-Liberatore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harnett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigg, D. C.</span><span> </span><span class="NLM_article-title">Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5419</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980400l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5410-5419&author=O.+Lavergneauthor=L.+Lesueur-Ginotauthor=F.+Pla+Rodasauthor=P.+G.+Kasprzykauthor=J.+Pommierauthor=D.+Demarquayauthor=G.+Prevostauthor=G.+Ulibarriauthor=A.+Rollandauthor=A.+M.+Schiano-Liberatoreauthor=J.+Harnettauthor=D.+Ponsauthor=J.+Camaraauthor=D.+C.+Bigg&title=Homocamptothecins%3A+synthesis+and+antitumor+activity+of+novel+E-ring-modified+camptothecin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm980400l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980400l%26sid%3Dliteratum%253Aachs%26aulast%3DLavergne%26aufirst%3DO.%26aulast%3DLesueur-Ginot%26aufirst%3DL.%26aulast%3DPla%2BRodas%26aufirst%3DF.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPommier%26aufirst%3DJ.%26aulast%3DDemarquay%26aufirst%3DD.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DUlibarri%26aufirst%3DG.%26aulast%3DRolland%26aufirst%3DA.%26aulast%3DSchiano-Liberatore%26aufirst%3DA.%2BM.%26aulast%3DHarnett%26aufirst%3DJ.%26aulast%3DPons%26aufirst%3DD.%26aulast%3DCamara%26aufirst%3DJ.%26aulast%3DBigg%26aufirst%3DD.%2BC.%26atitle%3DHomocamptothecins%253A%2520synthesis%2520and%2520antitumor%2520activity%2520of%2520novel%2520E-ring-modified%2520camptothecin%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5410%26epage%3D5419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tangirala, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, D. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6202</span><span class="NLM_x">–</span> <span class="NLM_lpage">6212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6202-6212&author=R.+S.+Tangiralaauthor=S.+Antonyauthor=K.+Agamaauthor=Y.+Pommierauthor=B.+D.+Andersonauthor=R.+Bevinsauthor=D.+P.+Curran&title=Synthesis+and+biological+assays+of+E-ring+analogs+of+camptothecin+and+homocamptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTangirala%26aufirst%3DR.%2BS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DB.%2BD.%26aulast%3DBevins%26aufirst%3DR.%26aulast%3DCurran%26aufirst%3DD.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520assays%2520of%2520E-ring%2520analogs%2520of%2520camptothecin%2520and%2520homocamptothecin%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6202%26epage%3D6212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gelderblom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentheroudakis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hooije, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seguy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prunonosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Principe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4101</span><span class="NLM_x">–</span> <span class="NLM_lpage">4107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=14519632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1OjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=4101-4107&author=H.+Gelderblomauthor=R.+Salazarauthor=J.+Verweijauthor=G.+Pentheroudakisauthor=M.+J.+de+Jongeauthor=M.+Devlinauthor=C.+van+Hooijeauthor=F.+Seguyauthor=R.+Obachauthor=J.+Prunonosaauthor=P.+Principeauthor=C.+Twelves&title=Phase+I+pharmacological+and+bioavailability+study+of+oral+diflomotecan+%28BN80915%29%2C+a+novel+E-ring-modified+camptothecin+analogue+in+adults+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Pharmacological and Bioavailability Study of Oral Diflomotecan (BN80915), a Novel E-Ring-modified Camptothecin Analogue in Adults with Solid Tumors</span></div><div class="casAuthors">Gelderblom, Hans; Salazar, Ramon; Verweij, Jaap; Pentheroudakis, George; de Jonge, Maja J. A.; Devlin, Martin; van Hooije, Christel; Seguy, Francis; Obach, Rosendo; Prunonosa, Joan; Principe, Paola; Twelves, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4101-4107</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Diflomotecan (BN80915) is an E-ring modified camptothecin analog that possesses greater lactone stability in plasma compared with other topoisomerase I inhibitors, a potential advantage for antitumor activity.  As with other camptothecins, oral administration has pharmacol. and clin. advantages.  This Phase I study was performed to assess the feasibility of the administration of oral diflomotecan, to det. the max.-tolerated, dose its bioavailability, and to explore the pharmacokinetics.  An initial i.v. bolus was administered to assess the bioavailability of diflomotecan.  Fourteen days later, diflomotecan was administered p.o. once daily for 5 days to adult patients with solid malignant tumors and repeated every 3 wk.  BN80915 and its open lactone form BN80942 were measured.  Twenty-two patients entered the study and received a total of 57 cycles of oral diflomotecan at flat dose levels of 0.10, 0.20, 0.27, and 0.35 mg.  The main toxicity was hematol., but some patients experienced alopecia, mild gastrointestinal toxicity, and fatigue.  At the 0.35-mg dose level, 2 of 4 patients experienced dose-limiting toxicity comprising grade 3 thrombocytopenia with epistaxis and febrile neutropenia in 1 patient and uncomplicated grade 4 neutropenia lasting for >7 days in another.  Toxicity was acceptable at the 0.27-mg dose level at which dose-limiting toxicities were obsd. in 3 of 12 patients (grade 4 neutropenia > 7 days, complicated by fever in 1 patient but without other signs of infection).  After two cycles of diflomotecan, 6 patients had disease stabilization, which was maintained in 2 patients for 9 mo and >1 yr, resp.  Diflomotecan pharmacokinetics were linear over the dose range studied.  Systemic exposure correlated with the fall in WBC counts.  The mean oral bioavailability (±SD) was 72.24 ± 59.2% across all dose levels.  Urinary excretion of BN80915 was very low.  The recommended oral diflomotecan dose for Phase II studies is 0.27 mg/day x 5 every 3 wk.  This regimen is convenient and generally well tolerated with a favorable pharmacokinetic profile and high but variable bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSiDIg38_dBbVg90H21EOLACvtfcHk0liLxLic-m2gjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1OjtLg%253D&md5=83f8727db7117be4cbe2925ededc6d0d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGelderblom%26aufirst%3DH.%26aulast%3DSalazar%26aufirst%3DR.%26aulast%3DVerweij%26aufirst%3DJ.%26aulast%3DPentheroudakis%26aufirst%3DG.%26aulast%3Dde%2BJonge%26aufirst%3DM.%2BJ.%26aulast%3DDevlin%26aufirst%3DM.%26aulast%3Dvan%2BHooije%26aufirst%3DC.%26aulast%3DSeguy%26aufirst%3DF.%26aulast%3DObach%26aufirst%3DR.%26aulast%3DPrunonosa%26aufirst%3DJ.%26aulast%3DPrincipe%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520pharmacological%2520and%2520bioavailability%2520study%2520of%2520oral%2520diflomotecan%2520%2528BN80915%2529%252C%2520a%2520novel%2520E-ring-modified%2520camptothecin%2520analogue%2520in%2520adults%2520with%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D4101%26epage%3D4107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Demarquay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huchet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulomb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesueur-Ginot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavergne, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigg, D. C.</span><span> </span><span class="NLM_article-title">BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4942</span><span class="NLM_x">–</span> <span class="NLM_lpage">4949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4942-4949&author=D.+Demarquayauthor=M.+Huchetauthor=H.+Coulombauthor=L.+Lesueur-Ginotauthor=O.+Lavergneauthor=J.+Camaraauthor=P.+G.+Kasprzykauthor=G.+Prevostauthor=D.+C.+Bigg&title=BN80927%3A+a+novel+homocamptothecin+that+inhibits+proliferation+of+human+tumor+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemarquay%26aufirst%3DD.%26aulast%3DHuchet%26aufirst%3DM.%26aulast%3DCoulomb%26aufirst%3DH.%26aulast%3DLesueur-Ginot%26aufirst%3DL.%26aulast%3DLavergne%26aufirst%3DO.%26aulast%3DCamara%26aufirst%3DJ.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DBigg%26aufirst%3DD.%2BC.%26atitle%3DBN80927%253A%2520a%2520novel%2520homocamptothecin%2520that%2520inhibits%2520proliferation%2520of%2520human%2520tumor%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4942%26epage%3D4949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hautefaye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimetiere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2731</span><span class="NLM_x">–</span> <span class="NLM_lpage">2735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2731-2735&author=P.+Hautefayeauthor=B.+Cimetiereauthor=A.+Pierreauthor=S.+Leonceauthor=J.+Hickmanauthor=W.+Laineauthor=C.+Baillyauthor=G.+Lavielle&title=Synthesis+and+pharmacological+evaluation+of+novel+non-lactone+analogues+of+camptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHautefaye%26aufirst%3DP.%26aulast%3DCimetiere%26aufirst%3DB.%26aulast%3DPierre%26aufirst%3DA.%26aulast%3DLeonce%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DJ.%26aulast%3DLaine%26aufirst%3DW.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLavielle%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520novel%2520non-lactone%2520analogues%2520of%2520camptothecin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2731%26epage%3D2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3229</span><span class="NLM_x">–</span> <span class="NLM_lpage">3238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1158%2F1535-7163.MCT-07-0441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=18089716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3229-3238&author=K.+Takagiauthor=T.+S.+Dexheimerauthor=C.+Redonauthor=O.+Sordetauthor=K.+Agamaauthor=G.+Lavielleauthor=A.+Pierreauthor=S.+E.+Batesauthor=Y.+Pommier&title=Novel+E-ring+camptothecin+keto+analogues+%28S38809+and+S39625%29+are+stable%2C+potent%2C+and+selective+topoisomerase+I+inhibitors+without+being+substrates+of+drug+efflux+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters</span></div><div class="casAuthors">Takagi, Kazutaka; Dexheimer, Thomas S.; Redon, Christophe; Sordet, Olivier; Agama, Keli; Lavielle, Gilbert; Pierre, Alain; Bates, Susan E.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3229-3238</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Camptothecin (CPT) analogs are powerful anticancer agents but are chem. unstable due to their α-hydroxylactone six-membered E-ring structure, which is essential for trapping topoisomerase I (Top1)-DNA cleavage complexes.  To stabilize the E-ring, CPT keto analogs with a five-membered E-ring lacking the oxygen of the lactone ring (S38809 and S39625) have been synthesized.  S39625 has been selected for advanced preclin. development based on its promising activity in tumor models.  Here, we show that both keto analogs are active against purified Top1 and selective against Top1 in yeast and human cancer cells.  The keto analogs show improved cytotoxicity toward colon, breast, and prostate cancer cells and leukemia cells compared with CPT.  The drug-induced Top1-DNA cleavage complexes induced by the keto analogs show remarkable persistence both with purified Top1 and in cells following 1-h drug treatments.  Moreover, we find that S39625 is not a substrate for either the ABCB1 (multidrug resistance-1/P-glycoprotein) or ABCG2 (mitoxantrone resistance/breast cancer resistance protein) drug efflux transporters, which sets S39625 apart from the clin. used CPT analogs topotecan or SN-38 (active metabolite of irinotecan).  Finally, we show that nanomolar concns. of S38809 or S39625 induce intense and persistent histone γ-H2AX.  The chem. stability of the keto analogs and the ability of S39625 to produce high levels of persistent Top1-DNA cleavage complex and its potent antiproliferative activity against human cancer cell lines make S39625 a promising new anticancer drug candidate.  Histone γ-H2AX could be used as a biomarker for the upcoming clin. trials of S39625.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsAvXCcUmkvLVg90H21EOLACvtfcHk0li-gZ-0FcCsow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3L&md5=3a428d2a4871232a86096569c4550fb2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0441%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DRedon%26aufirst%3DC.%26aulast%3DSordet%26aufirst%3DO.%26aulast%3DAgama%26aufirst%3DK.%26aulast%3DLavielle%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DA.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNovel%2520E-ring%2520camptothecin%2520keto%2520analogues%2520%2528S38809%2520and%2520S39625%2529%2520are%2520stable%252C%2520potent%252C%2520and%2520selective%2520topoisomerase%2520I%2520inhibitors%2520without%2520being%2520substrates%2520of%2520drug%2520efflux%2520transporters%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D3229%26epage%3D3238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=429-434&author=Y.+Pommier&title=Camptothecins+and+topoisomerase+I%3A+a+foot+in+the+door.+Targeting+the+genome+beyond+topoisomerase+I+with+camptothecins+and+novel+anticancer+drugs%3A+importance+of+DNA+replication%2C+repair+and+cell+cycle+checkpoints"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCamptothecins%2520and%2520topoisomerase%2520I%253A%2520a%2520foot%2520in%2520the%2520door.%2520Targeting%2520the%2520genome%2520beyond%2520topoisomerase%2520I%2520with%2520camptothecins%2520and%2520novel%2520anticancer%2520drugs%253A%2520importance%2520of%2520DNA%2520replication%252C%2520repair%2520and%2520cell%2520cycle%2520checkpoints%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2004%26volume%3D4%26spage%3D429%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1158%2F1535-7163.MCT-08-0706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=19383846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlGqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1008-1014&author=Y.+Pommierauthor=M.+Cushman&title=The+indenoisoquinoline+noncamptothecin+topoisomerase+I+inhibitors%3A+update+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives</span></div><div class="casAuthors">Pommier, Yves; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1008-1014</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Because camptothecins are effective against previously resistant tumors and are the only class of topoisomerase I (Top 1) inhibitors approved for cancer treatment, we developed the indenoisoquinolines.  Like camptothecins, the indenoisoquinolines selectively trap Top1-DNA cleavage complexes and have been cocrystd. with the Top1-DNA cleavage complexes.  Indenoisoquinolines show antitumor activity in animal models.  They have several advantages over the camptothecins: (a) They are synthetic and chem. stable.  (b) The Top1 cleavage sites trapped by the indenoisoquinolines have different genomic locations, implying differential targeting of cancer cell genomes.  (c) The Top1 cleavage complexes trapped by indenoisoquinolines are more stable, indicative of prolonged drug action.  (d) They are seldom or not used as substrates for the multidrug resistance efflux pumps (ABCG2 and MDR-1).  Among the >400 indenoisoquinolines synthesized and evaluated, three have been retained as leads for clin. development by the National Cancer Institute: NSC 706744, NSC 725776 (Indimitecan), and NSC 724998 (Indotecan).  The trapping of Top1 cleavage complexes by indenoisoquinolines in cells results in the rapid and sustained phosphorylation of histone H2AX (γ-H2AX).  We discuss the use of γ-H2AX as a pharmacodynamic biomarker for the clin. development of the indenoisoquinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouXo9kT-6EHbVg90H21EOLACvtfcHk0ljtjr2xyjmTVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlGqs7c%253D&md5=ed8a6657372e0ef2169b7df22129b3a3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0706%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DThe%2520indenoisoquinoline%2520noncamptothecin%2520topoisomerase%2520I%2520inhibitors%253A%2520update%2520and%2520perspectives%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1008%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hsiang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1722</span><span class="NLM_x">–</span> <span class="NLM_lpage">1726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=2832051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaL1cXhsl2ks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1988&pages=1722-1726&author=Y.+H.+Hsiangauthor=L.+F.+Liu&title=Identification+of+mammalian+DNA+topoisomerase+I+as+an+intracellular+target+of+the+anticancer+drug+camptothecin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin</span></div><div class="casAuthors">Hsiang, Yaw Huei; Liu, Leroy F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1722-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Camptothecin, a plant alkaloid with antitumor activity, was previously shown to be a potent inhibitor of nucleic acid synthesis and a strong inducer of DNA strand breaks in mammalian cells.  In addn., previous studies have shown that camptothecin inhibits purified mammalian DNA topoisomerase I by trapping a reversible enzyme-DNA "cleavable complex".  In L1210 cells and SV40-infected monkey cells, camptothecin-induced strand breaks were shown to be protein linked.  The linked protein is most likely DNA topoisomerase I, as revealed by immunoblot anal., using antibodies against purified mammalian DNA topoisomerase I.  Brief heating of camptothecin-treated cells to 65° resulted in a rapid redn. of the no. of protein-linked DNA breaks.  Reversal of the camptothecin-induced topoisomerase I-DNA complex by heat was also obsd. in an in vitro system by using purified mammalian DNA topoisomerase I.  The results suggest that camptothecin interferes with DNA topoisomerase I both in cultured mammalian cells and in the purified system by trapping an enzyme-DNA complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpgCHupGLH7Vg90H21EOLACvtfcHk0ljtjr2xyjmTVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhsl2ks7Y%253D&md5=950eeb566fe78ecd9143d7edc093d943</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiang%26aufirst%3DY.%2BH.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DIdentification%2520of%2520mammalian%2520DNA%2520topoisomerase%2520I%2520as%2520an%2520intracellular%2520target%2520of%2520the%2520anticancer%2520drug%2520camptothecin%26jtitle%3DCancer%2520Res.%26date%3D1988%26volume%3D48%26spage%3D1722%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Brangi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5938</span><span class="NLM_x">–</span> <span class="NLM_lpage">5946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5938-5946&author=M.+Brangiauthor=T.+Litmanauthor=M.+Ciottiauthor=K.+Nishiyamaauthor=G.+Kohlhagenauthor=C.+Takimotoauthor=R.+Robeyauthor=Y.+Pommierauthor=T.+Fojoauthor=S.+E.+Bates&title=Camptothecin+resistance%3A+role+of+the+ATP-binding+cassette+%28ABC%29%2C+mitoxantrone-resistance+half-transporter+%28MXR%29%2C+and+potential+for+glucuronidation+in+MXR-expressing+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrangi%26aufirst%3DM.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DCiotti%26aufirst%3DM.%26aulast%3DNishiyama%26aufirst%3DK.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DTakimoto%26aufirst%3DC.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DCamptothecin%2520resistance%253A%2520role%2520of%2520the%2520ATP-binding%2520cassette%2520%2528ABC%2529%252C%2520mitoxantrone-resistance%2520half-transporter%2520%2528MXR%2529%252C%2520and%2520potential%2520for%2520glucuronidation%2520in%2520MXR-expressing%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5938%26epage%3D5946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Liao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guirouilh-Barbat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=490-497&author=Z.+Liaoauthor=R.+W.+Robeyauthor=J.+Guirouilh-Barbatauthor=K.+K.+Toauthor=O.+Polgarauthor=S.+E.+Batesauthor=Y.+Pommier&title=Reduced+expression+of+DNA+topoisomerase+I+in+SF295+human+glioblastoma+cells+selected+for+resistance+to+homocamptothecin+and+diflomotecan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DGuirouilh-Barbat%26aufirst%3DJ.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DPolgar%26aufirst%3DO.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DReduced%2520expression%2520of%2520DNA%2520topoisomerase%2520I%2520in%2520SF295%2520human%2520glioblastoma%2520cells%2520selected%2520for%2520resistance%2520to%2520homocamptothecin%2520and%2520diflomotecan%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D490%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aida-Hyugaji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span> </span><span class="NLM_article-title">Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2Fj.canlet.2005.05.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16309825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit12itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2006&pages=81-89&author=H.+Nakagawaauthor=H.+Saitoauthor=Y.+Ikegamiauthor=S.+Aida-Hyugajiauthor=S.+Sawadaauthor=T.+Ishikawa&title=Molecular+modeling+of+new+camptothecin+analogues+to+circumvent+ABCG2-mediated+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer</span></div><div class="casAuthors">Nakagawa, Hiroshi; Saito, Hikaru; Ikegami, Yoji; Aida-Hyugaji, Sachiko; Sawada, Seigo; Ishikawa, Toshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Irinotecan (CPT-11) is a widely used potent antitumor drug that inhibits mammalian DNA topoisomerase I (Topo I).  However, overexpression of ABCG2 (BCRP/MXR/ABCP) reportedly confers cancer cells resistance to SN-38, the active form of CPT-11.  To circumvent the ABCG2-assocd. drug resistance, the structure-activity-relationship (SAR) of 14 new camptothecin (CPT) analogs has been studied with respect to the substrate specificity of ABCG2.  While the lactone E ring is a prerequisite for anticancer activity, modifications of the A or B rings do not significantly affect Topo I inhibition.  Based on the substrate specificity of ABCG2, it is strongly suggested that CPT analogs with a hydroxyl group at position 10 or 11 of the A ring are recognized by ABCG2 and are thereby effectively extruded from cancer cells.  To develop a platform for the mol. modeling to circumvent anticancer drug resistance, we have carried out quantum chem. calcns. and neural network SAR anal.  Electrostatic potential iso-surfaces generated by ab initio MO calcns. using RHF method have revealed that neg. potential localized at positions 10 or 11 in the A ring is important for recognition by ABCG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo49fog41xxd7Vg90H21EOLACvtfcHk0lgjb_tJ2YuDZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit12itb8%253D&md5=f56d9a592b46908ae09b94c1b5859413</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DIkegami%26aufirst%3DY.%26aulast%3DAida-Hyugaji%26aufirst%3DS.%26aulast%3DSawada%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DMolecular%2520modeling%2520of%2520new%2520camptothecin%2520analogues%2520to%2520circumvent%2520ABCG2-mediated%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D234%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fujimori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1339</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=1339-1346&author=A.+Fujimoriauthor=W.+G.+Harkerauthor=G.+Kohlhagenauthor=Y.+Hokiauthor=Y.+Pommier&title=Mutation+at+the+catalytic+site+of+topoisomerase+I+in+CEM%2FC2%2C+a+human+leukemia+cell+line+resistant+to+camptothecin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujimori%26aufirst%3DA.%26aulast%3DHarker%26aufirst%3DW.%2BG.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DHoki%26aufirst%3DY.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DMutation%2520at%2520the%2520catalytic%2520site%2520of%2520topoisomerase%2520I%2520in%2520CEM%252FC2%252C%2520a%2520human%2520leukemia%2520cell%2520line%2520resistant%2520to%2520camptothecin%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D1339%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Urasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laco, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourquier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gioffre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantazis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=1964-1969&author=Y.+Urasakiauthor=G.+S.+Lacoauthor=P.+Pourquierauthor=Y.+Takebayashiauthor=G.+Kohlhagenauthor=C.+Gioffreauthor=H.+Zhangauthor=D.+Chatterjeeauthor=P.+Pantazisauthor=Y.+Pommier&title=Characterization+of+a+novel+topoisomerase+I+mutation+from+a+camptothecin-resistant+human+prostate+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrasaki%26aufirst%3DY.%26aulast%3DLaco%26aufirst%3DG.%2BS.%26aulast%3DPourquier%26aufirst%3DP.%26aulast%3DTakebayashi%26aufirst%3DY.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DGioffre%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DPantazis%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520topoisomerase%2520I%2520mutation%2520from%2520a%2520camptothecin-resistant%2520human%2520prostate%2520cancer%2520cell%2520line%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D1964%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Meng, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.2174%2F1568026033452546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=12570765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=305-320&author=L.+H.+Mengauthor=Z.+Y.+Liaoauthor=Y.+Pommier&title=Non-camptothecin+DNA+topoisomerase+I+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy</span></div><div class="casAuthors">Meng, Ling-Hua; Liao, Zhi-Yong; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-320</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human DNA topoisomerase I is the target of camptothecins, which have been recently introduced in the clinic for cancer chemotherapy.  The discovery of novel non-camptothecin inhibitors is facilitated by the availability of biochem. and cellular assays for testing topoisomerase I activity.  Among the non-camptothecin inhibitors, the indolocarbazoles (NB-506 and J-107088) are the most advanced in their development, and are in clin. trials.  A no. of indenoisoquinolines and minor groove binders (benzimidazoles) have been reported recently.  Their antitumor activity is promising for further development.  The potential binding site(s) of topoisomerase I inhibitors in the enzyme I-DNA complex is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIJ1OCISjUd7Vg90H21EOLACvtfcHk0lgjb_tJ2YuDZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksg%253D%253D&md5=606576e24f65454321fb06904319695c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F1568026033452546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452546%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DL.%2BH.%26aulast%3DLiao%26aufirst%3DZ.%2BY.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DNon-camptothecin%2520DNA%2520topoisomerase%2520I%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D305%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusaba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanigawara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGovren, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natsumeda, Y.</span><span> </span><span class="NLM_article-title">Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1007%2Fs00280-005-0149-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=16308697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFGitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=173-182&author=Y.+Yamadaauthor=T.+Tamuraauthor=N.+Yamamotoauthor=T.+Shimoyamaauthor=Y.+Uedaauthor=H.+Murakamiauthor=H.+Kusabaauthor=Y.+Kamiyaauthor=H.+Sakaauthor=Y.+Tanigawaraauthor=J.+P.+McGovrenauthor=Y.+Natsumeda&title=Phase+I+and+pharmacokinetic+study+of+edotecarin%2C+a+novel+topoisomerase+I+inhibitor%2C+administered+once+every+3+weeks+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors</span></div><div class="casAuthors">Yamada, Yasuhide; Tamura, Tomohide; Yamamoto, Noboru; Shimoyama, Tatsu; Ueda, Yutaka; Murakami, Haruyasu; Kusaba, Hitoshi; Kamiya, Yoshikazu; Saka, Hideo; Tanigawara, Yusuke; McGovren, J. Patrick; Natsumeda, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-182</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Edotecarin (J-107088) is a potent indolocarbazole topoisomerase I inhibitor which is structurally distinct from the camptothecins.  This study aimed to det. the max. tolerated dose (MTD), the recommended dose for future Phase II studies and the safety, pharmacokinetic profile, and preliminary antitumor activity of edotecarin in a population of patients with advanced solid tumors.  Exptl. design: Edotecarin was administered as a single dose by IV infusion over 2 h every 21 days (with 1 wk permitted for recovery from toxicities, if needed) in patients with advanced solid tumors.  Doses ranged from 8 to 15 mg/m2.  Pharmacokinetic assessments were performed during and after the first administration.  Results: Twenty-four patients received 61 cycles of therapy.  Dose-limiting toxicities (infection, febrile neutropenia, constipation, ileus, and prolonged grade 4 granulocytopenia) were obsd. in 3 of 5 evaluable patients at the 15 mg/m2 dose, defining the MTD.  The most commonly reported non-hematol. toxicities were anorexia, nausea, malaise, and constipation.  Diarrhea was neither frequent nor severe.  Neutropenia was the most common hematol. toxicity (grade 3-4 in 21/23 patients during cycle 1).  Plasma concns. of edotecarin rose rapidly following the start of the 2-h infusion, reaching Cmax values of 103±17 ng/mL at the 13 mg/m2 dose, and decreased steeply after the end of the infusion.  Plasma concns. declined to approx. 1-2 ng/mL at 26 h post start of infusion, the last PK sampling time point.  The mean apparent plasma half-life of the drug was 20 h, which should be considered a preliminary est. until results from studies with a longer duration of plasma sampling are available.  A mean of 1.4-3.6% of the dose was recovered as unchanged drug in the urine over 48 h.  Unconfirmed tumor regression ≥50% was obsd. in 2 patients, 1 with metastatic gastric carcinoma and 1 with esophageal cancer.  Conclusions: The MTD of edotecarin administered IV over 2 h every 21 days was 15 mg/m2.  The recommended dose for Phase II studies with a 3-wk schedule (with 1 wk permitted for recovery from toxicities, if needed) is 13 mg/m2.  The obsd. safety profile and preliminary evidence of antitumor activity warrant further investigation of this drug in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiGySWL2mKV7Vg90H21EOLACvtfcHk0lhVgnMTfELeug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFGitrY%253D&md5=0b404d1baac4479af06b22560491a122</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-0149-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-0149-6%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DShimoyama%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DKusaba%26aufirst%3DH.%26aulast%3DKamiya%26aufirst%3DY.%26aulast%3DSaka%26aufirst%3DH.%26aulast%3DTanigawara%26aufirst%3DY.%26aulast%3DMcGovren%26aufirst%3DJ.%2BP.%26aulast%3DNatsumeda%26aufirst%3DY.%26atitle%3DPhase%2520I%2520and%2520pharmacokinetic%2520study%2520of%2520edotecarin%252C%2520a%2520novel%2520topoisomerase%2520I%2520inhibitor%252C%2520administered%2520once%2520every%25203%2520weeks%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2006%26volume%3D58%26spage%3D173%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Redinbo, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champoux, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span> </span><span class="NLM_article-title">Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1504-1513&author=M.+R.+Redinboauthor=L.+Stewartauthor=P.+Kuhnauthor=J.+J.+Champouxauthor=W.+G.+Hol&title=Crystal+structures+of+human+topoisomerase+I+in+covalent+and+noncovalent+complexes+with+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRedinbo%26aufirst%3DM.%2BR.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DChampoux%26aufirst%3DJ.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%26atitle%3DCrystal%2520structures%2520of%2520human%2520topoisomerase%2520I%2520in%2520covalent%2520and%2520noncovalent%2520complexes%2520with%2520DNA%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1504%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Staker, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feese, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembower, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgin, A. B.</span><span> </span><span class="NLM_article-title">Structures of three classes of anticancer agents bound to the human topoisomerase I−DNA covalent complex</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2336</span><span class="NLM_x">–</span> <span class="NLM_lpage">2345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049146p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2336-2345&author=B.+L.+Stakerauthor=M.+D.+Feeseauthor=M.+Cushmanauthor=Y.+Pommierauthor=D.+Zembowerauthor=L.+Stewartauthor=A.+B.+Burgin&title=Structures+of+three+classes+of+anticancer+agents+bound+to+the+human+topoisomerase+I%E2%88%92DNA+covalent+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm049146p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049146p%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DZembower%26aufirst%3DD.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26atitle%3DStructures%2520of%2520three%2520classes%2520of%2520anticancer%2520agents%2520bound%2520to%2520the%2520human%2520topoisomerase%2520I%25E2%2588%2592DNA%2520covalent%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2336%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Staker, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjerrild, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feese, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgin, A. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span> </span><span class="NLM_article-title">The mechanism of topoisomerase I poisoning by a camptothecin analog</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">15387</span><span class="NLM_x">–</span> <span class="NLM_lpage">15392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1073%2Fpnas.242259599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=12426403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15387-15392&author=B.+L.+Stakerauthor=K.+Hjerrildauthor=M.+D.+Feeseauthor=C.+A.+Behnkeauthor=A.+B.+Burginauthor=L.+Stewart&title=The+mechanism+of+topoisomerase+I+poisoning+by+a+camptothecin+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of topoisomerase I poisoning by a camptothecin analog</span></div><div class="casAuthors">Staker, Bart L.; Hjerrild, Kathryn; Feese, Michael D.; Behnke, Craig A.; Burgin, Alex B., Jr.; Stewart, Lance</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15387-15392</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report the x-ray crystal structure of human topoisomerase I covalently joined to double-stranded DNA and bound to the clin. approved anticancer agent topotecan.  Topotecan mimics a DNA base pair and binds at the site of DNA cleavage by intercalating between the upstream (-1) and downstream (+1) base pairs.  Intercalation displaces the downstream DNA, thus preventing re-ligation of the cleaved strand.  By specifically binding to the enzyme-substrate complex, topotecan acts as an uncompetitive inhibitor.  The structure can explain several of the known structure-activity relationships of the camptothecin family of anticancer drugs and suggests that there are at least two classes of mutations that can produce a drug-resistant enzyme.  The first class includes changes to residues that contribute to direct interactions with the drug, whereas a second class would alter interactions with the DNA and thereby destabilize the drug-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6ZhyvRMWZBLVg90H21EOLACvtfcHk0lhVgnMTfELeug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVGh&md5=fe1f9e01f0277f8d46e8726ba7866bdb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.242259599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.242259599%26sid%3Dliteratum%253Aachs%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DHjerrild%26aufirst%3DK.%26aulast%3DFeese%26aufirst%3DM.%2BD.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DStewart%26aufirst%3DL.%26atitle%3DThe%2520mechanism%2520of%2520topoisomerase%2520I%2520poisoning%2520by%2520a%2520camptothecin%2520analog%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D15387%26epage%3D15392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Ioanoviciu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staker, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span> </span><span class="NLM_article-title">Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4803</span><span class="NLM_x">–</span> <span class="NLM_lpage">4814</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050076b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4803-4814&author=A.+Ioanoviciuauthor=S.+Antonyauthor=Y.+Pommierauthor=B.+L.+Stakerauthor=L.+Stewartauthor=M.+Cushman&title=Synthesis+and+mechanism+of+action+studies+of+a+series+of+norindenoisoquinoline+topoisomerase+I+poisons+reveal+an+inhibitor+with+a+flipped+orientation+in+the+ternary+DNA-enzyme-inhibitor+complex+as+determined+by+X-ray+crystallographic+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050076b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050076b%26sid%3Dliteratum%253Aachs%26aulast%3DIoanoviciu%26aufirst%3DA.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520mechanism%2520of%2520action%2520studies%2520of%2520a%2520series%2520of%2520norindenoisoquinoline%2520topoisomerase%2520I%2520poisons%2520reveal%2520an%2520inhibitor%2520with%2520a%2520flipped%2520orientation%2520in%2520the%2520ternary%2520DNA-enzyme-inhibitor%2520complex%2520as%2520determined%2520by%2520X-ray%2520crystallographic%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4803%26epage%3D4814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kolb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Structure-based discovery of beta2-adrenergic receptor ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">6843</span><span class="NLM_x">–</span> <span class="NLM_lpage">6848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=6843-6848&author=P.+Kolbauthor=D.+M.+Rosenbaumauthor=J.+J.+Irwinauthor=J.+J.+Fungauthor=B.+K.+Kobilkaauthor=B.+K.+Shoichet&title=Structure-based+discovery+of+beta2-adrenergic+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DP.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DFung%26aufirst%3DJ.%2BJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DStructure-based%2520discovery%2520of%2520beta2-adrenergic%2520receptor%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D6843%26epage%3D6848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span> </span><span class="NLM_article-title">Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4940</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801622x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot1GntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4936-4940&author=H.+Liauthor=J.+Huangauthor=L.+Chenauthor=X.+Liuauthor=T.+Chenauthor=J.+Zhuauthor=W.+Luauthor=X.+Shenauthor=J.+Liauthor=R.+Hilgenfeldauthor=H.+Jiang&title=Identification+of+novel+falcipain-2+inhibitors+as+potential+antimalarial+agents+through+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Falcipain-2 Inhibitors as Potential Antimalarial Agents through Structure-Based Virtual Screening</span></div><div class="casAuthors">Li, Honglin; Huang, Jin; Chen, Lili; Liu, Xiaofeng; Chen, Tong; Zhu, Jin; Lu, Weiqiang; Shen, Xu; Li, Jian; Hilgenfeld, Rolf; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4936-4940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The SPECS database was screened against falcipain-2 with two different docking methods to identify structurally diverse nonpeptidic inhibitors.  Twenty-eight nonpeptidic mols. among 81 compds. tested were identified as potential inhibitors of falcipain-2.  One of the inhibitors exhibited in vitro activity with an IC50 value of 2.4 μM.  Furthermore, the similarity anal. has demonstrated that it is feasible to find novel diverse falcipain-2 inhibitors with similar steric shape through virtual screening of large-scale chem. libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNgaoOqTLV97Vg90H21EOLACvtfcHk0li5Yv6s3QGM1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot1GntLs%253D&md5=92c45808a829996aa45280f6225fe990</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm801622x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801622x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHilgenfeld%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520novel%2520falcipain-2%2520inhibitors%2520as%2520potential%2520antimalarial%2520agents%2520through%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4936%26epage%3D4940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Virtual screening of chemical libraries</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1038%2Fnature03197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=15602552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=862-865&author=B.+K.+Shoichet&title=Virtual+screening+of+chemical+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening of chemical libraries</span></div><div class="casAuthors">Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7019</span>),
    <span class="NLM_cas:pages">862-865</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Virtual screening uses computer-based methods to discover new ligands on the basis of biol. structures.  Although widely heralded in the 1970s and 1980s, the technique has since struggled to meet its initial promise, and drug discovery remains dominated by empirical screening.  Recent successes in predicting new ligands and their receptor-bound structures, and better rates of ligand discovery compared to empirical screening, have reignited interest in virtual screening, which is now widely used in drug discovery, albeit on a more limited scale than empirical screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSY9IbbFldkrVg90H21EOLACvtfcHk0li5Yv6s3QGM1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jK&md5=e351e226e8985d7c304a05fb67dfdc60</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature03197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03197%26sid%3Dliteratum%253Aachs%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DVirtual%2520screening%2520of%2520chemical%2520libraries%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D862%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Toshiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saburo, T.</span><span> </span><span class="NLM_article-title">Stucture eludidation and synthesis of alkaloids isolated from fruits of <i>Evodia rutaecarpa</i></span> <span class="citation_source-journal">Agric. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1271%2Fbbb1961.42.1515" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1978&pages=1515-1519&author=K.+Toshiyaauthor=M.+Shigeoauthor=T.+Saburo&title=Stucture+eludidation+and+synthesis+of+alkaloids+isolated+from+fruits+of+Evodia+rutaecarpa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1271%2Fbbb1961.42.1515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb1961.42.1515%26sid%3Dliteratum%253Aachs%26aulast%3DToshiya%26aufirst%3DK.%26aulast%3DShigeo%26aufirst%3DM.%26aulast%3DSaburo%26aufirst%3DT.%26atitle%3DStucture%2520eludidation%2520and%2520synthesis%2520of%2520alkaloids%2520isolated%2520from%2520fruits%2520of%2520Evodia%2520rutaecarpa%26jtitle%3DAgric.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D42%26spage%3D1515%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Kametani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, M.</span><span> </span><span class="NLM_article-title">A one-step synthesis of evodiamine and rutecarpine</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1976&pages=23-28&author=T.+Kametaniauthor=T.+Higaauthor=K.+Fukumotoauthor=M.+Koizumi&title=A+one-step+synthesis+of+evodiamine+and+rutecarpine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKametani%26aufirst%3DT.%26aulast%3DHiga%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DK.%26aulast%3DKoizumi%26aufirst%3DM.%26atitle%3DA%2520one-step%2520synthesis%2520of%2520evodiamine%2520and%2520rutecarpine%26jtitle%3DHeterocycles%26date%3D1976%26volume%3D4%26spage%3D23%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Whittaker, N.</span><span> </span><span class="NLM_article-title">The synthesis of emetine and related compounds. Part VI. Improvements in the synthesis of 3-alkyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxybenzo[<i>a</i>]quinolizin-2-ones and 3-alkyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-<i>a</i>]quinolizin-2-ones. Formation of some related diazabicyclo[3,3,1]nonanes</span> <span class="citation_source-journal">J. Chem. Soc. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaF1MXkslKmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1969&pages=85-89&author=N.+Whittaker&title=The+synthesis+of+emetine+and+related+compounds.+Part+VI.+Improvements+in+the+synthesis+of+3-alkyl-1%2C3%2C4%2C6%2C7%2C11b-hexahydro-9%2C10-dimethoxybenzo%5Ba%5Dquinolizin-2-ones+and+3-alkyl-1%2C2%2C3%2C4%2C6%2C7%2C12%2C12b-octahydroindolo%5B2%2C3-a%5Dquinolizin-2-ones.+Formation+of+some+related+diazabicyclo%5B3%2C3%2C1%5Dnonanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of emetine and related compounds.  VI.  Improvements in the synthesis of 3-alkyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxybenzo[a]quinolizin-2-ones and 3-alkyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-ones.  Formation of some related diazabicyclo[3.3.1]nonanes</span></div><div class="casAuthors">Whittaker, Norman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-9</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">A simplified procedure is reported for the almost quantitative conversion of 3,4-dihydro-6,7-di-methoxyisoquinoline (I) into benzo[a]quinolizines.  A byproduct formed in the prepn. of 1,3,4,6,7,11b-hexahydro-9,10-dimethoxybenzo[a]quinolizin-2-one is assigned the diisoquinopy-rimidine structure.  3,4-Dihydro-β-carboline condenses with Mannich bases in the presence of CO2 to give the indolo[2,3-a]quinolizines in good yield.  4-Dimethylamino-3-(dimethylaminomethyl)-2-butanone condenses with two mols. I to give 9,18-methanodiisoquino[2,1-a:1',2'-d][1,5]diazocine; similarly was prepd. the substituted 9,18-methanodiisoquino[2,1-a:2',1'-e]-[1,5]diazocine, together with a trace of a dipentacyclic ketone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7q6tHFtYe4LVg90H21EOLACvtfcHk0lhH_eW5Fc6rAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkslKmuw%253D%253D&md5=43ff9e3bddc72eb532bd4fc8e536ac93</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DN.%26atitle%3DThe%2520synthesis%2520of%2520emetine%2520and%2520related%2520compounds.%2520Part%2520VI.%2520Improvements%2520in%2520the%2520synthesis%2520of%25203-alkyl-1%252C3%252C4%252C6%252C7%252C11b-hexahydro-9%252C10-dimethoxybenzo%255Ba%255Dquinolizin-2-ones%2520and%25203-alkyl-1%252C2%252C3%252C4%252C6%252C7%252C12%252C12b-octahydroindolo%255B2%252C3-a%255Dquinolizin-2-ones.%2520Formation%2520of%2520some%2520related%2520diazabicyclo%255B3%252C3%252C1%255Dnonanes%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1969%26spage%3D85%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Schöpf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H.</span><span> </span><span class="NLM_article-title">Zur frage der biogenese des rutaecarpins und evodamins. Die synthese des rutaecarpins unter zellmöglichen bedingungen</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1947</span><span class="NLM_x">, </span> <span class="NLM_volume">558</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=1947&pages=124-36&author=C.+Sch%C3%B6pfauthor=H.+Steuer&title=Zur+frage+der+biogenese+des+rutaecarpins+und+evodamins.+Die+synthese+des+rutaecarpins+unter+zellm%C3%B6glichen+bedingungen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6pf%26aufirst%3DC.%26aulast%3DSteuer%26aufirst%3DH.%26atitle%3DZur%2520frage%2520der%2520biogenese%2520des%2520rutaecarpins%2520und%2520evodamins.%2520Die%2520synthese%2520des%2520rutaecarpins%2520unter%2520zellm%25C3%25B6glichen%2520bedingungen%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1947%26volume%3D558%26spage%3D124%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Heilbron, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitchen, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, G. D.</span><span> </span><span class="NLM_article-title">CCXCII.—Chemical reactivity and conjugation. Part II. The reactivity of the 2-methyl group in the 4-quinazolone series</span> <span class="citation_source-journal">J. Chem. Soc., Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1925</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2167</span><span class="NLM_x">–</span> <span class="NLM_lpage">2175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1039%2Fct9252702167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaB28XhslSi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1925&pages=2167-2175&author=I.+M.+Heilbronauthor=F.+N.+Kitchenauthor=E.+B.+Parkesauthor=G.+D.+Sutton&title=CCXCII.%E2%80%94Chemical+reactivity+and+conjugation.+Part+II.+The+reactivity+of+the+2-methyl+group+in+the+4-quinazolone+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical reactivity and conjugation. II. The reactivity of the 2-methyl group in the 4-quinazoline series</span></div><div class="casAuthors">Heilbron, I. M.; Kitchen, F. N.; Parkes, E. B.; Sutton, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Transactions</span>
        (<span class="NLM_cas:date">1925</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2167-75</span>CODEN:
                <span class="NLM_cas:coden">JCHTA3</span>;
        ISSN:<span class="NLM_cas:issn">0368-1645</span>.
    </div><div class="casAbstract">cf. C. A. 18, 267.  2,3-Dimethyl-4-quinazolone (I) contains a reactive Me group, the following condensation products being prepd.: 2-styryl-3-methyl-4-quinazolone, pale yellow, m. 167°; 4'-methoxy-2-styryl, bright yellow, m. 146°, giving an orange soln. in dil. HCl; 3',4'-dimethoxy-2-styryl, yellow, m. 208°; 3',4'-methylenedioxy-2-styryl, bright yellow, m. 185°; 4'-dimethylamino-2-styryl, orange-red, m. 175°.  o-MeNHC6H4CO2H gives a carbethoxy deriv., m. 108°.  The acid in ClCO2Et and AcCl gives quant. methylisatoic anhydride, m. 180°, which, with 0.88% NH4OH, gives quant.  o-MeNHC6H4CONH2, m. 162°, from which Ac2O gives an excellent yield of 1,2-dimethyl-4-quinazolone (II), m. 203°.  2-Styryl-1-methyl-4-quinazolone, cream-colored, m.245°; 4'-MeO deriv., bright yellow, m. 94° (contains 2H2O); anhyd., m. 156°; 3',4'-methylenedioxy deriv., yellow, m. 264°; 4'-dimethylamino deriv., orange, m. 274°.  5-Methoxyacetanthranil, m. 124°, in quant, yield from the acid and Ac2O; with excess NH4OH (0.88) there results 6-methoxy-2-methyl-4-quinazolone, m. 270°, and with MeNH2 the corresponding 2,3-di-Me deriv., m. (with 1H2O), 87°; anhyd., 133°; the latter does not condense with aromatic aldehydes.  5-Methoxymethylanthranilic acid, yellow, m. 163°; the amide, m. 145°, results by the action of NH4OH upon 6-methoxymethylisatoic anhydride, m. 233°.  6-Methoxy-1,2-dimethyl-4-quinazolone, m. 220°; piperonal gives the 3',4'-methylenedioxy-2-styryl deriv., yellow, m. 284°.  7-Methoxy-1,2-dimethyl-4-quinazolone,m. 193° or with 1H2O, m. 135°; 3',4'-methylenedioxy-2-styryl deriv., yellow, m. 280°; 4'-dimethylamino deriv., bright red, m. 266°.  7-Methoxy-2-methyl-4-quinazolone, m. 272°; Me2SO4 gives the 2,3-di-Me deriv., m. 149° or with 1H2O, m. 80°; 3',4'-methylenedioxy-2-styryl deriv., yellow, m. 193°.  5-Chloro-2-amino-4-methoxytoluene, m. 112°; Ac deriv., m. 183-4°.  The II appear to be more reactive than the I, probably because of the presence of the conjugated system O:CN:CMe; a certain retardation of activity is found in the case of the 7-MeO deriv. of II, thus showing that neutralization effects, although not sufficient to prevent reaction, do nevertheless come into play.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfOMDHLxZJzrVg90H21EOLACvtfcHk0lhH_eW5Fc6rAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB28XhslSi&md5=0b85ea5563c0bed17661dc1150221015</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2Fct9252702167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fct9252702167%26sid%3Dliteratum%253Aachs%26aulast%3DHeilbron%26aufirst%3DI.%2BM.%26aulast%3DKitchen%26aufirst%3DF.%2BN.%26aulast%3DParkes%26aufirst%3DE.%2BB.%26aulast%3DSutton%26aufirst%3DG.%2BD.%26atitle%3DCCXCII.%25E2%2580%2594Chemical%2520reactivity%2520and%2520conjugation.%2520Part%2520II.%2520The%2520reactivity%2520of%2520the%25202-methyl%2520group%2520in%2520the%25204-quinazolone%2520series%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Trans.%26date%3D1925%26volume%3D127%26spage%3D2167%26epage%3D2175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.</span><span> </span><span class="NLM_article-title">Evodiamine: a novel anti-cancer alkaloid from <i>Evodia rutaecarpa</i></span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1852</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.3390%2Fmolecules14051852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=19471205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1852-1859&author=J.+Jiangauthor=C.+Hu&title=Evodiamine%3A+a+novel+anti-cancer+alkaloid+from+Evodia+rutaecarpa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa</span></div><div class="casAuthors">Jiang, Junlin; Hu, Changping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1852-1859</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Traditional Chinese herbs are regarded as a new and promising source of potential anti-cancer remedies and new chemotherapy adjuvants to enhance the efficacy of chemotherapy and/or to ameliorate its side effects.  Extensive investigations have been undertaken both in the exptl. and clin. studies over the years to augment the efficacy of chemotherapy.  Evodia rutaecarpa is a very popular multi-purpose herb traditionally used in China for the treatment of headaches, abdominal pain, postpartum hemorrhage, dysentery and amenorrhea.  The major constituents of Evodia rutaecarpa are evodiamine and rutaecarpine.  Growing evidence demonstrates that evodiamine possesses anti-cancer activities both in vitro and in vivo by inhibiting proliferation, invasion and metastasis, inducing apoptosis of a variety of tumor cell lines.  This review is aimed to summarize the recent researches on evodiamine focusing on anti-cancer activity and to highlight mol. mechanisms during the past ten years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygUJ8nEBYU7Vg90H21EOLACvtfcHk0lj4eKcXcGm1CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D&md5=ce11dc87f32f3db73b2462180521e9fa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3390%2Fmolecules14051852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules14051852%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DC.%26atitle%3DEvodiamine%253A%2520a%2520novel%2520anti-cancer%2520alkaloid%2520from%2520Evodia%2520rutaecarpa%26jtitle%3DMolecules%26date%3D2009%26volume%3D14%26spage%3D1852%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Yoshizumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minakuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, T.</span><span> </span><span class="NLM_article-title">Effect of evodiamine on catecholamine secretion from bovine adrenal medulla</span> <span class="citation_source-journal">J. Med. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1997&pages=79-82&author=M.+Yoshizumiauthor=H.+Houchiauthor=Y.+Ishimuraauthor=M.+Hiroseauthor=T.+Kitagawaauthor=K.+Tsuchiyaauthor=K.+Minakuchiauthor=T.+Tamaki&title=Effect+of+evodiamine+on+catecholamine+secretion+from+bovine+adrenal+medulla"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizumi%26aufirst%3DM.%26aulast%3DHouchi%26aufirst%3DH.%26aulast%3DIshimura%26aufirst%3DY.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DT.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DMinakuchi%26aufirst%3DK.%26aulast%3DTamaki%26aufirst%3DT.%26atitle%3DEffect%2520of%2520evodiamine%2520on%2520catecholamine%2520secretion%2520from%2520bovine%2520adrenal%2520medulla%26jtitle%3DJ.%2520Med.%2520Invest.%26date%3D1997%26volume%3D44%26spage%3D79%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span> </span><span class="NLM_article-title">Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells</span> <span class="citation_source-journal">Metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2FS0026-0495%2899%2990241-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=10599984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFKlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1532-1535&author=H.+Linauthor=S.+C.+Tsaiauthor=J.+J.+Chenauthor=Y.+C.+Chiaoauthor=S.+W.+Wangauthor=G.+J.+Wangauthor=C.+F.+Chenauthor=P.+S.+Wang&title=Effects+of+evodiamine+on+the+secretion+of+testosterone+in+rat+testicular+interstitial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells</span></div><div class="casAuthors">Lin, Ho; Tsai, Shiow-Chwen; Chen, Jiann-Jong; Chiao, Yu-Chung; Wang, Shyi-Wu; Wang, Guei-Jane; Chen, Chieh-Fu; Wang, Paulus S.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1532-1535</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Evodiamine, a bioactive component isolated from the Chinese medicine Wu-chu-yu, exhibits vasodilative and antianoxic action.  Although evodiamine indeed has many biol. effects, its effects on the endocrine system are not clear.  The present study explored the effects of evodiamine on testosterone secretion in vitro.  Rat collagenase-dispersed testicular interstitial cells (TICs) were incubated with evodiamine (0 to 10-4 mol/L) in the presence or absence of human chorionic gonadotropin (hCG), forskolin, 8-bromo-adenosine 3':5'-cyclic monophosphate (8-Br-cAMP), or steroidogenic precursors (including 25-hydroxycholesterol, pregnenolone, progesterone, 17α-hydroxyprogesterone, and androstenedione) at 34° for 1 h.  The testosterone concn. in the media samples was measured by RIA.  Evodiamine 10-4 mol/L was effective to reduce both basal and hCG-stimulated testosterone secretion in rat TICs after 1, 2, and 4 h of incubation.  The stimulatory effect of forskolin on testosterone release in TICs was prevented by administration of evodiamine.  Evodiamine 10-4 mol/L also decreased 8-Br-cAMP- and androstenedione-stimulated testosterone secretion.  These results suggest that evodiamine reduces testosterone secretion in rat TICs via a mechanism involving reduced activity of cAMP-related pathways and 17β-hydroxysteroid dehydrogenase (17β-HSD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPLvcqWNq3SbVg90H21EOLACvtfcHk0lj4eKcXcGm1CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFKlsrw%253D&md5=dc76a4fb28a26ba146d6ca82b7d5b479</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2899%2990241-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252899%252990241-X%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DH.%26aulast%3DTsai%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DChiao%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BF.%26aulast%3DWang%26aufirst%3DP.%2BS.%26atitle%3DEffects%2520of%2520evodiamine%2520on%2520the%2520secretion%2520of%2520testosterone%2520in%2520rat%2520testicular%2520interstitial%2520cells%26jtitle%3DMetabolism%26date%3D1999%26volume%3D48%26spage%3D1532%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshikuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, T.</span><span> </span><span class="NLM_article-title">Capsaicin-like anti-obese activities of evodiamine from fruits of <i>Evodia rutaecarpa</i>, a vanilloid receptor agonist</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2001&pages=628-633&author=Y.+Kobayashiauthor=Y.+Nakanoauthor=M.+Kizakiauthor=K.+Hoshikumaauthor=Y.+Yokooauthor=T.+Kamiya&title=Capsaicin-like+anti-obese+activities+of+evodiamine+from+fruits+of+Evodia+rutaecarpa%2C+a+vanilloid+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DKizaki%26aufirst%3DM.%26aulast%3DHoshikuma%26aufirst%3DK.%26aulast%3DYokoo%26aufirst%3DY.%26aulast%3DKamiya%26aufirst%3DT.%26atitle%3DCapsaicin-like%2520anti-obese%2520activities%2520of%2520evodiamine%2520from%2520fruits%2520of%2520Evodia%2520rutaecarpa%252C%2520a%2520vanilloid%2520receptor%2520agonist%26jtitle%3DPlanta%2520Med.%26date%3D2001%26volume%3D67%26spage%3D628%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Chiou, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shum, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span> </span><span class="NLM_article-title">Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/doi/10.1021/np960495z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=708-711&author=W.+F.+Chiouauthor=Y.+J.+Sungauthor=J.+F.+Liaoauthor=A.+Y.+Shumauthor=C.+F.+Chen&title=Inhibitory+effect+of+dehydroevodiamine+and+evodiamine+on+nitric+oxide+production+in+cultured+murine+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fnp960495z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp960495z%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DW.%2BF.%26aulast%3DSung%26aufirst%3DY.%2BJ.%26aulast%3DLiao%26aufirst%3DJ.%2BF.%26aulast%3DShum%26aufirst%3DA.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BF.%26atitle%3DInhibitory%2520effect%2520of%2520dehydroevodiamine%2520and%2520evodiamine%2520on%2520nitric%2520oxide%2520production%2520in%2520cultured%2520murine%2520macrophages%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1997%26volume%3D60%26spage%3D708%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. S.</span><span> </span><span class="NLM_article-title">Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=44-56&author=S.+F.+Kanauthor=C.+H.+Yuauthor=H.+F.+Puauthor=J.+M.+Hsuauthor=M.+J.+Chenauthor=P.+S.+Wang&title=Anti-proliferative+effects+of+evodiamine+on+human+prostate+cancer+cell+lines+DU145+and+PC3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKan%26aufirst%3DS.%2BF.%26aulast%3DYu%26aufirst%3DC.%2BH.%26aulast%3DPu%26aufirst%3DH.%2BF.%26aulast%3DHsu%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DP.%2BS.%26atitle%3DAnti-proliferative%2520effects%2520of%2520evodiamine%2520on%2520human%2520prostate%2520cancer%2520cell%2520lines%2520DU145%2520and%2520PC3%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D101%26spage%3D44%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Yang, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205)</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=924-933&author=Z.+G.+Yangauthor=A.+Q.+Chenauthor=B.+Liu&title=Antiproliferation+and+apoptosis+induced+by+evodiamine+in+human+colorectal+carcinoma+cells+%28COLO-205%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BG.%26aulast%3DChen%26aufirst%3DA.%2BQ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DAntiproliferation%2520and%2520apoptosis%2520induced%2520by%2520evodiamine%2520in%2520human%2520colorectal%2520carcinoma%2520cells%2520%2528COLO-205%2529%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D924%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Kobayashi, Y.</span><span> </span><span class="NLM_article-title">The nociceptive and anti-nociceptive effects of evodiamine from fruits of <i>Evodia rutaecarpa</i> in mice</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=425-428&author=Y.+Kobayashi&title=The+nociceptive+and+anti-nociceptive+effects+of+evodiamine+from+fruits+of+Evodia+rutaecarpa+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26atitle%3DThe%2520nociceptive%2520and%2520anti-nociceptive%2520effects%2520of%2520evodiamine%2520from%2520fruits%2520of%2520Evodia%2520rutaecarpa%2520in%2520mice%26jtitle%3DPlanta%2520Med.%26date%3D2003%26volume%3D69%26spage%3D425%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Chiou, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shum, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span> </span><span class="NLM_article-title">The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1016%2F0014-2999%2892%2990039-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=1327805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK38XksVSis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=1992&pages=277-283&author=W.+F.+Chiouauthor=C.+J.+Chouauthor=A.+Y.+Shumauthor=C.+F.+Chen&title=The+vasorelaxant+effect+of+evodiamine+in+rat+isolated+mesenteric+arteries%3A+mode+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries:  mode of action</span></div><div class="casAuthors">Chiou, Wen Fei; Chou, Cheng Jen; Shum, Andrew Yau Chik; Chen, Chieh Fu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">277-83</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The roles of the endothelium, Ca2+ and K+ fluxes in the evodiamine-induced attenuation of vascular contractile responses to vasoactive agents were examd.  The results showed that: (1) in rat mesenteric artery rings, evodiamine elicited a concn.-dependent attenuation in the contractile response generated by phenylephrine.  The inhibitory potency was greater for intact than for endothelium-denuded prepns.  Thus, the vasodilator action of evodiamine appeared to be partially endothelium-interactive (dependent).  (2) Evodiamine pretreatment had a greater inhibitory effect on the phenylephrine-induced tonic contraction (via Ca2+ influx) than on the phasic contraction (via Ca2+ release).  In addn., evodiamine more potently inhibited the restoration by CaCl2 of contractile responses to phenylephrine than a potassium depolarizing soln. in media that had been kept calcium-free.  These results suggest that block of the Ca2+ influx through receptor-mediated Ca2+ channels may be the major mechanism underlying the vasodilator effect of evodiamine.  (3) A K+ channel blocker, tetraethylammonium, almost completely abolished the vasodilatation induced by minoxidil (a known K+ channel opener) but no evodiamine.  The possible involvement of K+ channel activation of the vasodilator effect produced by evodiamine was therefore excluded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPa3bmNnmaz7Vg90H21EOLACvtfcHk0lgOVQyWk8yv9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XksVSis7o%253D&md5=f542d494562c74600bc0f006d2d4dd1b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2892%2990039-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252892%252990039-7%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DW.%2BF.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DShum%26aufirst%3DA.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BF.%26atitle%3DThe%2520vasorelaxant%2520effect%2520of%2520evodiamine%2520in%2520rat%2520isolated%2520mesenteric%2520arteries%253A%2520mode%2520of%2520action%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D215%26spage%3D277%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Tsai, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. C.</span><span> </span><span class="NLM_article-title">Thermoregulatory effects of alkaloids isolated from Wu-chu-yu in afebrile and febrile rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=293-298&author=T.+H.+Tsaiauthor=T.+F.+Leeauthor=C.+F.+Chenauthor=L.+C.+Wang&title=Thermoregulatory+effects+of+alkaloids+isolated+from+Wu-chu-yu+in+afebrile+and+febrile+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DT.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BF.%26aulast%3DChen%26aufirst%3DC.%2BF.%26aulast%3DWang%26aufirst%3DL.%2BC.%26atitle%3DThermoregulatory%2520effects%2520of%2520alkaloids%2520isolated%2520from%2520Wu-chu-yu%2520in%2520afebrile%2520and%2520febrile%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1995%26volume%3D50%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm100387d&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgOVQyWk8yv9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Thomsen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, M. H.</span><span> </span><span class="NLM_article-title">MolDock: a new technique for high-accuracy molecular docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3315</span><span class="NLM_x">–</span> <span class="NLM_lpage">3321</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051197e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFyiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3315-3321&author=R.+Thomsenauthor=M.+H.+Christensen&title=MolDock%3A+a+new+technique+for+high-accuracy+molecular+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">MolDock: A New Technique for High-Accuracy Molecular Docking</span></div><div class="casAuthors">Thomsen, Rene; Christensen, Mikael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3315-3321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this article we introduce a mol. docking algorithm called MolDock.  MolDock is based on a new heuristic search algorithm that combines differential evolution with a cavity prediction algorithm.  The docking scoring function of MolDock is an extension of the piecewise linear potential (PLP) including new hydrogen bonding and electrostatic terms.  To further improve docking accuracy, a re-ranking scoring function is introduced, which identifies the most promising docking soln. from the solns. obtained by the docking algorithm.  The docking accuracy of MolDock has been evaluated by docking flexible ligands to 77 protein targets.  MolDock was able to identify the correct binding mode of 87% of the complexes.  In comparison, the accuracy of Glide and Surflex is 82% and 75%, resp.  FlexX obtained 58% and GOLD 78% on subsets contg. 76 and 55 cases, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwtjNdC1qG7Vg90H21EOLACvtfcHk0lhB6_lDD8lKPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFyiu7w%253D&md5=e800cc1d47cb87d896ba080067faaaff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm051197e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051197e%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DR.%26aulast%3DChristensen%26aufirst%3DM.%2BH.%26atitle%3DMolDock%253A%2520a%2520new%2520technique%2520for%2520high-accuracy%2520molecular%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3315%26epage%3D3321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm100387d&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm100387d&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+docking+using+a+Lamarckian+genetic+algorithm+and+empirical+binding+free+energy+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0lhB6_lDD8lKPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520docking%2520using%2520a%2520Lamarckian%2520genetic%2520algorithm%2520and%2520empirical%2520binding%2520free%2520energy%2520function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S. A</span><span> </span><span class="NLM_article-title">Semiempirical free energy force field with charge-based desolvation</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1145-1152&author=R.+Hueyauthor=G.+M.+Morrisauthor=A.+J.+Olsonauthor=D.+S.+A+Goodsell&title=Semiempirical+free+energy+force+field+with+charge-based+desolvation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%2BA%26atitle%3DSemiempirical%2520free%2520energy%2520force%2520field%2520with%2520charge-based%2520desolvation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2007%26volume%3D28%26spage%3D1145%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I','PDB','1T8I'); return false;">PDB: 1T8I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1K4T','PDB','1K4T'); return false;">PDB: 1K4T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SCU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SCU','PDB','1SCU'); return false;">PDB: 1SCU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SC7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SC7','PDB','1SC7'); return false;">PDB: 1SC7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1TL8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1TL8','PDB','1TL8'); return false;">PDB: 1TL8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i49"><a href="/doi/suppl/10.1021/jm100387d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51334"></div></div></div></div></div><hr /></hr><p class="last">Computational details and results of docking methods validation and molecular dynamic simulations; Tanimoto similarity indices between purchased compounds and camptothecin; results of TopoI inhibitory activity for hits at lower concentrations. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100387d/suppl_file/jm100387d_si_001.pdf">jm100387d_si_001.pdf (231.07 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100387d&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm100387d" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100387d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac088def63d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
